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Brucellosis at a livestock / human / wildlife interface in South Africa: 
understanding the epidemiology and control. 
 
by Gregory Simpson 
 
Summary 
 
Brucellosis is seen as a neglected zoonosis that affects a wide variety of species. This 
research focuses on a South African “One Health” setting where there are wildlife, 
domestic animals and humans existing in close proximity. There are five studies to this 
research, the first is a systematic review of brucellosis in wildlife in Africa, which revealed 
that evidence for Brucella infection was found serologically in sixty-one wildlife species 
and identified the Brucella species (Brucella abortus, Brucella melitensis, Brucella suis 
and Brucella inopinata).  
 
This research then took an in-depth look into the epidemiology of the Brucella infection at 
a human, domestic animal and wildlife interface in Eastern South Africa in a site that we 
saw as an example of a communal livestock ranching setting in the proximity of wildlife in 
Africa. Besides B. abortus infection, we identified B. melitensis infection in buffalo 
(Syncerus caffer) in the Kruger National Park. Yet, we found low serological evidence of 
infection cattle and goats and none in dogs and humans. The goats were deemed to not 
be infected by confirmatory tests (indirect enzyme-linked immunosorbent assay (iELISA) 
and brucellin skin test). The dogs were all classified negative by the RBT. The cattle were 
found to have a low serological prevalence (1.4%), decreasing serology with age and 
significantly less males positive than females, which is not indicative of a wildtype B. 
abortus infection. This indicated the serological positives could be due to residual vaccine 
antibodies, which was supported by our inability to identify the organism when doing 
further focused testing with serology, brucellin skin test and culture.  
 
This led us to conduct a longitudinal cohort study to investigate the immune response to 
the state regulated “high dose” Strain 19 vaccination of heifers between 4 – 8 months. 
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We found a comprehensive and rapid serological response that peaked at 2 weeks for 
Rose-Bengal test (RBT) and 10 weeks for indirect Enzyme-Linked Immunosorbent Assay  
(iELISA). The response declined more sharply with RBT compared to iELISA (5% RBT 
positive and 17% iELISA positive between 10 and 14 months after vaccination). We found 
evidence of an immunological response four and a half years after vaccination. This 
serological persistence can, as hypothesized, interfere with disease control methods 
using serology for identification of infected animals. To reduce the risk of cross-reaction 
with disease surveillance and given the low incidence observed, a more appropriate 
vaccination method for this setting maybe a “low dose” or a subconjunctival means of 
administration, although it could be challenging to restrain heifers sufficiently in this 
setting for this type of administration.  
 
These research outcomes are of significant relevance to disease control authorities trying 
to focus limited resources on brucellosis control in similar settings. The infected wildlife in 
close proximity is a risk to both humans and domestic animals. The identification of B.  
melitensis for the first time in buffalo in Africa is of significance as this suggests a spillover 
from a reservoir species, most likely small stock species, although it could have been 
from another unknown infected wildlife species. Yet, we found that the domestic animals 
and therefore their products at this site were free of Brucella infection and thus currently 
not a risk to the humans. Our research showed the effectivity of the vaccination program 
in eliciting an immune response in this African “One Health” setting, suggesting that the 
induced herd immunity would protect animals in the case of the introduction of a wild type 
B. abortus strain.  
 
Future research in these settings should study the epidemiology of brucellosis in wildlife 
further, ideally with genetic testing of the bacteria to identify the sources and transmission 
of Brucella spp. between species, and other vaccination protocols in cattle that result in 
less serological persistence and therefore interfere less with herd disease categorisation.  
  
4 
 
Articles Information 
 
The following chapters of the results have been published: 
 
Chapter 3 
Documenting the absence of brucellosis in cattle, goats and dogs in a “One Health” 
interface in the Mnisi community, Limpopo, South Africa 
Gregory Simpson, Tanguy Marcotty, Elodie Rouille, Nelson Matekwe, Jean-Jacques 
Letesson, Jacques Godfroid: Documenting the absence of brucellosis in cattle, goats and 
dogs in a “One Health” interface in the Mnisi community, Limpopo, South Africa. Tropical 
Animal Health and Production 12/2017; 50(4)., DOI:10.1007/s11250-017-1495-1 
 
Chapter 4 
Investigation of brucellosis in humans and human risk factors at a human-wildlife-
livestock interface in Mpumalanga Province, South Africa 
Gregory J.G. Simpson, Vanessa Quan, John Frean, Darryn L. Knobel, Jennifer Rossouw, 
Jacqueline Weyer, Tanguy Marcotty, Jacques Godfroid, Lucille H. Blumberg: Prevalence 
of Selected Zoonotic Diseases and Risk Factors at a Human-Wildlife-Livestock Interface 
in Mpumalanga Province, South Africa. Vector Borne and Zoonotic Diseases 04/2018;, 
DOI:10.1089/vbz.2017.2158 
 
Chapter 5 
Immunological response to Brucella abortus strain 19 vaccination of cattle in a communal 
area in South Africa 
Gregory J.G. Simpson, Tanguy Marcotty, Elodie Rouille, Abel Chilundo, Jean-Jacques 
Letteson, Jacques Godfroid: Immunological response to Brucella abortus strain 19 
vaccination of cattle in a communal area in South Africa. Journal of the South African 
Veterinary Association 03/2018; 3(1)., DOI:10.4102/jsava.v89i0.1527 
 
The following published article is in the appendix as it gives background 
information to the study: 
5 
 
 
Amanda M. Berrian, Jacques van Rooyen, Beatriz Martínez-López, Darryn Knobel, 
Gregory J.G. Simpson, Michael S. Wilkes, Patricia A. Conrad: One Health profile of a 
community at the wildlife-domestic animal interface, Mpumalanga, South Africa. 
Preventive Veterinary Medicine 08/2016; 130:119-128., 
DOI:10.1016/j.prevetmed.2016.06.007 
See appendix I. 
 
The following chapter of the results has been submitted: 
 
Chapter 1 
Brucellosis in wildlife in Africa: a systematic review and meta-analysis 
 
The following chapter of the results is ready to be submitted: 
 
Chapter 2 
Isolation and identification of Brucella melitensis in buffalos in the Kruger national park 
  
6 
 
TABLE OF CONTENTS  
 
ABBREVIATIONS ........................................................................................................... 9 
ACKNOWLEDGEMENTS ............................................................................................. 11 
INTRODUCTION ........................................................................................................... 12 
Aetiological agents of brucellosis ............................................................................... 12 
Pathogenesis of brucellosis ....................................................................................... 16 
Diagnosis of brucellosis ............................................................................................. 19 
Identification and typing ......................................................................................... 23 
Staining methods ................................................................................................ 23 
Culture ................................................................................................................ 23 
Nucleic acid recognition methods ....................................................................... 24 
Multilocus sequencing and Multiple loci VNTR analysis ..................................... 25 
Serological testing .................................................................................................. 26 
Buffered Brucella antigen tests (BAT) ................................................................ 27 
Complement fixation test (CFT) .......................................................................... 27 
Enzyme linked immunosorbent assay (ELISA) ................................................... 28 
Florescent polarisation assay (FPA) ................................................................... 28 
Serum agglutination test (SAT)........................................................................... 29 
Native hapten and cyctosol protein-based tests ................................................. 29 
Milk tests ................................................................................................................ 29 
Milk iELISA ......................................................................................................... 30 
Milk ring test (MRT) ............................................................................................ 30 
Test for cellular immunity ....................................................................................... 30 
Brucellin skin test (ST) ........................................................................................ 30 
Interferon gamma release assay (IGRA) ............................................................ 31 
Control of brucellosis ................................................................................................. 31 
Immunity against Brucella ...................................................................................... 31 
Brucella abortus strain 19 vaccine ...................................................................... 31 
Brucella abortus strain RB51 vaccine ................................................................. 32 
Brucella melitensis strain Rev 1 vaccine ............................................................ 33 
Brucellosis and the environment ................................................................................ 33 
Study site ................................................................................................................... 33 
RATIONAL STATEMENT AND OBJECTIVES .............................................................. 41 
RESULTS ...................................................................................................................... 42 
CHAPTER 1 .............................................................................................................. 43 
Brucellosis in wildlife in Africa: a systematic review and meta-analysis ..................... 43 
Abstract .................................................................................................................. 43 
Introduction ............................................................................................................ 44 
Materials and Methods ........................................................................................... 45 
Systematic review protocol ................................................................................. 45 
Literature search and data collection .................................................................. 45 
Inclusion criteria, quality control and data extraction .......................................... 46 
Statistical analysis .............................................................................................. 49 
Results ................................................................................................................... 51 
Epidemiology and disease control studies .......................................................... 51 
7 
 
Bacteriological studies ........................................................................................ 54 
Spatial distribution of prevalence study results ................................................... 55 
Statistical analysis of prevalence studies ........................................................... 56 
Univariate meta-analysis of prevalence .............................................................. 60 
Multivariable meta-regression of selected prevalence studies ........................... 66 
Discussion .............................................................................................................. 71 
Conclusion ............................................................................................................. 77 
CHAPTER 2 .............................................................................................................. 79 
Isolation and identification of Brucella abortus and B. melitensis in buffalos in the 
Kruger national park .................................................................................................. 79 
Abstract .................................................................................................................. 79 
Introduction ............................................................................................................ 79 
Methods ................................................................................................................. 80 
Results ................................................................................................................... 81 
Discussion .............................................................................................................. 81 
Conclusion ............................................................................................................. 82 
CHAPTER 3 .............................................................................................................. 84 
Documenting the absence of brucellosis in cattle, goats and dogs in a “One Health” 
interface in the Mnisi community, Limpopo, South Africa .......................................... 84 
Abstract .................................................................................................................. 84 
Introduction ............................................................................................................ 85 
Materials and Methods ........................................................................................... 87 
Research site ...................................................................................................... 87 
Study design ....................................................................................................... 88 
Disease diagnostics ............................................................................................ 91 
Data analysis ...................................................................................................... 92 
Ethics approval ................................................................................................... 93 
Results ................................................................................................................... 94 
Cattle .................................................................................................................. 94 
Goats .................................................................................................................. 97 
Dogs ................................................................................................................... 97 
Discussion .............................................................................................................. 98 
CHAPTER 4 ............................................................................................................ 101 
Investigation of brucellosis in humans and human risk factors at a human-wildlife-
livestock interface in Mpumalanga Province, South Africa ...................................... 101 
Introduction .......................................................................................................... 101 
Prevalence of selected zoonotic diseases and risk factors at a human-wildlife-
livestock interface in Mpumalanga Province, South Africa ...................................... 103 
Abstract ................................................................................................................ 103 
Introduction .......................................................................................................... 104 
Materials and methods ......................................................................................... 106 
Study site .......................................................................................................... 106 
Participant recruitment ...................................................................................... 108 
Laboratory methods .......................................................................................... 109 
Statistical analysis ............................................................................................ 112 
Ethical clearance .................................................................................................. 112 
8 
 
Results ................................................................................................................. 113 
Participant demographics and symptoms ......................................................... 113 
Clinical and laboratory findings ......................................................................... 113 
Article discussion ................................................................................................. 116 
Article conclusions ............................................................................................... 119 
Discussion ............................................................................................................ 121 
Conclusions ......................................................................................................... 122 
CHAPTER 5 ............................................................................................................ 123 
Immunological response to Brucella abortus strain 19 vaccination of cattle in a 
communal area in South Africa ................................................................................ 123 
Abstract ................................................................................................................ 123 
Introduction .......................................................................................................... 124 
Research methods and design............................................................................. 126 
Setting .............................................................................................................. 126 
Study design ..................................................................................................... 128 
Sampling .......................................................................................................... 128 
Serological testing ............................................................................................ 128 
Brucellin skin test (ST) ...................................................................................... 129 
Statistical analysis ............................................................................................ 129 
Results ................................................................................................................. 129 
Discussion ............................................................................................................ 132 
Limitations of the study ........................................................................................ 134 
Recommendations ............................................................................................... 135 
Conclusions ......................................................................................................... 136 
GENERAL CONCLUSIONS AND PERSPECTIVES ................................................... 138 
REFERENCES ............................................................................................................ 147 
APPENDICES ............................................................................................................. 166 
Appendix I ................................................................................................................ 166 
One Health profile of a community at the wildlife-domestic animal interface, 
Mpumalanga, South Africa ...................................................................................... 166 
 
  
9 
 
ABBREVIATIONS  
 
AFI Acute febrile illness 
AT Agglutination test 
BAT Buffered Brucella antigen test 
BPAT Buffered plate agglutination test 
CA Contagious abortion 
cELISA complement Enzyme-linked immunosorbent assay 
CFT Complement fixation test 
CFU Colony forming units 
CI Confidence interval 
DNA Deoxyribonucleic acid 
FPA Fluorescence polarisation assay 
FPSR False positive serological reaction 
GLTFCA Greater Limpopo transfrontier conservation area 
HHWRS Hans Hoheisen wildlife research station 
HIV Human immunodeficiency virus 
iELISA indirect Enzyme-linked immunosorbent assay 
IgA Immunoglobulin A 
IgG Immunoglobulin G 
IgM Immunoglobulin M 
IGRA Interferon gamma release assay 
IQR Interquartile range 
KNP Kruger national park 
LMIC Low to middle income countries 
LNN Lymph node 
LPS Lipopolysaccharide 
MCP 
MLST 
MLVA 
Mnisi Community Program 
Multilocus sequence typing 
Multiple loci variable number of tandem repeats analysis 
MRT Milk ring test 
10 
 
MVS Mpumalanga veterinary services 
MZN Modified Ziehl Nielsen  
OBP Oderstepoort Biological Products 
OPS O specific polysaccharide 
OR Odds ratio 
OVI Onderstepoort Veterinary Institute 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
RBT Rose bengal test 
S19 Strain 19 
SANP South African national parks 
SAT Serum agglutination test 
SLPS smooth lipopolysaccharides  
ST Brucellin skin test 
SVL Skukuza Veterinary Laboratory 
TFCA Transfrontier conservation area 
 
  
11 
 
ACKNOWLEDGEMENTS 
 
The study was funded by a grant from the Belgium Institute of Tropical Medicine through 
collaboration with the University of Pretoria, research funds from the University of Pretoria 
and the Swedish Civil Contingencies Agency (MSB) and Swedish International 
Development Cooperation Agency (SIDA) and by the Global Disease Detection Program. 
 
I wish to acknowledge the assistance of the Mpumalanga Veterinary Services and 
specifically the animal health technician Gypsey Mathumbo, environmental monitor 
Godfrey Tsela and veterinarians Drs Oupa Rikhotso and Bjorn Reininghaus. We thank 
Sr. Aletta Ennica Ntlemo for her hard work collecting the information and samples from 
patients and following them up and the staff of Gottenburg, Utha and Welverdiend Clinics, 
and patients and herders who volunteered for the study.  
 
This study would not have been possible without the facilities, staff and students of the 
Hans Hoheisen Wildlife Research Station and Hluvukani Animal Clinic. I also wish to 
acknowledge the support of the Veterinary Faculty, University of Pretoria, and importantly 
the Drs Henry Annandale, Richard Burroughs and Rebone Moerane who gave me the 
time to work on this research. The Department of Tropical Disease, in particular Dr 
Henriette van Heerden, has been instrumental to this research. My co-workers Dr Elodie 
Rouille, Dr Nelson Matekwe, Barbara Glover put in large amounts of work to help achieve 
these results. They are much appreciated.  
 
The Faculty of Science, University of Namur, and in particular Profs Jean-Jacques 
Letesson and Xavier De Bolle, have been fundamental for this research to come to 
completion, their contributions are greatly appreciated. This work would not have 
happened without the vision and perseverance of Prof Jacques Godfroid and Dr Tanguy 
Marcotty and for them I am eternally grateful. I am also very thankful for the contributions 
and criticism of the jury. 
  
12 
 
INTRODUCTION 
 
This manuscript represents a body of work on the epidemiology and control of brucellosis 
at a wildlife/livestock/human interface setting in a communal pastoral farming area in 
southern Africa. This is an example of a South African “One Health” setting, where 
humans, domestic animals and wildlife interact directly and indirectly and exist in close 
proximity.  
 
This introduction gives the background to the disease and the context relevant to the 
setting. In low and middle income countries (LMIC), with limited resources, control of the 
disease can be harder to achieve than upper income countries and greater awareness of 
its presence and the workings of cost effective control mechanisms will benefit brucellosis 
prevention, treatment and control in these resource limited settings.  
 
In the body of this thesis a systematic review and meta-analysis then collates the 
published information on brucellosis in wildlife in Africa. The work then investigates the 
disease in domestic animals, humans and wildlife at the study site. These investigations 
use a variety of diagnostic techniques to ascertain the absence or presence and 
identification of Brucella spp.  
 
We then investigate the immunological response to the vaccine at the study site that is 
used in heifers according to government regulations. This response has a confounding 
effect on using serology for disease diagnosis and control. Thereafter the conclusions 
and insights from all this work are discussed.  
 
Aetiological agents of brucellosis 
 
In 1860 Dr J.A. Maraston in Malta gave the first accurate description of brucellosis in 
humans calling it “Mediterranean gastric remittent fever”. In 1886 Dr David Bruce 
identified the responsible organism that was later to be called Brucella melitensis. 
Nineteen years later Dr Themistocles Zammit identified goats as the source of B. 
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melitensis. Brucellosis caused by bacteria of Brucella spp. is currently the commonest 
anthropozoonosis worldwide (Ariza et al. 2007) with significant economic, public health 
and veterinary importance (Pappas 2010). Since it’s identification over 120 years ago in 
humans it has been isolated in wide variety of animals and found to have a global 
distribution (Figure 1).  
 
 
Figure 1. Worldwide incidence of human brucellosis (Pappas et al. 2006) (Reprinted with 
permission from Elsevier). 
 
Brucella spp. are gram negative and facultative intracellular pathogens (Ghazaei 2016).  
The predominant pathological aetiological agents for humans are Brucella abortus (25% 
of cases) and B. melitensis (70% of cases) (Doganay et al. 1997), which are mainly 
carried by large and small ruminants respectively (Njeru et al. 2016). Over 500 000 human 
cases are estimated to occur annually (Pappas et al. 2006). There is also the other 
species B. suis, B. canis and B. ceti from animals that are known to infect humans (Figure 
2 & Table 1).  
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Figure 2. Phylogenetic relationships of the recognized Brucella species (Pappas 
2010)(Reprinted with permission from Elsevier). 
 
Table 1. A provisional Brucella spp. taxonomy with animal hosts and human disease 
(Pappas 2010; Marcotty et al. 2013; Godfroid et al. 2010; Whatmore et al. 2014) 
Species  Biovar Animal host  Human disease 
Old species  
  
B. melitensis  1-3 Sheep, goats, 
camels 
The most common cause of human 
brucellosis  
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B. abortus  1-6, 9 Cattle, buffalo, 
elk, yaks, camels 
The second most common cause of 
human infection 
B. suis  1,3 Domestic pigs  Pathogenic to humans 
B. suis 2 Wild boar Pathogenic to humans, of increasing 
interest with hunters of wild boar at 
risk 
B. suis 4 Reindeer, 
caribou 
Pathogenic to humans 
B. suis 5 Rodents Not reported 
B. canis  - Canines  Pathogenic to humans, increasing 
reports, particularly from South 
America, possibly understudied 
elsewhere 
B. ovis  - Sheep  Not reported 
B. neotomae  - Rodents  Pathogenic to humans 
Novel species  
  
B. ceti  - Porpoises, 
dolphins, whales  
Reports of complicated disease 
(neurobrucellosis, spondylitis) and 
one laboratory infection 
B. pinnipedialis  - Seals Not reported 
B. microti  - Red foxes, 
common voles 
(also isolated 
from soil)  
Not reported 
B. inopinata  - Human  Isolated from a human case 
(prosthetic breast implant infection) 
B. papionis  Baboons Not reported 
 
The lipopolysaccharide (LPS) on the surface of the Brucella bacteria is the most important 
virulence factor, antigenic and immunogenic structure (Kianmehr et al. 2015). It has three 
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domains: lipid A, the core oligosaccharide and the O-antigen / chain (Figure 2) (Cardoso 
et al. 2006). The LPS structure divides the Brucella species into two groups based on 
colony morphgology: smooth (S-LPS), which have a O-antigen, and rough (R-LPS), 
without an O-antigen (Cardoso et al. 2006). The smooth group includes B. abortus, B. 
melitensis, B. suis and the rough includes B.ovis and B. canis (World Organisation for 
Animal Health 2016). 
 
 
Figure 2. The structure of lipopolysaccharide of Brucella spp. (Cardoso et al. 2006) (Open 
access). 
 
Pathogenesis of brucellosis 
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Brucellosis in humans can lead to severe disease characterised by fever, malaise, 
anorexia, arthralgia and back ache (Doganay et al. 1997); however often it presents 
atypically with non-specific symptoms, making it difficult to diagnose (Corbel 2006). There 
is a lack of a clear clinical algorithm that is predictive for brucellosis, which highlights the 
need for diagnostic and epidemiological information (Njeru et al. 2016). In Africa, acute 
febrile patients with brucellosis are often undiagnosed and treated for malaria (Njeru et 
al. 2016). Human brucellosis is considered a neglected disease (Pappas 2010; Marcotty 
et al. 2009) with fewer than 10% of human cases being diagnosed, treated or reported 
(Mantur et al. 2007). There is no vaccine available for humans. 
 
Brucella spp. are well adapted to their hosts, they successfully bypass the bactericidal 
effects of phagocytes. The bacteria enters the body by ingestion, inhalation, penetration 
of intact skin, abrasions or conjunctival mucosa (Doganay et al. 1997). When ingested, 
the gastric environment is not favourable to the bacteria, providing some protection from 
infection, but once into the circulatory system the serum only has moderate anti-Brucella 
properties (Doganay et al. 1997). Neutrophils destroy some strains, but lack activity 
against B. melitensis. Virulent Brucella organisms can infect phagocytic and non-
phagocytic cells where they reproduce in the endoplasmic reticulum and resulting in 
expansion and transmission to new cells (Doganay et al. 1997). Brucella spp. infection in 
humans results in formation of granulomas of epitheliod, polymorphonuclear leukocytes, 
lymphocytes and giant cells (Doganay et al. 1997). This is more characteristic of B. 
abortus than B. melitensis and B. suis.  
 
Brucellosis is a systemic disease that can involve any organ system. It can be 
symptomatic or asymptomatic. Osteoarticular localisations are the most common 
complication in humans and the most severe is cardiac that results in bacterial 
endocarditis and death (Doganay et al. 1997).  
 
The main sources of Brucella spp. for humans are animal products such as milk, meat, 
cheese, etc. and animal urine, blood and abortion material (Doganay et al. 1997). B. 
abortus in cattle spreads to humans through infected milk and contaminated tissue 
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(Mcdermott & Arimi 2002). Brucellosis in cattle can lead to abortion, lower milk production, 
infertility and hygromas and abscesses (Corbel 2006; J Godfroid et al. 2005). Bulls 
generally do not become functionally infertile, but their semen quality maybe affected and 
the semen can be infected (Bercovich 2000). 
 
In pregnant animals B. abortus has a predilection for the gravid uterus of cattle. It localizes 
and replicates in the rough endoplasmic reticulum of the trophoblastic epithelium (Figure 
3) (Detilleux 1989). This cell invasion and replication results in cell death leading to 
placentitis and abortion (Detilleux 1989).  
 
 
Figure 3. Electron micrograph of B. abortus located in cisternae of vero cell (Detilleux 
1989) (Reprinted with permission from American Society for Microbiology). 
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Diagnosis of brucellosis 
 
Diagnosis of infection and disease in humans and other animals is through a combination 
of history of exposure, clinical signs, serological responses, isolation and ideally 
identification. A combination of growth characteristics, serological, bacteriological or 
molecular methods are required for species distinction (World Organisation for Animal 
Health 2016; Cardoso et al. 2006). There are a variety of laboratory tests and each has it 
pros and cons (Table 2). Antigen isolation and identification is the most definitive as 
positive animals are shown to be infected by the bacteria. Yet, antigen isolation and 
identification is too costly and time consuming for routine surveillance. They are suitable 
for a smaller number of individuals to identify the organism and confirm what is shown by 
the other testing methods when an outbreak is suspected in a population.  
 
Table 2. Tests methods available for Brucella abortus, melitensis and suis and their 
appropriate purposes (World Organisation for Animal Health 2016)(Open access). 
 
 PURPOSE 
TEST Population 
free from 
infection 
Individual 
free from 
infection* 
Used in 
parallel for 
eradication*
* 
Confirmation 
of suspect or 
clinical 
cases*** 
Surveillance 
of herd/flock 
prevalence 
Antigen test      
Staining  - - - + - 
Culture - - - +++ - 
PCR - - - -/++ - 
Serological 
test 
     
BAT (RBT or 
BPAT) 
+++ ++ +++ + +++ 
FPA ++ ++ + ++ ++ 
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CFT ++ ++ +++ ++ +++ 
iELISA +++ ++ +++ ++ +++ 
cELISA ++ + + + ++ 
SAT ++ + + - + 
NH and 
cytosol protein 
based tests 
- - + ++ - 
Milk tests +++ - +++ + +++ 
Cellular test      
BST ++ - + +++ ++ 
Legend: +++ = recommended method, ++ = suitable method, + = maybe used but 
application limited, - = not applicable. * this applies to herds/flock, countries or regions 
free from infection. ** to improve efficacy of eradication policies in infected herds/flocks it 
is advisable to use tests in parallel eg BBAT or FPA and CFT or iELISA and sensitivity is 
increased by adding BST. ***in low prevalence settings or almost free setting the 
predictive value of a serological positive will be low and agent identification is needed. 
Abbreviations: BAT-buffered Brucella antigen test, FPA- Fluorescence polarization 
assay, CFT- complement fixation test, iELISA-indirect Enzyme linked immunosorbent 
assay, cELISA-competitive Enzyme linked immunosorbent assay, SAT- Serum or slow 
agglutination test, MRT- milk ring test, BST- Brucellin skin test.  
 
Humoral immunity responds to the exposure of an antigen that results in a primary and a 
secondary immune response. The primary response occurs the first time an antigen is 
encountered and the responding cells are naïve B or T cells and results in memory cells 
highly specific for the antigen (Figure 4). Antibodies, mainly IgM are produced, usually in 
low numbers and production peaks by seven to ten days. In the secondary immune 
response the memory cells producing many times the amount of antibodies compared to 
the primary response. The antibodies in the secondary immune response are primarily 
IgG, but also IgM and IgA. The antibody levels in the secondary immune response remain 
higher for longer and have a higher affinity for the antigen.  
 
21 
 
 
Figure 4. Primary and secondary immune response showing responsive immune cells 
and antibody production over time (Abbas, Abul, Lichtman, Andrew, Pillai 2011)( 
Reprinted with permission from Elsevier). 
 
An infection with Brucella spp. induces both a humoral and a cellular immunity. The 
humoral antibodies appear to play a role in resistance to Brucella spp and the cell-
mediated immunity appears to be the principal mechanism of recovery (Doganay et al. 
1997). Identifying antibodies to Brucella spp. is an easier and more economical than 
isolation and identification. Serological antibody testing is therefore more suitable for 
infection screening. Samples can be taken from animals without causing detriment and 
they are simple, quick and cheap testing methods that can be done at small district or 
regional laboratories. 
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In brucellosis serology, the Brucella immunodominant antigens are associated with the 
surface “smooth” lipopolysaccharide (S-LPS) which is shared by all the naturally occurring 
“smooth” Brucella species. Besides being 100% sensitive and 100% specific, an ideal 
serological test should make it possible to differentiate infectious animals from infected or 
exposed ones. Unfortunately, such a test does not exist. Brucellosis serology has other 
drawbacks, among which is the impossibility to ascribe which Brucella species induced 
antibodies in the host and the impossibility (per definition) to detect “latent” infection, 
defined as a seronegative Brucella-infected animal. 
 
There are differing sensitivities and specificities between the available tests and this must 
be taken in to account interpreting results (Table 3). In infected populations a positive 
serological result should be considered as confirmation in a clinical case and if there are 
no clinical signs the animal should be considered infected (World Organisation for Animal 
Health 2016). In low prevalence or almost free regions serological reactions must be 
confirmed by culture, PCR or ST and in free regions suspect animals must be positive to 
a screening and confirmatory serological test and may be confirmed by culture, PCR or 
ST (World Organisation for Animal Health 2016). There are standard operating 
procedures for disease status recognition for countries or compartments provided by the 
World Organisation for Animal Health.  
 
Table 3. Sensitivity and specificity of indirect tests for the diagnosis of cattle brucellosis 
(Godfroid et al. 2010)(Open access). 
TEST Sensitivity % Specificity % 
Serological test   
BAT  87 97.8 
FPA 96.6 99.1 
CFT 90-91.8 99.7-99.9 
iELISA 97.2 97.1-99.8 
cELISA 95.2 99.7 
SAT 81.5 98.9 
Milk tests 
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MRT 88.5 77.4 
FPA 76.9 100 
iELISA 98.6 99 
Cellular test   
BST 78-93 99.8 
Legend: Abbreviations: BAT-buffered Brucella antigen test, FPA- Fluorescence 
polarization assay, CFT- complement fixation test, iELISA-indirect Enzyme linked 
immunosorbent assay, cELISA-competitive Enzyme linked immunosorbent assay, SAT- 
Serum or slow agglutination test, MRT- milk ring test, ST- Brucellin skin test.  
 
Identification and typing 
 
Identification of the Brucella spp. bacteria can be through a combination of staining to 
identify organism morphology, colony growth with associated characteristics and 
morphology and urease and oxidase tests where they stain positive (World Organisation 
for Animal Health 2016).  
Staining methods 
Brucella coccobacilli are normally arranged singly, non-motile, without spores or true 
capsules, no flagella or pili and their morphology is fairly constant (Figure 4) (World 
Organisation for Animal Health 2016). They are gram negative and are resistant to 
decolourisation to weak acids and therefore stain red with a blue background with Stamps 
modification of the Ziehl-Neelsen’s method (Alton et al. 1988). A fluorochrome or 
peroxidase-labelled antibody conjugate based technique could also be used (World 
Organisation for Animal Health 2016). Weakly acid fast intracellular organisms of Brucella 
morphology is presumptive evidence of brucellosis (World Organisation for Animal Health 
2016).   
 
Culture 
Culture can provide a definitive identification of bacterial species. Samples for culture can 
be collected from tissues (placenta, foetus, inguinal lymph nodes and epidydimus), 
vaginal discharge, milk, dairy products and hygroma. Tissues are cut into small pieces 
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and macerated with a small amount of sterile PBS before being added to culture media. 
Bacterial isolation is slow, expensive and cumbersome, although often not considered 
sensitive, but should be done to confirm the disease and determine the species/biovar 
(World Organisation for Animal Health 2016). Isolation and culture is usually done on solid 
media. Antibiotics are added to supress growth of organisms besides Brucella spp. 
Adding CO2 to the atmosphere (5-10%) helps the culture of all Brucella spp. but is not 
needed for growth of B. melitensis or B. ovis (World Organisation for Animal Health 2016). 
Biovar identification or biotyping needs more complicated tests such as phage lysis and 
agglutination with anti-A, -M or –r monospecific sera (World Organisation for Animal 
Health 2016). Different biovars can have different preferred hosts so knowing the biovar 
can help understanding the epidemiology of an infection. Identifying the biotype is only 
relevant for smooth colonies of B. abortus, B. melitensis and B. ovis.  
  
Vaccine strains can also be identified by their growth characteristics in culture (World 
Organisation for Animal Health 2016). B. abortus S19 has growth properties of B. abortus 
bv1, does not need CO2, does not grow in benzyl-penecillin, thionin blue nor erythritol and 
uses L-glutamate, while Rev 1 vaccine grows like B. melitensis, but has smaller colonies, 
does not grow with fuschin, thionin, nor benzyl-penecillin, does not grow in streptomycin 
and B. abortus strain RB51 is different from smooth B. abortus biovar 1 as it has a rough 
morphology (Alton et al. 1988). 
 
Nucleic acid recognition methods 
 Polymerase chain reaction 
The polymerase chain reaction (PCR) is another method to detect and identify Brucella 
spp. Even though there is a degree of DNA homology within the Brucella genus methods 
such as PCR, PCR restriction fragment length polymorphism, Southern blot, field gel 
electrophoresis have been developed to identify different species and biovars (Bricker 
2002; World Organisation for Animal Health 2016). A new multiplex PCR (Bruce ladder) 
that can identify and differentiate most biovars (B. abortus bv. 3, 5, 6, 9 and B. suis bv 2, 
3, 4, 5) and vaccine strains (B. abortus S19 and RB51 and B. melitensis Rev 1) has been 
developed (World Organisation for Animal Health 2016). Another new multiplex PCR can 
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differentiate other Brucella organisms (B. suis, B. canis and B. microti), the vaccine strains 
and the marine species. The new PCRs are better than the first PCRs (e.g. AMOS) that 
could not identify all the biovars. There are other methods such as single nucleotide 
polymorphism, multilocus sequencing scheme that provide more information at the 
subspecies level (World Organisation for Animal Health 2016).  
 
Multilocus sequencing and Multiple loci VNTR analysis 
Multilocus sequencing has become the major approach applicable to studying the global 
epidemiology of bacteria and is also frequently used for phylogenetic studies. In its 
classical form multilocus sequence typing (MLST) involves the sequencing of short 
fragments (c. 500 bp) of a number of housekeeping genes which are subject to purifying 
selection and slow evolution and within which variation is nearly neutral. Nine discrete 
genomic loci corresponding to 4,396 bp of sequence were examined from 160 Brucella 
isolates. By assigning each distinct allele at a locus an arbitrary numerical designation 
the population was found to represent 27 distinct sequence types (STs) (Whatmore et al. 
2007). 
 
Multiple loci variable number of tandem repeats analysis (MLVA) uses the tandemly 
repeated DNA sequences to identify Brucella spp. on selected and characterised loci and 
can be used to trace the source of a particular strain, which can be useful for outbreak 
analysis. After amplification repetition can be analysed and the results compared to 
references to identify the spp,. type and possibly source of the bacteria. This technique 
has identified 21 loci with over 100 sequence types for the whole Brucella spp. population 
structure (Vergnaud et al. 2018).  
Both MLVA and MLST can assess genetic diversity of Brucella strains and identify newly 
emerged or atypical isolates as novel species, which is not possible on phenotypic 
characterization alone (Scholz & Vergnaud 2013). They are both robust and accurate and 
may replace the classical phenotyping scheme of Brucella spp. and biovar (Vergnaud et 
al. 2018). 
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Serological testing  
 
Unfortunately, there is not one serological test that is appropriate in all situations as all 
tests have limitations especially when screening individual animals (World Organisation 
for Animal Health 2016). Vaccination with smooth Brucella spp. and infection with Yersinia 
enterocolita O:9 and other bacteria may create false positive reactions which interferes 
with accurate serological diagnosis (World Organisation for Animal Health 2016).  
 
Serum agglutination tests (SAT) are generally regarded as being unsatisfactory for 
international trade, while the complement fixation test (CFT) is more specific and has a 
standardised system of unitage, but some enzyme linked immunosorbent assays 
(ELISAs) and the fluorescent polarisation assay are comparable to or better than the CFT 
with regards to diagnostic performance (World Organisation for Animal Health 2016). 
Different serological tests also react to different antibodies and so their results can 
depend on the antibody levels at the time of testing. Antibody IgM is produced first 
followed by IgG (Figure 5) and IgA , but IgG1 can appear simultaneously with IgM 
(Bercovich 2000).  
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Figure 5. Outcome of serum or slow agglutination test and enzyme linked immunosorbent 
assay tests performed at different times post-infection (Godfroid et al. 2010)(Open 
access). 
 
Below are the most commonly used serological diagnostic tests. OIE standardised 
reference sera should be used for tests requiring reference sera.  
 
Buffered Brucella antigen tests (BAT) 
Rose Bengal test (RBT) 
This test produces an agglutination using a B. abortus S99 or S11119-3 antigen stained 
with a sodium salt called rose Bengal, which detects IgG1 and to a lesser extent IgM and 
IgG2 (Bercovich 2000). A positive result shows agglutination of antigen and antibody. It is 
very sensitive, but can give false positive serological reaction (FPSR) due to S19 or Rev 
1 vaccination or other reasons so therefore it should be used with a confirmatory test 
(World Organisation for Animal Health 2016). RBT rarely produces false negative 
serological reaction. It is a simple and cheap test that can be done in a resource limited 
setting, which makes it ideal for screening cattle, sheep and goats in low to middle income 
countries (Ducrotoy & Bardosh 2017), to detect infected herds or guarantee absence of 
infection (World Organisation for Animal Health 2016).  
 
Buffered plate agglutination tests (BPAT) 
This test uses an antigen from B. abortus S11119-3 and two staining solutions of brilliant 
green and crystal violet. Like the RBT, it is a sensitive screening agglutination test for 
cattle.  
 
Complement fixation test (CFT) 
This test, although complex and needing good laboratory facilities and staff, is widely 
performed (World Organisation for Animal Health 2016). Accurate titration and 
maintenance of reagents is needed. It detects IgM and IgG1 antibodies (Bercovich 2000) 
and enables the distinction between antibodies of vaccination and infection (Fensterbank 
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1986). The serum, antigen and complement are incubated resulting in antigen antibody 
complexes that bind to added complement protein, which stops the solution turning pink 
when sheep red blood cells with pre-bound antibodies are added (World Organisation for 
Animal Health 2016). The test can be quantified by setting up a series of dilutions of the 
sample serum to determine the highest dilution that will still yield a positive result. Animals 
vaccinated with S19 or Rev 1 are considered to be infected if they give a positive fixation 
result at a titre of 30 or greater at 18 months old or older (World Organisation for Animal 
Health 2016). It is deemed very specific, but less sensitive than RBT and ELISA (Alton et 
al. 1975).  
 
Enzyme linked immunosorbent assay (ELISA) 
Indirect ELISA (iELISA)  
There are numerous variations of iELISA for antibody detection using different antigen 
preparations, antiglobulin-enzyme conjugates and substrate chromogens (World 
Organisation for Animal Health 2016). B. abortus S19 or S1119-3 or B. melitensis S16M 
can be used for antigens and whole cells, smooth lipopolysaccharide (S-LPS) or O 
specific polysaccharide (OPS) can be used as the antigens (World Organisation for 
Animal Health 2016). 
Competitive ELISA (cELISA) 
There are also several variations of cELISA for antibody detection using S-LPS or OPS 
as antigens from smooth Brucella strains, different antiglobulin-enzyme conjugates, 
substrate or chromagens (World Organisation for Animal Health 2016). The use of a 
monoclonal antibody (Mab) specific for one of the epitopes of the Brucella spp., which 
competes with antibodies from vaccination and infections of cross reacting bacteria 
(Ducrotoy & Bardosh 2017), usually results in less FPSR and is higher in specificity than 
BAT and iELISA, but tends to have less sensitivity (Muñoz et al. 2005).  
 
Florescent polarisation assay (FPA) 
The FPA is a simple and rapid test measuring antigen and antibody interaction using an 
OPS of B. abortus 1119-3 conjugated with a fluorescein isothiocyanate. The antibody 
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attaches to the antigen complex and its rotation is measured by the rate of light 
depolarisation and compared to when there is no antibody attached (Nielsen & Gall 2001). 
It can be performed in the field and laboratories using a homogenous assay and portable 
equipment. The accuracy should be equal to or greater than the BPAT, FPA, iELISA and 
cELISA (Nielsen & Gall 2001). 
 
Serum agglutination test (SAT) 
The antigen is a suspension of B. abortus S99 or B. abortus S1119-3 in phenol and saline 
(World Organisation for Animal Health 2016). This is mixed with dilutions of serum and 
agglutination is measured. It is for cattle only and has been well used in northern Europe 
but requires incubation. It detects antibodies of IgM, IgG1, IgG2 and IgA, so can detect 
acute infections (Bercovich 2000). This test has contributed to international harmonisation 
of brucellosis control and eradication, however it can give false positive and false negative 
reactions, so it is better for detection on a herd rather than individual level (Bercovich 
2000). Cattle are considered infected when they test ≥ 30 international units (IU).  
 
Native hapten and cyctosol protein-based tests  
These test are valuable when used with RBT in cattle that have been vaccinated with S19 
(World Organisation for Animal Health 2016). They use a native hapten or Brucella 
cytosol that does not give FPSR due to Yersinia enterocolitica O:9, nor for heifers two 
months after vaccination and adults 4-5 months after vaccination (World Organisation for 
Animal Health 2016). Thus, in areas where S19 or Rev 1 vaccination occurs, this test can 
help differentiating antibodies due vaccination from those due to infection (World 
Organisation for Animal Health 2016). 
 
Milk tests 
 
Bulk milk testing is an efficient way to screen dairy herds that if showing positive reactions 
can then have individuals blood sampled for serological tests. They detect IgM and IgA 
bound to milk fat globules (Brothers et al. 2011) 
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Milk iELISA 
Several commercial variations of this test is available and they tend to give less FSPR 
than the blood test (World Organisation for Animal Health 2016). It could be used in sheep 
and goats, but the cut-off needs to be properly validated (World Organisation for Animal 
Health 2016). 
 
Milk ring test (MRT) 
This test is applicable to bovine milk. The antigen used is B. abortus S99 or S1119-3, 
which is added to a staining solution that makes a blue ring if positive above the milk 
column (World Organisation for Animal Health 2016). False positive reactions may occur 
if cattle are vaccinated within 4 months before testing or if there is colostrum or mastitis 
(World Organisation for Animal Health 2016).  
 
Test for cellular immunity 
Brucellin skin test (ST) 
An allergen is injected into the dermis and three days later in cattle or two days in goats 
the difference in skin thickness is measured, with a result greater than 1.1 mm increase 
being deemed positive (Saegerman et al. 1999). The ST measures the cell-mediated 
immune response as opposed to serological test that measure the humoral response 
(Godfroid et al. 2010). The brucellin skin test has such a high specificity such that positive 
unvaccinated animals that are serologically negative should be deemed positive (Pouillot 
et al. 1997). Yet, the test has been considered inadequate in the past due to the 
discrepancy that may occur between it and serological and bacteriological tests 
(Bercovich 2000). The brucellin is an LPS-free extract from rough B. melitensis B115, 
which does not result in antibodies reactive to serological tests (World Organisation for 
Animal Health 2009). However, as this rough strain contains Brucella OPS sugars, 
repeated inoculation of brucellin could elicit antibodies, interfering with other diagnostic 
tests (World Organisation for Animal Health 2016). The skin test response is less dramatic 
than when using the tuberculin antigen, but an allergic reaction in vaccinated animals 
could be detected up to four and a half years after vaccination and this test clearly 
excludes FPSR due to Yersinia enterocolitica O:9 (Saegerman et al. 1999).  
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Interferon gamma release assay (IGRA) 
This test involves stimulation of lymphocytes in whole blood with a brucellin antigen that 
results with gamma interferon production that is detected with ELISA (World Organisation 
for Animal Health 2016). It can be seen as a rapid and convenient alternative to the ST 
and complementary to serological diagnosis (Weynants et al. 1995) as it is a useful test 
to distinguish FPSR, but more specific antigens are needed and protocol improvement 
(World Organisation for Animal Health 2016).  
 
 
Control of brucellosis 
 
The control and eventually the eradication of B. abortus includes several measures (J 
Godfroid et al. 2005). Control in livestock is by systematic vaccination (Rock et al. 2009), 
testing for disease and slaughtering of animals deemed positive (Zhang et al. 2018). 
Methods to prevent transmission to humans include pasteurization, boiling of milk, 
avoiding contact with abortion material and use of protective materials (Mantur et al. 
2007). In South Africa, heifers between 4 and 8 months are vaccinated with 
Onderstepoort Biological Products Brucella abortus strain 19 vaccine (manufactured in 
Pretoria, South Africa). Males are not vaccinated because of the potential complication of 
orchitis (J Godfroid et al. 2005). 
 
Immunity against Brucella 
 
There are three commercially available vaccines for livestock. They are live cultures of 
Brucella spp. and can cause disease in humans.  
 
Brucella abortus strain 19 vaccine 
This smooth strain was first described in 1930, isolated from infected milk that was 
attenuated by being in room temperature for a year, and is the most widely used vaccine 
(Schurig et al. 2002). It is seen as the reference vaccine and this live attenuated vaccine 
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is normally given as single dose of 5-8 x 1010 colony forming units (CFU) or viable 
organisms subcutaneously to heifers between 3 and 6 months of age producing good 
immunity against B. abortus and B. melitensis (World Organisation for Animal Health 
2016). Although it is of low virulence for cattle it can cause abortions if used in pregnant 
cattle (Beckett & MacDiarmid 1985). A reduced dose of 3 x 108 to 5 x 109 CFUs can be 
given by subcutaneous to adult cattle, but may result in persistent antibody titres, abortion 
or excretion of the vaccine strain in milk (World Organisation for Animal Health 2016). A 
reduced dose given in conjunctival sac in one or two doses of 5 x 109 CFUs can be given 
at any age without these side effects (World Organisation for Animal Health 2016). The 
route of administration does not appear to affect the effectivity of the vaccine (Nicoletti 
1984).  
 
The presence of the LPS with an O chain results in the appearance and persistence of 
antibodies that are detected with serology making it difficult to differentiate vaccinated 
from infected cattle (Schurig et al. 2002).  
 
Brucella abortus strain RB51 vaccine 
This vaccine has become the official vaccine in several countries since 1996 although 
there is disagreement of its performance compared to S19 (World Organisation for Animal 
Health 2016). A dose of 1-3.4 x 1010 CFU of live attenuated vaccine is given to calves 
subcutaneously between 4 and 12 months, with either no follow-up dose or a follow-up 
dose at 12 months or a reduced dose of 1-3 x 109 CFU (World Organisation for Animal 
Health 2016). It can cause abortion if given to pregnant cattle, but using the reduced dose 
in pregnant animals should not induce abortion. The reduced dose in calves does not 
create adequate protection (World Organisation for Animal Health 2016). (Schurig et al. 
2002). It can also be safely used in mature males (Edmonds et al. 1999), unlike S19. This 
rough strain has almost no OPS and therefor does not induce antibodies causing FPSR 
to the standard tube agglutination tests as dose S19 (Schurig et al. 2002), but antibodies 
can be detected by ELISA for a few months post vaccination (Stevens, Olsen & Cheville 
1995). Experimentation in mice indicates that RB51 is able to protect against infections 
with B. abortus, B. melitensis, B. suis and B. ovis (Winter et al. 1996), but in cattle the 
33 
 
protection against B. melitensis is unknown (World Organisation for Animal Health 2016). 
This vaccine is not effective for B. melitensis in sheep (World Organisation for Animal 
Health 2016). Oral administration of this vaccine to cattle provided a degree of protection 
and opens the possibility of this mode of administration as a model for wild ungulates 
(Elzer et al. 1998).  
 
Brucella melitensis strain Rev 1 vaccine 
This live attenuated vaccine stimulates protection against infection with B. melitensis in 
sheep and goats and rams against B. ovis (Schurig et al. 2002). It can cause abortions if 
given during pregnancy, but is avirulent to rams (Schurig et al. 2002). There is still some 
discussion on the effectivity of the S19 vaccine against B. melitensis, but the Rev 1 may 
be able to control B. melitensis infection in cattle from small stock (World Organisation for 
Animal Health 2016).  
 
There is also no vaccination against brucellosis in humans and in wildlife, although some 
degree of protection has been documented by the use of RB51 in bison in the Greater 
Yellowstone Conservation Area, USA (Olsen et al. 2006). 
 
Brucellosis and the environment 
 
Brucella spp. are an environmental contaminant. They contaminate the environment 
through foetal materials (the highest concentrations of bacteria), milk and other tissues. 
The survival of the bacteria outside of the host’s body depends on environmental 
conditions, such as sunshine, and was found to be up to 60 days in water (Falenski et al. 
2011) and 21-81 days foetal membranes, soil and tissue in the Yellowstone National Park, 
USA (Aune et al. 2012).  
 
Study site 
 
In sub-Saharan Africa, cattle and small stock are widespread across the continent, with 
lower densities in arid (North and South-west) and forested zones (Central Africa) (Figure 
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6). In Eastern Africa the incidence of brucellosis in animals was found to be the highest 
in pastoral or communal production systems (Mcdermott & Arimi 2002). A study in 
Tanzania, where livestock and wildlife graze together and share water points and there 
is human consumption of buffalo bush meat, found anti-Brucella spp. antibodies in 0.6% 
of humans, 6.8% of cattle, 1.6% of goats and 7.9% of buffalos (Assenga et al. 2015). It 
would be interesting to look deeper into the epidemiology of brucellosis in such a setting 
to understand the risk of transmission between these three categories.  
 
The study site, in a Transfrontier Conservation Areas (TFCAs) in South-east Africa, has 
humans and their livestock living close to wildlife reserves. TFCAs are large areas 
covering multiple land uses, including protected conservation areas and one or more 
international boundaries (Anon 2018). TFCAs have humans, domesticated animals, and 
wildlife living in close proximity. Land adjacent to protected conservation areas commonly 
belongs to traditional authorities or is communal i.e. belongs to the local community and 
is used for housing, subsistence crop growing and grazing. Humans and animals often 
travel across protected conservation area boundaries that may or may not be fenced. The 
Greater Limpopo Transfrontier Conservation Area (Figure 7), which houses the study site, 
is the second largest TFCA in the world. It includes land in Mozambique, South Africa, 
and Zimbabwe (Figure 7) covering almost 100 000 square kilometres, with land uses 
ranging from core wilderness areas to communal areas and private nature reserves 
focused on wildlife utilisation (Cumming 2004).  
 
The study site includes the Kruger National Park (KNP) and communal land to the west 
of the KNP (Figure 8 and 9). The KNP has near 40 000 buffalo. Brucellosis 
seroprevalence in these buffalo is estimated to be 13-38% (Chaparro et al. 1990; Herr & 
Marshall 1981). Evidence of brucellosis infection has been serologically identified in 
several wildlife species including African buffalo (Syncerus caffer), hippopotamus 
(Hippopotamus amphibious), zebra (Equus burchelii), eland (Taurotragus oryx), 
waterbuck (Kobus elipsiprymnus), and impala (Aerpyceros melampus) (Chaparro et al. 
1990). African buffalos and wildlife are considered a possible source of infection for cattle 
in the nearby communal areas (Gradwell et al. 1977; Muma, Samui, et al. 2007). 
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Fig. 6. Cattle and small ruminant densities in Africa. Livestock density is expressed as the 
number of cattle or small ruminants per square kilometre according to categories of 
different sizes in order to clearly differentiate between zones of low and high livestock 
density (Ducrotoy et al. 2017)(Open access). 
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Figure 7. Map of the Great Limpopo Transfrontier Conservation Area with Great Limpopo 
Transfrontier Park and white ring showing research area (Peace Parks Foundation 2018). 
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Figure 8. The study site is in the Kruger National Park (dark green) and Mnisi communal 
land (orange). The base for the study is the Hluvukani Animal Health Clinic/Centre and 
the Hans Hoheisen Wildlife Research Station. (Courtesy of Dr L van Schalkwyk). 
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Figure 9. Mnisi communal land study site with diptanks (green flags). Image courtesy of 
Mnisi Community Programme, University of Pretoria. 
 
Brucella abortus is the most abundant zoonotic Brucella species in South Africa. Cattle 
are the main domestic reservoir of B. abortus in South Africa (Mcdermott & Arimi 2002). 
In the province neighbouring the study site, communal cattle were found to have a 
prevalence of 0-15.6% (Hesterberg et al. 2008).  
 
The Mnisi community (Figure 9), in our study, has 40 000 humans, 16 000 cattle, 3 500 
goats and about 4000 dogs. Communal rangeland farming is practiced (Figure 10), where 
the cattle and goats are housed at night and sent out to graze or browse during the day. 
There is limited animal husbandry infrastructure at the households (Figure 11), normally 
just fencing to keep the animals housed at night. Each village will have one to two diptanks 
(Figure 12), which are maintained by the provincial state veterinary services. The 
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diptanks, where the cattle go to weekly, have wooden races to examine the cattle in large 
numbers for foot and mouth disease. The races are also used for cattle management 
procedures such as blood sampling and vaccination. 
 
 
Figure 10. Veterinary students conducting a farmer questionnaire on disease control 
showing the extensive pastoral farming nature of the study site.  
 
40 
 
 
Figure 11. The most common method of restraint of cattle for examination and sampling 
at the study site is tying the horns to a pole. 
 
 
Figure 12. A cattle diptank is a focal point for farmer education and disease control and 
where most of the sampling of domestic animals was conducted in the study site.   
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RATIONAL STATEMENT AND OBJECTIVES 
 
Brucellosis is a neglected zoonosis according to the WHO and could be an important 
infection in “One Health” communities infecting numerous domestic and wild animal 
species and humans and a causing a significant health burden in humans and domestic 
animals that is going unnoticed. Communities living close to wildlife, with their domestic 
animals, might be at higher risk, than communities not near wildlife reservoirs.  
 
The goal of this research is to better understand the epidemiology and transmission 
patterns of Brucella infections in animals and humans of the Mnisi community and wildlife 
in the neighbouring Kruger National Park, which are both in the Greater Limpopo 
Transfrontier Conservation Area.  
 
This research is made up of five objectives (studies) to achieve this goal:  
1. To review the literature on brucellosis in wildlife in Africa to collate information on 
wildlife infection and potential reservoir to domestic animals and humans. 
2. To identify Brucella spp. infecting buffalo neighbouring the Mnisi community. 
3. To assess the presence of Brucella spp. infection in cattle and if present identify 
the organism causing brucellosis in cattle in the Mnisi community.  
4. To assess the presence of Brucella spp. infection in goats and dogs in the Mnisi 
community. 
5. To explore the prevalence of brucellosis in humans. 
6. To field test the Brucella abortus strain 19 vaccine using the current government 
vaccination protocol to monitor the emergence of specific antibodies and therefore 
understand the influence that may have on objective three above.  
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RESULTS 
 
The results and discussions are divided into five chapters.  
 
1. Chapter 1 is a systematic review and meta-analysis of brucellosis in wildlife in 
Africa. This review focuses on detection, isolation and prevalence studies of 
Brucella spp. in wildlife in Africa, but also includes control and prevention studies. 
 
2. Chapter 2 is an investigation into the detection and identification of brucellosis in 
buffalo in the wildlife park neighbouring Mnisi community.  
 
3. Chapter 3 refers to the studies on the detection, prevalence and isolation attempt 
of brucellosis in cattle and the detection studies in goats and dogs in the Mnisi 
community. These studies have been published.  
 
4. Chapter 4 is a serological detection investigation in humans in the Mnisi 
community. The studies are of sick individuals presenting with fever at three 
government clinics and high-risk healthy individuals presenting at the government 
diptanks for cattle inspection for foot and mouth disease. These studies have been 
published as a more diverse study into eight zoonotic diseases in humans. 
 
5. Chapter 5 is a study on the immunological response to S19 vaccination in case 
group of heifers versus a control group of male calves in the Mnisi community. This 
study has been published. 
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CHAPTER 1  
Brucellosis in wildlife in Africa: a systematic review and meta-analysis 
 
Abstract 
This study aims to consolidate current knowledge of wildlife brucellosis in Africa and 
analyse available predictors of infection. The Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses guidelines were followed searching the Web of Science, 
Scopus, Cochrane library, Africa-wide Info and Wildlife and Ecology Studies Worldwide 
databases and Google scholar website. Information on species, test used, test results, 
area, rainfall, livestock and wildlife contact and year of study data were extracted. The 
systematic review revealed 42 prevalence studies, 9 disease control articles and 6 articles 
on epidemiology. Brucella abortus, Brucella melitensis, Brucella inopinata and Brucella 
suis were reported in wildlife in nine different articles. The prevalence studies revealed 
serological evidence of brucellosis in buffalo, antelope (positive in 14/28 species), 
carnivores (4/12) and other species (7/20) over the last five decades. A meta-analysis 
was performed, after eight studies were removed due to irrelevant species or insufficient 
information, on the remaining 34 prevalence studies. Pooled prevalence was estimated 
using an inverse variance heterogeneity model and meta-regression to identify factors 
associated with seroprevalence was done using a zero-inflated negative binomial model. 
Buffalo populations were more likely to be infected and had a higher seroprevalence than 
other species; the pooled seroprevalence was 13.7% (95% CI: 10.3-17.3%) in buffalo, 
7.1% (95% CI: 1.1-15.5%) in carnivores and 2.1% (95% CI: 0.1-4.9%) in antelope. The 
pooled prevalence in the buffalo and antelope had a heterogeneity over 75%, which 
heterogeneity means the results must be interpreted with caution. There was a positive 
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prevalence association with high rainfall areas (≥800 mm) compared to low rainfall areas 
(<500 mm) and studies published after 2000 had a positive prevalence association 
compared to before 1980. Domestic animal contact was found to have an positive 
prevalence association in antelope and carnivore species, but not in buffalo, suggesting 
buffalo may be a reservoir species able to sustain Brucella infection without the influx of 
bacteria from other host species. These results may facilitate more appropriate selection 
of preventive and control measures against brucellosis at the wildlife/livestock/human 
interface. 
 
Introduction 
Brucellosis caused by Brucella spp. is a disease of significant economic, public health 
and veterinary importance. Since it’s identification over 120 years ago in humans it has 
been isolated in wide variety of animals and found to have a global distribution.  The 
predominant pathological aetiological agents in humans are Brucella abortus and Brucella 
melitensis, which are predominantly carried by large and small ruminants respectively.  
 
Brucellosis in wild animals in Africa has been documented in a variety of countries since 
the early 1960’s with serological studies and some Brucella isolations in many wildlife 
species (Bengis 1998).  Most studies have been serological prevalence surveys to try to 
better understand the epidemiological situation in wildlife, with the understanding that 
wildlife infected with Brucella spp. may have implications to domestic animals and 
humans.  
The objectives of this systematic review were to update our answers to the questions: 
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I. Which wildlife species have been exposed to brucellosis and where 
are they found? 
II. Which Brucella species are infecting wildlife species? 
III. Are wildlife species a brucellosis risk to domestic animals and vice-
versa? 
 
Materials and Methods 
Systematic review protocol 
The guidelines made by the Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) were followed.  
 
Literature search and data collection 
We searched the Web of Science (1910 - June 2017), Scopus (1823 - June 2017), 
Cochrane library (June 2017), Google Scholar (June 2017), Africa-wide Info (June 2017) 
and Wildlife and Ecology Studies Worldwide (June 2017).  We used the Boolean 
Operators “or” and “and” for our search and used the following terms, in free word test 
and topic or subject heading: 
I. “(Brucella OR brucellosis) AND  
II. (wildlife OR wild) AND  
III. Africa”. 
No time limits were set. The databases search revealed 304 articles. The Web of 
Science (237), Scopus (20), Cochrane library (0), Africa-wide info (42) and Wildlife and 
ecology studies worldwide (5) (Figure 1). 
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Inclusion criteria, quality control and data extraction 
The titles and abstracts or the full article were then screened by the primary author to 
ensure the following criteria: 
I. The article appeared in a peer-reviewed journal and books. 
Conference proceedings and lay-media were excluded, 
II. The article was for a study partially or fully conducted in Africa, 
III. The article referred to brucellosis or Brucella spp., 
IV. The article involved wildlife (undomesticated animals living in the 
wild), 
V. The article either provided information on prevalence, incidence or 
isolation of Brucella spp. or the article provided information on control, diagnosis, 
epidemiology or risk factors to brucellosis in wildlife in Africa. 
Duplicates removed 60 and screening with above criteria removed 193 articles. The 
remaining 51 articles, plus 6 added articles selected from references in the reviewed 
articles were separated into epidemiology and control (10) and bacteriological and 
prevalence (42) categories. The results were then analysed and reported in the results 
section. Bacteriological results were reported separately. 
 
The prevalence study articles were grouped and the detail of the articles was assessed 
as to whether they had the following requirements for the meta-analysis: 
I. The species, study sites, sample sizes and results were described 
II. The species were terrestrial mammals, excluding rodents 
III. Serology were done and test described 
IV. Risk factors for brucellosis infection had estimates of association. 
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Prevalence studies that did not meet the above requirements were not included in the 
meta-analysis. Eight of the above studies were removed before statistical analysis for the 
following reasons: the study was of fish (El-Tras et al. 2010), dolphins (Lane et al. 2014), 
rats (Salem et al. 1974), no sample sizes given (Condy 1968; Condy & Vickers 1969; Bell 
et al. 1977), no serological tests were done (Gradwell et al. 1977) and one study used a 
card test not used by any other study leaving 34 studies for the meta-analysis.  
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Fig 1. Flow diagram of study methodology 
 
 
 
 
  
Articles removed as not suitable for statistical model (n=8) 
Articles identified through searching databases 
(n=304) 
Remaining articles’ title and / or abstract and / or full text for 
screening (n=244) 
Duplicate articles removed (n=60) 
Full text records assessed for quality (n=51) 
 
Article excluded (n193) 
• Not wildlife (n=83) 
• Not journal (n=70) 
• Not Brucella spp. (n=12) 
• Not Africa (n=11)  
• Not relevant (n=15) 
• Not English (n=3) 
• Article not procured (n=2) 
Prevalence article (n=37) 
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49 
 
The remaining prevalence study articles had the following variable extracted for the 
statistical model: 
I. Location of study 
II. Rainfall extrapolated from place of study 
III. Livestock wildlife contact (none, low degree, high degree, unknown) 
IV. Species involved 
V. Number of animals 
VI. Years of study 
VII. Type of study 
VIII. Diagnostics used 
IX. Test results. 
 
The rainfall was calculated by using gridded mean annual precipitation data for the period 
~1970-2000 (Fick & Hijmans 2017) obtained at 10-minute spatial resolution from 
www.worldclim.org (accessed 22 Sep 2017). Annual rainfall was recorded as the cell 
value for the location of the study if reported, or the mean of all the cell values contained 
within the geographic extent of the study location. For protected areas, shapefiles were 
obtained from www.protectedplanet.net (accessed 22 Sep 2017) and spatial overlays 
performed in ArcGIS 10.2 (Esri, Redlands, CA).  
 
Statistical analysis  
Group data were used for analysis, where a group represented data for a particular 
species and location that could be identified from a publication. Some publications 
therefore yielded several groups, each of which was therefore regarded as a separate 
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study to be included in the meta-analysis. Meta-analysis of prevalence was done for all 
groups combined, as well as separately for each species category, using the double 
arcsine transformation (Barendregt et al. 2013) in an inverse variance heterogeneity 
model, implemented in the MetaXL 5.3 add-in for Excel (EpiGear n.d.). In this model, each 
study is weighted by the inverse variance of its prevalence estimate, but the variance of 
the pooled estimate is inflated to account for the heterogeneity (Doi et al. 2015). 
Heterogeneity of estimates was assessed using the Higgins I2 statistic (Higgins et al. 
2003), with I2>75% indicating high heterogeneity, and statistical significance of 
heterogeneity was assessed using the Cochrane’s Q statistic. In order to visually 
represent the data, multiple groups within a publication were aggregated and separate 
meta-analyses of prevalence were done for each species category. Assessment of 
potential publication or selective reporting bias was done using funnel plots, overall and 
by species category. 
 
To investigate the factors associated with variation in seroprevalence, i.e. heterogeneity, 
meta-regression was done using a zero-inflated negative binomial model. The number of 
animals tested was used as the exposure variable, thus adjusting for differences in 
sample size and also appropriately weighting each group in the meta-regression. The 
negative binomial component modelled the number of positive reactors (i.e. the 
seroprevalence within an infected population), while the inflation component accounted 
for the excess number of zero outcomes by modelling the odds of the outcome being zero 
(i.e. the population not being infected). Predictor variables assessed were species, year, 
annual rainfall, serological test used and the degree of contact with livestock. The model 
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was developed by backward elimination, with variables retained if significant (P<0.05) or 
if they acted as confounders. Due to the likely differing nature of the wildlife-livestock 
interface for different wildlife species categories, the interaction term between species 
and livestock contact was also assessed. Robust (Huber-Eicker-White-sandwich) error 
variances were used to account for clustering. The suitability of the negative binomial 
model compared to a Poisson model was assessed using a likelihood ratio test of the null 
hypothesis that the overdispersion parameter (α) equals zero. The fit of the zero-inflated 
negative binomial model compared to the regular negative binomial model was assessed 
using Akaike’s information criterion (AIC), with lower values indicating better fit. Meta-
regression analysis was done using Stata 15.1 (StataCorp, College Station, TX, U.S.A.) 
and significance was assessed at P<0.05. 
 
Results 
 
Epidemiology and disease control studies 
The five epidemiological articles (Bengis & Erasmus 1988; Worthington & Bigalke 2001; 
Eisenberg et al. 2012; Mühldorfer et al. 2017; Schiemann & Staak 1971) and five articles 
(Roy et al. 2011; Munag’andu et al. 2006; Ducrotoy et al. 2017; Muma et al. 2014; Bekker 
et al. 2012) with a focus on control covered a variety of topics. These articles come to the 
following conclusions. Dynamical modelling using compartment models for infected and 
susceptible hosts such as wildlife and livestock could be integrated into strategic disease 
surveillance to tackle disease control and understand the multi-host pathogen system for 
diseases such as West Nile virus, Rift Valley fever and brucellosis (Kathleen A Alexander 
et al. 2012). But, reservoir dynamics in wildlife populations are complex and often without 
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sufficient knowledge about the specific role of the species in maintaining the pathogen in 
the system (Kathleen A Alexander et al. 2012). A brucellosis network modelling study 
excluded wildlife because of the difficulty in parameterising wildlife-related transmission 
rates needed for compartment models and suggested these rates are better modelled as 
random quantities (Roy et al. 2011).  
 
Brucella abortus biovar 1 is reported to have limited impact on buffalo (Syncerus caffer) 
in the wild, even though it does cause abortions in buffalo (Worthington & Bigalke 2001). 
Few in utero deaths were found in more than 3000 pregnant buffalo culled and a 12-15% 
annual increase despite predation (Bengis & Erasmus 1988). Yet, in another study buffalo 
serologically positive for brucellosis had a lower body condition score, increased mortality, 
but did not affect fecundity and the population growth in infected herds was lower than 
uninfected herds (Gorsich et al. 2015).  
 
Brucellosis appears to be a disease that has moved from domestic animals to wildlife, 
without wildlife being a source to cattle (Bengis & Erasmus 1988). Yet, wildlife in Africa 
was later seen as contributing to the re-emergence of the disease (Bekker et al. 2012). 
Interaction between Kafue lechwe antelope (Kobus leche kafuensis) and cattle was seen 
as an important risk factor for increased brucellosis in Zambia (Muma et al. 2014). 
Brucellosis may have originated from cattle and it has been suggested that it has now 
established itself in Kafue lechwe antelope, which could become a reservoir for other 
animals (Muma et al. 2011). Black lechwe antelope (Kobus leche smithemani), currently 
uninfected could be easily infected if cattle move into their area (Muma et al. 2011). There 
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is a cautious statement that gregarious wildlife species such as buffalo, eland 
(Taurotragus oryx), impala (Aepyceros melampus) and wildebeest (Connochaetes 
taurinus) were found to have a higher seroprevalence than more solitary animals such as 
black (Diceros bicornis) and white (Ceratotherium simum) rhinoceros (Ducrotoy et al. 
2017). 
 
The creation of large landscapes under the transfrontier conservation initiatives have 
allowed sharing of ecological systems by humans, wildlife and domestic animals and may 
promote inter-species transmission of Brucella spp. (Ducrotoy et al. 2017). The presence 
of Brucella spp. in domestic animals and wildlife compounds the public health risk, 
especially to resource poor communities living in this ecological setting (Ducrotoy et al. 
2017). The control of brucellosis in domestic animals is key to reducing the risk to 
humans. Infected bush meat can be a risk to humans in shared ecosystems (Kathleen 
Anne Alexander et al. 2012). Yet, the control in wildlife is hardly practical (Ducrotoy et al. 
2017). Surveillance of wildlife may need to be added to routine domestic animal 
surveillance as wildlife could be a potential source of a direct source of infection for 
humans (Kathleen Anne Alexander et al. 2012). But, there is a need to investigate the 
performance of serological tests in wildlife (Ducrotoy et al. 2017). Atypical Brucella spp. 
have been found in frog species that are common in many parts of Africa and are used 
as human consumption as food or traditional medicine, indicating amphibians may play a 
bigger role in public health than thought (Mühldorfer et al. 2017). 
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Bacteriological studies 
There were nine studies found to detail the identification of Brucella spp. from across the 
continent (Table 1). They were from a variety of species including buffalo, antelope, rat, 
fish and frog.  
 
Table 1. Brucella spp. isolation studies in Africa with biovar, year of study, and country. 
Species Country Year Brucella Biovar Author 
Rodents Kenya 1963 B. suis 3 * (Heisch et al. 
1963) 
Buffalo (Syncerus 
caffer) 
Tanzania 1969 B. abortus 3 (Kaliner & 
Staak 1973) 
Impala (Aepyceros 
melampus) 
Tanzania 1971 B. 
melitensis 
1 (Schiemann 
& Staak 
1971) 
Wild rats Egypt 1974 B. abortus 3 (Salem et al. 
1974) 
Buffalo (Syncerus 
caffer) 
South 
Africa 
1977 B. abortus 1 (Gradwell et 
al. 1977) 
Waterbuck (Kobus 
ellipsiprymnus) 
Zimbabwe 1969 B. abortus 1 (Condy & 
Vickers 
1969) 
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Eland (Tragelaphus 
oryx) 
Zimbabwe 1972 B. abortus 1 (Condy & 
Vickers 
1972) 
Nile catfish (Clarias 
gariepinus) 
Egypt 2008 B. 
melitensis 
3 (El-Tras et 
al. 2010) 
African bullfrogs 
(Pyxicephalus 
edulis) 
Tanzania 2012 B. inopinata  (Eisenberg et 
al. 2012) 
Table 1 legend.  
* Possible misclassification because the species and the biovar were ascribed by 
phenotypic characterization only. 
 
Spatial distribution of prevalence study results 
The studies were predominantly in southern and eastern Africa. The most being in 
Zimbabwe (11), South Africa (9) and Tanzania (7) (Table 2).  
 
Table 2. Prevalence studies per country in decreasing order with associated region 
(according to the African Union). 
Country No of Studies Region 
Zimbabwe 11 Southern 
South Africa 9 Southern 
Tanzania 7 Eastern 
Zambia 4 Southern 
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Namibia 3 Southern 
Uganda 2 Eastern 
Kenya 2 Eastern 
Egypt 2 Northern 
Botswana 2 Southern 
Democratic Republic of Congo 1 Central 
Mozambique 1 Southern 
 
 
Statistical analysis of prevalence studies 
There were buffalo, 28 antelope, twelve carnivore and twenty other species tested for 
brucellosis in the selected prevalence studies (Table 4). The prevalence of positive results 
varied from zero to 100% but all the 100% positive studies only had one animal in the 
study. Buffalo had the greatest number of studies per species at 25, followed by 13 for 
impala, 11 for blue wildebeest (Connochaetes taurinus) and ten for giraffe (Giraffa 
camelopardalis). The studies used the RBT, the serum agglutination test, (SAT), the 
complement fixation test (CFT), indirect and competitive enzyme linked immunosorbent 
assays (ELISA) and the fluorescence polarization assay (FPA). The RBT and SAT were 
grouped in the analysis and labelled agglutination tests (AT). 
 
Table 4. Range of serological prevalence results and number of studies by species 
arranged in groups: buffalo, antelope, carnivores and all other species.  
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Buffalo 
No of 
studies 
Seroprevalence 
(%) 
Buffalo (Syncerus caffer) 25 0-53 
Antelope   
Blesbok (Damaliscus dorcas phillipsi) 1 0 
Bushbuck (Tragelaphus scriptus) 5 0-10 
Dik dik (Rhynchotragus kirkii) 1 0 
Duiker (Silvicapra grimmia) 2 0-2.7 
Eland (Taurotragus oryx) 8 0-27.3 
Gemsbok (Oryx gazella) 1 0 
Grant's gazelle (Nanger granti) 2 0 
Grysbok (Raphicerus sharpei) 1 4 
Hartebees (Alcelaphus buselaphus) 3 0 
Impala (Aepyceros melampus) 13 0-11.5 
Impala black faced (Aepyceros melampus 
petersi) 
1 0 
Klipspringer (Oreotragus oreotragus) 1 0 
Kudu (Tragelaphus strepsiceros) 8 0-3 
Lechwe (Kobus leche) 2 0 
Lechwe black (Kobus leche smithemani) 1 0 
Lechwe Kafue (Kobus leche kafuensis)  3 10-42.3 
Nyala (Tragelaphus angasi) 2 0 
Reedbuck (Redunca arundinum) 5 0 
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Roan (Hippotragus equinus) 3 0 
Sable (Hippotragus niger) 4 0-5.2 
Springbok (Antidorcas marsupialis) 3 0 
Steenbok (Raphicerus campestris) 3 0 
Suni (Nesotragus moschatus) 1 0 
Thomson's gazelle (Eudorcas thomsonii) 2 0-2.4 
Topi (Damaliscus korrigum) 2 2.3 
Tsessebe (Damaliscus lunatus) 5 0-11 
Waterbuck (Kobus ellipsiprymnus) 7 0-100 
Wildebeest blue (Connochaetes taurinus) 11 0-27.3 
Carnivores   
Bat-eared fox (Otocyon megalotis) 1 0 
Banded mongoose (Mungos mungo) 1 0 
Black-backed jackal (Canis mesomelas) 1 42.9 
Civets and genets (Viverridae) 2 0 
Genet Cat (Genetta genetta) 2 0 
Honey badger (Mellivora capensis) 1 0 
Leopard (Panthera pardus) 1 0 
Lion (Panthera leo) 5 0-50 
Serval (Felis serval) 1 0 
Spotted hyaena (Crocuta crocuta) 3 0-50 
White tailed mongoose (Ichneumia 
albicauda) 
1 0 
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Wild dog (Lycaon pictus) 1 33.3 
Others   
Antbear (Orycteropus affer) 2 0 
Baboon (Papio ursinus) 5 0-27 
Bottle nose & Indo-pacific humpback 
dolphin (Tursiops aduncus & Sousa 
plumbea) 
1 0 
Bushpig (Potamachoerus porcus) 1 0 
East African Hare (Lepus capensis) 1 0 
Elephant (Loxodonta africana) 6 0 
Giraffe (Giraffa camelopardalis) 10 0-100 
Hippopotamus (Hippopotamus 
amphibius) 
4 11.1-25.5 
Jumping hare (Pedetes surdaster) 1 0 
Nile catfish (Clarias gariepinus) 1 9.2 
Porcupine (Hystrix Africae-Australis) 1 0 
Primates (Papio spp., Cercopithecus 
spp.) 
1 0 
Rhinoceros white (Ceratotherium simum) 5 0 
Rhinoceros black (Diceros bicornus) 3 0-6.3 
Rockrabbit (Procavia capensis) 1 0 
Rodents (Pedetes, Lepus, Hystrix spp.) 1 0 
Spring hare (Pedetes capensis) 1 0 
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Tubulidentata or Antbears (Orycteropus 
spp.) 
2 0 
Warthog (Phacochoerus aethiopicus) 7 0-1.5 
Zebra (Equus burchelli) 9 0-100 
 
Univariate meta-analysis of prevalence 
The overall pooled estimate of seroprevalence in all wildlife species combined was 4.6% 
(95%CI: 2.2-7.4%), with high heterogeneity (I2=87%; P<0.001). Pooled estimates of 
seroprevalence were highest in buffalo and lowest in antelope, and heterogeneity was 
high in all species categories except in carnivores (Table 5). Overall, the study that had 
the greatest weight and influence in the analysis was the report by Madsen (1995) of 1920 
impala in Zimbabwe that all tested negative; omission of this study from the analysis 
resulted in a pooled prevalence estimate of 6.0% overall and 3.4% in antelope. 
 
Table 5. Pooled prevalence and heterogeneity estimates in a meta-analysis of prevalence 
of brucellosis in African wildlife species. 
    Heterogeneity 
Species 
No. of 
prevalence 
reports 
Pooled 
prevalence 
(%) 
95% CI Higgins’ I2 P-value 
Buffalo 65 13.7 10.3 - 17.3 82% <0.001 
Antelope 115 2.1 0.1 - 4.9 85% <0.001 
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Carnivores 19 7.1 1.1 - 15.5 28% 0.130 
Other 72 2.8 0.6 - 5.6 74% <0.001 
Total 271 4.6 2.2 - 7.4 87% <0.001 
 
Seroprevalences aggregated by publication and in chronological order, are shown for 
African buffalo in Fig 2a, for antelope species in Fig 2b, for carnivore species in Fig 2c 
and for other species in Fig 2d. The pooled prevalence and heterogeneity estimates 
shown in the forest plots differ slightly from those in Table 5 as sub-studies within a 
publication were combined.  
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Fig 2a. African buffalo 
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Fig 2b.  African wild antelope species 
 
Fig 2c. African wild carnivore species 
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Fig 2d. African wildlife species excluding buffalo, antelope and carnivores 
 
Figs 2a-d legend. Forest plot of Brucella seroprevalence in African buffalo (2a), African 
wild antelope species (2b), African wild carnivore species (2c) and African wildlife 
excluding buffalo, antelope and carnivores (2d) aggregated by publication, with weight 
contribution to pooled prevalence estimate, proportional to the inverse variance of each 
study’s prevalence estimate. Studies are shown chronologically from top to bottom. 
Squares show point estimates, with size of square indicating sample size; horizontal lines 
indicate 95% confidence intervals; diamond shows point estimate and 95% confidence 
interval for pooled estimate. I2 is the heterogeneity, indicating the proportion of variability 
between study results attributed to heterogeneity. Q is the Cochran’s statistic used to test 
the null hypothesis that I2=0.  
 
The funnel plot for all publications combined (Fig. 3) shows marked asymmetry, with lower 
precision, i.e. smaller, studies tending to show higher prevalence estimates. This is most 
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likely due to publication bias, with smaller studies showing “negative” results less likely to 
have been published. This was seen in all species categories except buffalo, where only 
very minor asymmetry was observed, suggesting that studies performed on buffalo were 
likely to be published irrespective of outcome. The plot also shows a large horizontal 
spread of points due to high heterogeneity. 
 
Figure 3. Funnel plot of published studies on Brucella seroprevalence in African wildlife 
showing study precision vs. transformed prevalence estimate.  
 
Fig 3 Legend 
Curved lines indicate cut-off for statistically significant difference (p<0.05) vs. pooled 
estimate (vertical line). 
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Multivariable meta-regression of selected prevalence studies 
In the zero-inflated negative binomial meta-regression model (Table 6), the count model 
assessed factors associated with seroprevalence within infected populations, while the 
inflation model assessed factors associated with the population being non-infected. 
Several factors were associated both with the likelihood of a population being infected 
and with the seroprevalence within infected populations. The significance of the 
overdispersion parameter confirmed the suitability of the negative binomial vs. Poisson 
model and the AIC of 804 vs. 841 for the negative binomial model confirmed the suitability 
of the zero-inflated model. Note that the odds ratios (OR) in the inflation model in Table 
6 refer to the odds of being negative, therefore their reciprocal, the odds ratios for being 
infected, are quoted in the summary below. In addition, the interaction between species 
and degree of livestock contact was significant in the count model (P=0.041), therefore 
the association of livestock contact with seroprevalence is shown separately for each 
species in Table 7. 
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Table 6.  Meta-regression model of factors associated with seropositivity to Brucella in 
published studies of African wildlife.  
Variable and 
category 
Parameter 
estimate 
95% 
confidence 
interval 
P-value 
Count model 
Count 
ratio* 
  
Species    
Buffalo 1† – – 
Antelope 0.42 0.25 - 0.68 0.001 
Carnivore 1.19 0.53 - 2.71 0.673 
Other 0.92 0.47 - 1.78 0.796 
Year    
<1980 1† – – 
1980-2000 1.38 0.84 - 2.28 0.208 
>2000 1.73 1.17 - 2.56 0.006 
Annual rainfall (mm)    
<500 1† – – 
500-599 1.25 0.84 - 1.85 0.271 
600-799 1.31 0.92 - 1.89 0.138 
≥800 1.82 1.10 - 3.02 0.019 
Serological test    
AT 1† – – 
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CFT 0.79 0.51 - 1.24 0.306 
ELISA 1.06 0.64 - 1.75 0.815 
FPA 0.36 0.19 - 0.68 0.001 
  
Inflation model Odds ratio‡   
Species    
Buffalo 1† – – 
Antelope 14.8 3.06 - 71.3 0.001 
Carnivore 62.7 3.23 - >103 0.006 
Other 43.8 6.18 - 310 <0.001 
Year    
<1980 1† – – 
1980-2000 2.26 0.43 - 11.8 0.334 
>2000 0.71 0.09 - 5.30 0.736 
Annual rainfall (mm)    
<500 1† – – 
500-599 0.25 0.03 - 1.82 0.171 
600-799 0.51 0.11 - 2.48 0.405 
≥800 0.07 0.00 - 0.91 0.043 
Serological test    
AT 1† – – 
CFT 3.45 0.77 - 15.4 0.104 
ELISA 6.03 1.21 - 29.9 0.028 
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FPA 0.73 0.06 - 8.47 0.802 
Table 6 legend.  
The AT (agglutination tests) are the RBT and SAT grouped together.  
α (overdispersion parameter) = 0.37 (95% CI: 0.21-0.66; P = 0.001); AIC = 804 
* Ratio of seroprevalence vs. reference category, within infected population 
† Reference category 
‡ Ratio of odds of population being non-infected vs. reference category 
 
Table 7.  Association between degree of livestock contact and seroprevalence to Brucella 
in different wildlife species categories 
Level of livestock 
contact 
Count 
ratio* 
95% 
confidence 
interval 
P-value 
Buffalo    
None 1† – – 
Low 0.92 0.49 - 1.71 0.781 
High 1.05 0.63 - 1.75 0.863 
Unknown 1.09 0.61 - 1.96 0.763 
Antelope    
None 1† – – 
Low 6.53 1.47 - 29.1 0.014 
High 10.9 2.37 - 50.4 0.002 
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Unknown 8.25 1.86 - 36.6 0.006 
Carnivore    
None 1† – – 
Low >103 >103 - >103 <0.001 
High >103 >103 - >103 <0.001 
Unknown 0.25 0.02 - 3.04 0.278 
Other    
None 1† – – 
Low 1.24 0.36 - 4.34 0.733 
High 0.17 0.03 - 0.96 0.045 
Unknown 2.68 1.16 - 6.20 0.021 
Table 7 legend.  
* Ratio of seroprevalence vs. reference category, within infected population 
† Reference category 
 
Buffalo populations were the most likely to be infected, with antelope (OR=0.07; 
P=0.001), carnivores (OR=0.01; P=0.006) and other species (OR=0.02; P<0.001) less 
likely to be infected. Within infected populations, antelope showed a lower seroprevalence 
than buffalo (OR=0.42; P=0.001). 
 
Seroprevalence appeared to increase over time, being significantly higher after 2000 than 
pre-1980 (OR=1.73; P=0.006). Although year was not significant in the inflation model 
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(P=0.137), it was retained as a confounder, and populations did tend to be more likely to 
test positive post-2000 than during 1980-2000 (OR=3.19; 95% CI: 0.90-11.3; P=0.071). 
 
Seroprevalence also had an association with rainfall; in areas with annual rainfall >800 
mm populations were more likely to be infected (OR=14.3; P=0.043) and the 
seroprevalence was higher (OR=1.82; P=0.019). 
 
The type of diagnostic test used was a significant source of variation in both components 
of the model (P=0.022); however, its inclusion was primarily in order to control for 
confounding. 
 
The degree of livestock contact was associated with seroprevalence in antelope and 
carnivore species (Table 8), with a high degree of contact associated with the highest 
seroprevalence in antelope (OR=10.9; P=0.001). However, this was not seen in buffalo 
or in other species. 
 
Discussion 
 
This systematic review and meta-analysis aimed to collate the knowledge on which 
African wildlife species have been exposed to brucellosis by which Brucella species and 
to what extent wildlife species are able to sustain Brucella infections. This review found a 
large number of wildlife species infected or showing serological evidence of exposure to 
Brucella spp. However, the ability to maintain a sustainable infection within a given wildlife 
species without exposure from other sources has often not been addressed and remains 
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to be studied. In addition, if a population sustains a Brucella infection it does not mean it 
will transmit if to other species as that depends on many factors such as whether 
abortions occur, behaviour during parturition and management practices. Consequences 
of infected wildlife for public health depends on prevalence of Brucella infection and 
presence of bacteria as well as human activities related to infected wildlife species such 
as hunting, dressing of carcasses, meat handling, consumption, wildlife sampling and 
management in more intensive settings. The need for understanding cost-effectiveness 
and economic implications of a control program in low to middle income countries was 
highlighted in this review (Zinsstag et al. 2016). Disease control focus must be given to 
where the greatest health benefit will be attained, this has also been highlighted in foot 
and mouth disease control (Souley Kouato et al. 2018). This is difficult for a Brucella 
reservoir wildlife species as there is no vaccine available for brucellosis in wildlife 
(Godfroid et al. 2010). 
 
Investigation of exposure to Brucella spp. in wildlife species is first done by serology. The 
RBT is a simple and reliable serological test recommended by the world organisation for 
animal health (OIE). However, when using it in wildlife, one is confronted with two 
problems interfering with the partly subjective reading of the agglutination, and these are 
likely to yield a biased result: 1) The presence of haemolysis (difficult for reading) and 2) 
fat (fat globules are wrongly identified as agglutinates) in the sera. Moreover, some false 
positive serological reaction can also be observed in agglutination tests (Erume et al. 
2016). Serological studies for which only RBT has been used should always be analysed 
with caution and RBT should rather be compared to ELISA results and if there are large 
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discrepancies between results in both tests, a chloroform/centrifugation cleaning up of 
sera should be performed prior to RBT testing (Godfroid et al. 2016).  
 
Although our meta-analysis allowed us to estimate a pooled prevalence for each species 
group, its primary aim was rather to assess the factors responsible for heterogeneity, i.e. 
the varying determinants of seropositivity within individuals as well as populations. The 
zero-inflated model allowed us to do this while correctly weighting the contribution of each 
study. The seroprevalence within infected populations was positively associated with 
studies after the year 2000 as compared to before 1980. This could be due to the disease 
spreading in wildlife populations recently, researchers focusing more on infected 
populations or it could be due to publication bias as studies with positive results are more 
likely to be published. The areas of higher rainfall, over 800mm, showed positive 
association with herds being infected with brucellosis and having a higher prevalence, 
which could be due the higher rainfall leading to an increased carrying capacity with a 
resultant increased transmission. Seropositivity in cattle in Zimbabwe was found to be 
progressively higher with increasing stocking density and herd size (Matope et al. 2010). 
In Uganda, a bimodal increase in prevalence was found in livestock associated with the 
rainfall seasons (Mwebe et al. 2011). This is thought to be due to the calving periods that 
occur during this time and hence the increased presence of bacteria due to parturition 
material and milk. It could also possibly be due to the fact that the bacteria survives longer 
in the environment in colder, wetter conditions with less sunlight as found in bison (Bison 
bison) in the USA (Aune et al. 2012).  This is worth bearing in mind from a disease control 
point of view.  
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Serological studies only inform on possible exposure to Brucella spp. In order to identify 
which Brucella species is responsible for seroconversion, isolation of Brucella spp. or its 
DNA identification is necessary. In this respect, it is worth mentioning that recently, 
besides Brucella abortus, B. melitensis has been identified infecting water buffalo 
(Bubalus bubalis) in Egypt (Hamdy & Zaki 2018) and buffalo in South Africa (Henriette 
Van Heerden, personal communication). The latter raises questions on the origin of the 
infection, its sustainability in buffalo, its spillover potential to other wildlife species and its 
importance for veterinary public health. Additionally, molecular analysis will inform on the 
origin, the epidemiology and the transmission of Brucella spp. within and between 
different species but the veracity of this information is dependant to the regular molecular 
typing of the circulating strains of Brucella spp. 
 
We found individual studies, which show proximity to wildlife reserves and porous nature 
of fences of wildlife reserves to be statistically significant risk factors for brucellosis in 
cattle (Enström et al. 2017; Ndengu et al. 2017). In our meta-analysis the livestock and 
wildlife contact was found to be positively associated with brucellosis infection in antelope 
and carnivore species and possibly other species, but not buffalo. This suggests that 
buffalo may be able to sustain B. abortus infections in infected herds without influx (inputs) 
from other sources. There has been a huge focus on buffalo due to other controlled 
diseases such as foot and mouth disease and tuberculosis for which they are also 
reservoir hosts. This particular scientific interest in buffalo may also explain why we found 
less evidence of publication bias for buffalo than in other species, i.e. in buffalo serological 
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results for Brucella were likely to be published irrespective of outcome, whereas in other 
species there was evidence that positive serological findings were more likely to be 
published than negative ones. 
 
One of the hallmarks of Brucella infection is host specificity or preference given that 
specificity is not absolute. There is ample information in the literature highlighting that 
different wildlife species have been exposed to Brucella spp. However, very few studies 
address the sustainability of Brucella infection in wildlife. i.e. the ability to maintain the 
infection within a wildlife species without any external source of bacteria from a reservoir 
host species. The wildlife species are reservoir species, while those that cannot sustain 
the infection without recurrent contact with an external source (usually a reservoir 
species) are called spillover species (Godfroid 2002).  It is of the utmost importance to be 
able to assess, in a given time, if a wildlife species is a reservoir or a spillover host as this 
has important implications for the control of the disease (Martin et al. 2011). Indeed, 
management/control measures should always be first implemented in reservoir species, 
not spillover species (Godfroid et al. 2013). In this respect, it is worth noting that the red 
deer (Cervus elaphus) is only a spillover host, rarely exposed to B. abortus infection in 
Europe, whereas the elk (Cervus canadensis) is considered to be a maintenance host in 
the Yellow Stone Greater Conservation Area and has nowadays replaced bison as a 
source of infection for cattle (Kamath et al. 2016). Spillback infection from elk to cattle is 
now of great concern and a cause of great controversy between wildlife managers, 
hunters and livestock owners. As there is currently no vaccine registered for wildlife 
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management options are currently based on spatio-temporal segregation between bison, 
elk and cattle (Kamath et al. 2016).  
 
There is strong evidence that buffalo is a reservoir host for B. abortus (Gorsich et al. 
2015). Although B. abortus infection has a significant impact on individual animals, it is 
not considered a direct threat to the sustainability of buffalo herds in Kruger National Park, 
South Africa (Gorsich et al. 2015; Bengis & Erasmus 1988). In a maintenance host like 
buffalo, higher herd infection rates and prevalences could be due to their herd dynamics 
of having large herds that maintain close contact within the group in comparison to other 
species. Tuberculosis, although a different disease, is seen to spread well between 
buffalo due to their social nature and large herd sizes, an average of 250 per herd in the 
Kruger National Park (Michel et al. 2006). This is likely to be the case for B. abortus 
infections too. It thus remains to be known if other wildlife species besides buffalo are 
maintenance hosts (as suggested for Kafue lechwe by Muma and Pandey (Pandey et al. 
1999)) and if as such they can be potential sources of infection for other wildlife and 
livestock species (Godfroid 2002).  
 
There could have been biases between studies analysed as there was not measurement 
conformity of contact between livestock and wildlife between the different studies. There 
were also assumptions made with regards to contact depending on the description of the 
study and place of the study sites. Ideally, in the future studies should be conducted with 
variables that could be compared easily e.g. distance between domestic and wildlife 
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species and settings well explained i.e. are there functioning fences between wildlife and 
domestic animals and what are the vaccination practices in livestock.  
 
Most of the publications were from southern and eastern Africa, which leaves gaps in the 
knowledge for the whole continent. Also, smaller studies showing negative serological 
results are less likely to be published, except in the case of buffalo. It would be of benefit 
for more negative studies and studies from western and northern Africa to be published 
to give a more complete understanding of the epidemiological situation on the African 
continent. There is also a large gap in knowledge of brucellosis in domestic and wild suids 
in Africa. Although, it is thought that Brucella suis is prevalent in suids in Africa, its 
isolation from suids in sub Saharan Africa has not been reported in the scientific literature. 
Interestingly, it has been reported in cattle (Menshawy et al. 2014) and swine (Ibrahim 
1996) in Egypt and in cattle in Zimbabwe (Ledwaba et al. 2014). Brucella suis is not a 
sustainable infection in cattle and the source of the infection has still to be identified in 
either domestic or wild/feral suids (Mathew et al. 2015; Fretin et al. 2013). In addition, the 
pig population distribution is influenced by religion taboos, which can partially explain the 
low numbers of isolation of B. suis in the Sahel countries. Lastly, new Brucella species 
have been described and the importance of Brucella exposure in marine mammals 
(Maurin 2005), ectotherms (such as frogs and fish (El-Tras et al. 2010; Eisenberg et al. 
2012)) and primates (such as baboons (Whatmore et al. 2014)) needs to be assessed in 
the African context. 
 
Conclusion 
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This systematic review highlights that exposure to Brucella spp. has been detected by 
serological studies in a wide variety of wildlife species and that brucellosis has been 
identified through culture in only a few wildlife species in Africa over the last five decades. 
The number of published studies on brucellosis in Africa has increased drastically since 
the year 2010, indicating a growing interest in research on brucellosis in wildlife. Although 
seroprevalences were higher in studies after the year 2000 compared to before the year 
1980, it is not possible to ascribe this to an actual true biological trend. Epidemiological, 
serological and bacteriological evidences support the fact that buffalo is a reservoir 
species, able to sustain B. abortus infection without influx from other sources. 
Consequently, livestock and wildlife contact was found to be positively associated with 
brucellosis exposure for antelope and carnivore species (spillover species), but not for 
buffalo (reservoir species). Buffalo herds are more likely to be infected than any other 
species and show higher prevalences. As population growth drives wildlife habitat loss 
and increased contact between domestic animals and wildlife, understanding brucellosis 
epidemiology in wildlife is of increasing importance. Future research on brucellosis in 
Africa should focus on deciphering which wildlife species can sustain Brucella infections 
and what are the drivers for sustaining infections. In this respect, the recent isolation of 
B. melitensis in buffalo raises new questions about its sustainability in buffalo populations 
and highlights the importance of Brucella isolation to be able to identify changes in the 
epidemiology of brucellosis in wildlife. 
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CHAPTER 2 
Isolation and identification of Brucella abortus and B. melitensis in buffalos in the 
Kruger national park 
 
Abstract 
 
Brucella spp.are known to infect a wide variety of domestic and wild animals globally. In 
Africa, serological studies overwhelm isolation studies, particularly for wildlife. The 
objective of this study is to isolate and identify Brucella spp. from buffalo (Syncerus 
caffer), the wildlife species found to have the highest brucellosis seropositivity in Africa. 
Opportunistic blood, tissue, amniotic fluid and milk samples were taken during the routine 
animal offtake operations in the Kruger National Park in South Africa.  Blood samples 
were collected from ninety-six buffalo, of which 22% (21/96) were Rose Bengal Test 
(RBT) positive. Colonies compatible with Brucella spp. were isolated from tissue samples 
of six RBT positive animals on Brucella selective media. DNA was extracted and Brucella 
DNA was detected by the genus-specific 16S-23S rDNA interspacer region PCR. Besides 
B. abortus, B. melitensis was identified by AMOS PCR and confirmed by the Bruce ladder 
PCR. This is the first-time that B. melitensis has been identified in buffalo in the Kruger 
National Park. We need further research, ideally genetic testing, to identify the source of 
the spillover of the bacterium or if the buffalo are reservoir hosts of B. melitensis. 
 
Introduction 
 
Brucellosis in wild animals in Africa has been documented since the early 1960’s with a 
variety of countries publishing serological studies and confirming positive isolations 
(Bengis 1998). Most brucellosis studies in wildlife have been serological surveys mainly 
to assess if wildlife infected with Brucella spp. may infect domestic animals (spillback) 
and humans.  
 
Very few studies reporting the isolation of Brucella spp. in wildlife in Africa have been 
published, with most being in the 1960’s and 1970’s. Isolation and identification of 
Brucella spp. is needed to understanding the epidemiology of the infection across the 
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wildlife/livestock/interface (Simpson et al. 2018; Godfroid et al. 2018). In mammals, 
Brucella abortus has been identified in buffalo in Tanzania (Kaliner & Staak 1973) and 
Kruger National Park (KNP), South Africa (Gradwell et al. 1977), waterbuck (Kobus 
ellipsiprymnus) (Condy & Vickers 1969) and eland (Tragelaphus oryx) in Zimbabwe 
(Condy & Vickers 1972), while B. melitensis has been isolated in impala (Aepyceros 
melampus) in Tanzania (Schiemann & Staak 1971) and B. suis in rodents in Kenya 
(Heisch et al. 1963). 
 
South Africa’s largest national park, KNP, has over 37 000 buffalo with a brucellosis 
seroprevalence in populations varying from 8.7 to 47.6% (Gorsich et al. 2015). African 
buffalos and wildlife are considered a possible source of infection for domestic animals in 
the nearby communal areas (Muma, Samui, et al. 2007) and vice-versa. The predominant 
zoonotic Brucella species in South Africa is Brucella abortus with cattle as the main 
reservoir (Mcdermott & Arimi 2002). However, recently Brucella melitensis has also been 
isolated in goats in South Africa (Ribeiro et al. 1990), sable (Kriek 2018) and recently in 
cattle (Kolo et al. 2018). Interestingly, a case of human B. melitensis infection has been 
reported in a patient in the Western Cape province, South Africa resulting in the exposure 
of staff members at two medical microbiology laboratories (Wojno et al. 2016).  
 
Methods  
 
The animal sampling was done during the routine animal offtake in the KNP in 2017, 
according to the standard operating procedures of the South African National Parks. 
Carcasses were inspected for any gross pathology. Samples (blood, lymphnodes, spleen, 
testes, amniotic fluid and milk samples from lactating cows) were also collected. Rose 
Bengal tests (RBTs) were performed as described (Alton et al. 1988) using standardised 
Brucella abortus antigen obtained from Onderstepoort Biological Product (OBP), South 
Africa. The RBT positive animals then had their tissue samples subjected to culture 
colonies on Brucella selective CITA agar (Vicente et al. 2014; World Organisation for 
Animal Health 2016). DNA was extracted from cultures, and the Brucella DNA was 
detected by the genus-specific 16S-23S rDNA interspacer region PCR (Keid et al. 2007), 
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identified by AMOS PCR (Bricker & Halling 1995) and confirmed by the Bruce ladder PCR 
(García-Yoldi et al. 2006). 
 
Results  
 
Out of 96 animals that were tested by RBT, 22 were classified positive. Tissue samples 
from six RBT positive animals, including a milk sample from a lactating cow, yielded 
Brucella suspected colonies on Brucella selective CITA agar. Besides Brucella abortus, 
B. melitensis was identified by AMOS PCR and confirmed by the Bruce ladder PCR. 
 
Discussion 
 
The brucellosis seropositivity of buffalo in this study (22%) is comparable to the 
prevalence reported previously in the KNP (Gorsich et al. 2015). Brucella abortus was 
first isolated in 1977 in buffalo in the KNP (Gradwell et al. 1977). This study reports for 
the first-time B. melitensis infection in buffalo in the KNP and has not been reported 
elsewhere in Africa. However it has been identified previously in impala in Tanzania 
(Schiemann & Staak 1971) and recently in sable antelope (Hippotragus niger) in South 
Africa (Kriek 2018). Brucella melitensis has recently been isolated in cattle in South Africa 
(Kolo et al. 2018). Scientific literature suggests that cattle are not reservoir hosts but 
spillover hosts of B. melitensis (Muma, Godfroid, et al. 2007; J Godfroid et al. 2013). This 
is likely to be the case for buffalo too since they belong to the same subfamily Bovinae 
as bovines (Bos taurus). Altogether, this suggests that there is a reservoir host for B. 
melitensis, likely in livestock, i.e. sheep and/or goats in South Africa.  
 
Brucella melitensis infection in goats was thought to have been eradicated in South Africa 
by 2002 (Emslie & Nel 2002). Following the human B. melitensis case reported in the 
Western Cape, South Africa, in 2016, it was noted that in 2014, the state veterinarian’s 
investigation revealed that two other people who had lambed goats on a nearby farm had 
become ill and were subsequently diagnosed with brucellosis, based on serological 
testing. Of the 100 goats sampled on the farm in question, 44 tested positive for Brucella 
spp. on serological testing. The farm was quarantined but no attempt was made to isolate 
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the Brucella spp. (Wojno et al. 2016). These facts indicate that B. melitensis has not been 
eradicated in South Africa. 
 
We thus hypothesize that B. melitensis has spilled over from its livestock reservoir to 
another livestock species (cattle) and to a wildlife species (buffalo), However, we cannot 
exclude that there may be an unknown B. melitensis infected wildlife species and that 
infection may have spilled over to buffalo. It is worth re-emphasizing that B. melitensis is 
the principal etiological agent of brucellosis in humans and is an important zoonotic 
disease with more than 500 000 new human cases per year.  
 
In October 2017, a technical report entitled “Revisiting Brucellosis in the Greater Yellow 
Stone Area (GYA)” was published by the US National Academies (National Academies 
of Sciences 2017). In its preface, the following is mentioned: “This report examines the 
changing dynamic of brucellosis in the GYA, providing a comprehensive update of what 
is new since the 1998 National Research Council report “Brucellosis in the Greater 
Yellowstone Area” and exploring various options for addressing the challenge of 
brucellosis disease management. Much has changed in the 19 years since the previous 
report. There is now clear evidence that transmission of B. abortus to domestic livestock 
in the GYA has come from infected elk, not bison, posing greater challenges for control 
of transmission to domestic species” and indicating that previous assumptions were 
incorrect. 
 
Conclusion 
 
Our findings provide new information on the epidemiology of brucellosis in buffalo. 
Besides B. abortus infection, B. melitensis infection has been identified in buffalo in the 
KNP. Brucella melitensis has likely spilled over from small stock, although we cannot 
exclude that other B. melitensis reservoir exists in other non-identified wildlife species. 
The fact that B. melitensis was cultured from buffalo milk, suggests that the infection could 
be transmitted in buffalo herds. There is thus a need to prevent B. melitensis spill over 
from livestock to buffalo populations to avoid B. melitensis infection in buffalo, or other 
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African wildlife species. We must fill the knowledge gaps in brucellosis infections at the 
wildlife/livestock interface in order to identify sources and transmission routes. We 
therefore call for action to decipher the epidemiology of B. melitensis infections in South 
African livestock. 
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CHAPTER 3 
Documenting the absence of brucellosis in cattle, goats and dogs in a “One Health” 
interface in the Mnisi community, Limpopo, South Africa 
 
Abstract 
 
This study examines the status of the world’s most common bacterial zoonoses caused 
by Brucella abortus and Brucella melitensis in cattle, goats and dogs in a communal 
rangeland farming community bordering wildlife reserves (with a buffalo B. abortus 
prevalence of 8.7-47.6%) in South Africa. Heifers aged 4 to 8 months are vaccinated 
against brucellosis with the live Strain 19 vaccine. 
 
An apparent prevalence of 1.4% (21/1470) was observed in cattle sampled in a random 
manner and tested with the Rose-Bengal test (RBT). All cattle in herds with one positive 
animal were then tested with RBT (17/416 = 4.1% positive) and indirect enzyme linked 
immunosorbent assay (iELISA) (35/416 = 8.4% positive). Nine seropositive animals (6 
RBT and iELISA positive and three only RBT positive) then had an intradermal Brucellin 
skin test and three were positive. The only skin test positive male was slaughtered and 
selected organs cultured for Brucella with negative results.  
 
The cattle results showed a low seroprevalence, a decreasing seroprevalence with age 
after four years in females and a significant difference between the males and females. 
These characteristics are contrary to a wild-type infection. This suggests that Brucella 
seropositivity in cattle is due to S19 vaccination in less than one-year-old females and not 
natural infections. This conclusion is reinforced by a negative tissue culture result of the 
slaughtered Brucellin skin test positive male and the absence of Brucella seropositivity in 
goats (1/593 RBT positive, but iELISA and skin test negative) and dogs (0/315), which 
can be seen as potential spill over hosts. The close proximity of brucellosis-infected 
wildlife has not infected the domestic animals in this setting with vaccination, fencing 
between domestic animals and wildlife and cloven hoofed animal movement control.  
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Introduction 
 
Transfrontier Conservation Areas (TFCAs) are large areas with land uses ranging from 
core wilderness areas and private nature reserves focused on wildlife utilisation to 
communal farming areas (Cumming 2004). In TFCAs the humans, domesticated animals 
and wildlife live in close proximity with the transfer of disease between different species 
of growing concern. Viral diseases such as rabies and foot and mouth disease have been 
shown to spill over from wildlife to domestic animals and bovine tuberculosis caused by 
Mycobacterium bovis has moved from cattle to a variety of wildlife species (Kock 2014). 
Another disease of public health importance is brucellosis, the world’s most common 
bacterial zoonosis with over half a million new human cases annually (Franco et al. 2007). 
Brucellosis has been serologically identified in several herbivore wildlife species including 
African buffalo (Syncerus caffer) (Bengis et al. 2004; Chaparro et al. 1990; Schiemann & 
Staak 1971; Gradwell et al. 1977; Kaliner & Staak 1973). South Africa’s largest national 
park, adjacent to the research site, has over 37 000 buffalo (South African National Parks 
2011) with a brucellosis seroprevalence estimated to be 13-38% in 1981 (Chaparro et al. 
1990; Herr & Marshall 1981) and 8.7-47.6% in 2015 (Gorsich et al. 2015). African buffalos 
and wildlife are considered a possible source of infection for domestic animals in the 
nearby communal areas (Gradwell et al. 1977; Muma, Samui, et al. 2007).  
 
Brucella abortus is the most abundant zoonotic Brucella species in South Africa with cattle 
as the main domestic reservoir (Mcdermott & Arimi 2002). In the KwaZulu-Natal province, 
neighbouring the study site province, communal cattle were found to have a mean 
provincial prevalence of 1.45% (Hesterberg et al. 2008). Brucellosis is spread from 
domestic animals to humans through infected milk, milk products and contaminated tissue 
(Mcdermott & Arimi 2002). There is only anecdotal rare human to human transmission 
(Mesner et al. 2007; Meltzer et al. 2010; Vigeant et al. 1995). Brucellosis in humans is 
thus almost always from zoonotic origin and can lead to severe disease (Doganay et al. 
1997). However, often it presents atypically with non-specific symptoms, making it difficult 
to diagnose (Corbel 2006). Human brucellosis is considered a neglected disease 
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(WHO/DFID-AHP et al. 2006), which is underdiagnosed and underreported (Franco et al. 
2007), and there is no human vaccine (Jacques Godfroid et al. 2005).  
 
There is a need to conduct studies on the prevalence of brucellosis (Gwida et al. 2010) 
in communities’ livestock living alongside parks or wildlife reserves as they are thought to 
be at a greater risk of contracting brucellosis than communities not living next to wildlife 
(Bengis et al. 2004; Gomo, de Garine-Wichatitsky, et al. 2012; Mellau et al. 2009; Muma, 
Samui, et al. 2007).  
 
Brucellosis in small ruminants is generally caused by B. melitensis but spillover of B. 
abortus from cattle to small ruminant is a possibility (Godfroid et al. 2011). Brucella 
melitensis has been reported in central South Africa in 1990 (Ribiero et al., 1990). Since 
then, there is no other report of infection in the scientific literature although infections have 
occurred intermittently in isolated herds of goats in central South Africa (Dr Jacob Pienaar 
2015, personal communication, 3 September 2016). Although, none of these cases have 
occurred in the Mpumalanga province, the B. melitensis infection status in the Mnisi 
community still needs to be explored. 
 
Dogs may also be infected by Brucella spp. when feeding on aborted materials and 
afterbirths (Cadmus et al. 2011; Wareth et al. 2017). Therefore, dogs could be an indicator 
of B. abortus and B. melitensis infection in cattle and goats. 
 
The control of B. abortus includes several measures: systematic vaccination of heifers 
(Rock et al. 2009), calving management, testing for disease and slaughtering of animals 
deemed positive and movement control (Godfroid et al. 2004). In South Africa, heifers 
between 4 and 8 months are vaccinated with Onderstepoort Biological Products Brucella 
abortus strain 19 vaccine (manufactured in Pretoria, South Africa). This vaccine contains 
around 5 x 1010 Colony Forming Units (CFU) per 5 millilitres dose (R. Macdonald, 
Onderstepoort Biological Products, personal communication, September 3rd 2014) which 
is within the 5-8x1010 CFU per dose (100 microliters), as recommended by the World 
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Organisation for Animal Health (World Organisation for Animal Health 2016). Males are 
not vaccinated because of the potential complication of orchitis (Godfroid et al. 2004).  
 
The objectives of this study are to determine the presence of brucellosis in the domestic 
animal species and if present if the disease could have come from wildlife and whether 
there is a brucellosis public health risk in this community.  
 
Materials and Methods 
 
Research site 
The Mnisi community research site, surrounding the Hluvukani Animal Clinic, consists of 
34 000 hectares of bushveld savannah on the border of the Kruger National Park (KNP) 
in South Africa (Figure 1). The study area is surrounded on three sides by private and 
public nature reserves containing the ‘big five’ and associated wildlife. It is populated by 
around 40 000 people (Berrian et al. 2016) of whom 1497 are cattle owners with 16,418 
cattle, 3350 goats (Mpumalanga Veterinary Services 2010) and an estimated 4000 dogs. 
There is a close association between animal handlers and their animals in this area. Cattle 
and goats are taken out daily to graze by humans and their dogs and brought back for 
overnight kraaling in the afternoon. 
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Figure 1. Research site in the Mnisi Community in South Africa. Black dots are research 
diptanks (see legend). 
 
Study design 
This was a cross-sectional study in cattle, goats, and dogs. The strategy in cattle was to 
estimate the seroprevalence, confirm brucellosis using a skin test and isolate Brucella 
spp. through organ culture of a skin test positive animal. The Rose Bengal Plate 
Agglutination test (RBT) was used as a cost effective and sensitive screening test to 
determine seroprevalence (Godfroid et al. 2010; World Organisation for Animal Health 
2016). Indirect enzyme linked immunosorbent assay (iELISA), deemed more specific than 
RBT, and skin delayed-type hypersensitivity test (ST), the most specific test for the 
diagnosis of B. abortus infection in cattle (Godfroid et al. 2010) were then used on RBT 
seropositive animals as confirmatory tests. Organ culture was done on a male bovine that 
was deemed most likely to be infected with Brucella spp. by above testing regime and did 
not have a history of vaccination with S19. The strategy for goats and dogs was to 
establish the presence of B. abortus or B. melitensis infection using RBT and confirm with 
iELISA and also in goats the ST. 
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Cattle 
The cattle study was conducted in two stages. The first stage was to calculate prevalence 
and identify infected herds of data collection and was conducted from May to June 2010. 
The second stage was to identify infected animals and identify the Brucella spp. and was 
conducted from April to September 2012. 
 
The prevalence of brucellosis was expected to be 1% based on a prevalence reports and 
studies elsewhere in a similar context in South Africa (Hesterberg et al. 2008). The 
calculated sample size (1390) for calculation of prevalence corresponds to a population 
of 16000, an expected prevalence of 1%, a precision of 0.5% and 95% confidence 
(Thrusfield 1995). A herd was defined as all cattle belonging to one owner. There are 19 
diptanks, 1-3 per village, each with 14-135 herds and each herd with one to over 100 
cattle. Cattle owners are obliged by law and encouraged by free acaricide application to 
present their cattle weekly to the state veterinary services at the diptanks for foot and 
mouth disease inspection. This is generally well attended and statistics of cattle numbers 
fairly accurate. The aging of the animals was done by owners’ knowledge and physical 
features of teeth, size and condition.  
 
In the first stage every tenth animal in order of appearance at the diptank was sampled, 
with 1480 samples taken. Some of the diptanks took more than one visit as herds were 
missing the first sampling or due to time constraints. Ten millilitres of blood was collected 
from the jugular or tail vein. Blood was collected and demographic data including age, 
sex, and vaccination history were recorded. All sera were tested for brucellosis antibodies 
using the RBT. All RBT positive cattle were also tested with the iELISA. There was not 
sufficient funds to test all animals with iELISA so three out of five seronegative cattle (875 
samples) were also tested with iELISA. 
 
In the second stage, the entire herd of any subject seropositive by RBT or iELISA from 
the first stage was included in the study. All cattle were tested by RBT and iELISA. 
Animals that tested seropositive to both RBT and iELISA and were older than two years, 
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as the serological tests were deemed less likely to be false positive due to vaccination by 
strain 19 after two years (Plommet et al. 1976; Saegerman et al. 1999) were tested by 
the ST. A male that was seropositive and reactive to the intradermal skin test was 
slaughtered for Brucella spp. isolation. 
 
Goats 
During April and June 2012 goats from every diptank in the study site were sampled. A 
herd was again defined as all goats belonging to one owner. There are just over 600 
owners with almost 3500 goats. The sample size was calculated to have a 95% chance 
to detect a minimum of one seropositive goat if the prevalence was 0.5 % (Lilenbaum et 
al. 2007). A minimum of 550 samples was necessary, which represents about 17 % of 
the goat population (Thrusfield 1995). 
 
Due to the fact that goats do not present at diptanks in the same manner as cattle, herds 
were selected by random sampling using a table of random digits (random function of 
excel) and the whole herd sampled. Five hundred and ninety-three animals were sampled 
from 92 herds by visiting the home of the goat herd owner. Ten millilitres of blood was 
sampled from the jugular vein. RBT was used as a screening test, all positives and the 
rest of the herd were then tested with iELISA and ST. 
 
Dogs 
The dog population was estimated to be near 4000 as a household survey in two villages 
had given a ratio of humans to dogs as 10 to 1 and there are about 40.000 people. The 
sample size was calculated to have a 95% chance to detect B. abortus or B. melitensis 
in the dog population. We considered an expected prevalence of 1% although there is no 
relevant publication for this basis. A minimum of 288 samples was deemed necessary 
(Thrusfield 1995). Brucella canis was not looked for in this population.  
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There was no register of dog owners so opportunistic sampling was done at diptanks and 
Hluvukani Animal Clinic from April to July 2012. Blood was collected from 315 dog from 
the jugular or saphenous vein.  
 
Disease diagnostics 
Serology 
All sera were separated by centrifugation at 1200g for 10 min, within 24 hours after blood 
collection and clot formation. One point four millilitres of each serum was stored in 
biological banking tubes (manufactured by Micronic, Lelystad, the Netherlands) at -20°C. 
The RBT (Onderstepoort Biological Products), the most suitable screening test for 
brucellosis was used (Corbel 2006; Godfroid et al. 2004). The RBT was performed as 
described (Alton et al. 1988) using standardised B. abortus antigen obtained from 
Onderstepoort Veterinary Institute, South Africa. The same cell concentration was used 
for both cattle and goats as recommended by the OIE. Any visible agglutination deemed 
the test as positive. 
 
The indirect enzyme linked immunosorbent assay (iELISA) test is deemed more of a 
confirmatory test for Brucella spp. than the RBT (Godfroid et al. 2010). The iELISA used 
was the IDEXX Brucellosis serum antibody ELISA (Pourquier®) test kit (IDDEX, 
Montpellier, France). Samples with S/P percentage ≤110% were considered negative for 
the presence of Brucella antibodies. Samples with S/P percentage >110% and <120% 
were considered suspicious positive. Samples with S/P percentage ≥120% were 
considered positive for the presence of Brucella antibodies. 
  
Brucellin skin test 
The skin delayed-type hypersensitivity (ST) test utilising a Brucella antigen is more 
specific for B. abortus than a serological test (Saegerman et al. 1999; Godfroid et al. 2002; 
MacDiarmid & Hellstrom 1987) and is useful for monitoring brucellosis free herds 
(Doganay et al. 1997). This test is less likely to give false positives to other bacteria as 
the RBT and ELISA tests do (Bercovich 2000). The brucellin skin test was performed as 
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described (Saegerman et al., 1999) using standardized antigen, prepared from B. 
melitensis B115 rough strain (BRUCELLERGENE OCB®, Synbiotics Europe, France). In 
cattle one side of the neck skin was clipped and an average skin thickness was measured 
with a calliper before 100 µl of brucellin was injected intradermally. Seventy-two hours 
later the skin thickness at the site of injection was measured in the same manner again. 
If the average of the measurements three days later were more than 1.1 mm thicker than 
the initial measurements the test was viewed as positive. In goats the skin test was done 
just below the eyelid and the skin thickness measured again 48 hours later (World 
Organisation for Animal Health 2016). If the average of the measurements two days later 
were more than 1.1mm thicker than the initial measurements the test was viewed as 
positive.  
 
Bacterial culture 
Tissues for Brucella culture were obtained by sacrificing the animal. Pre-scapular lymph 
nodes, superficial inguinal lymph nodes, testes, epididymes and the spleen were sent to 
Onderstepoort Veterinary Institute Laboratory (Onderstepoort, South Africa) on ice for 
culture to identify Brucella spp. Farrell’s medium has been used for bacterial culture, 
which contains antibiotics to inhibit the growth of other bacteria and the sample were 
checked from 5 to 10 days and identified according to characteristics for Brucella spp. 
(morphology, microscopy with Stamp’s stain, agglutination with monospecific antisera, 
growth on media containing dyes, phage lysis, antimicrobial susceptibility testing). In the 
absence of any visible colony after 4 weeks, the results were considered as negative. 
 
Data analysis 
Serological data was analysed in logistic regressions (StataCorp. Version 11.0. 2009. 
Stata Statistical Software: Release 14. College Station, TX: StataCorp LP) Sex was first 
used as only explanatory variable. Then, age was used as continuous explanatory 
variable in females only for lack of positive data in males. Design effects were evaluated 
but ignored since herds had no clustering effect on the data. Phase 1 ELISA data was 
weighted to compensate the fact that sampling fractions were different among RBT 
positive and RBT negative samples. In the absence of positives in a category, a Fisher 
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exact test was applied and 95% confidence interval was calculated using the exact 
method. P-values > 0.05 were considered statistically non-significant. Apparent 
prevalence estimates were transformed into true prevalence using published test 
sensitivity and specificity values. The specificity ascribed for the iELISA was higher for 
the estimation of the true prevalence at stage 2 of the study. The rationale for this is that 
animals belonging to herds that have been selected following the detection of positive 
RBT or iELISA individuals at stage 1, are more likely to be infected with Brucella spp. 
than the animals belonging to herds in which no seropositive animal has been detected 
during stage 1. We have chosen to ascribe the lower limit of specificity and the higher 
limit of sensitivity published in the literature for the iELISA, for stage 1 and stage 2 of our 
study, respectively (Godfroid et al. 2010). 
 
Ethics approval 
Ethics approval for the study was obtained from the University of Pretoria Animal Use and 
Care Committee (V026-12). 
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Results 
 
Cattle 
Stage 1 
One thousand four hundred eighty cattle were sampled. Ten animals were excluded 
because of incomplete information, leaving 1470 for analysis. 1102 (75%) of cattle were 
female.  
 
The RBT resulted in 21/1470 (1.43%) cattle being positive (Table 1). The female cattle 
had 19/1102 (1.72%) and the males had 2/368 (0.54%) RBT seropositive (Table 1). 
Almost all (20/21) of the RBT positive cattle were tested with iELISA with 12/20 (60%) 
being iELISA positive. Only 6/19 (32%) of the diptanks had at least one RBT seropositive 
animal. The RBT positive percentage per diptank varied from 0 to 4.8%. The RBT 
negative samples that were tested with iELISA had 13/875 (1.48%) positive. Twenty-two 
of the twenty-five (88%) iELISA positive samples from this stage were from females. The 
true prevalences were less than zero for both RBT and iELISA in males and females 
except when a greater specificity of 99.8% (true prevalence 2) was used which resulted 
in prevalences of 2.5% for females and 1% for males (Tables 1). 
 
Table 1. Estimated apparent and true prevalences in phase 1 and phase 2 using RBT 
and iELISA as diagnostic tools (with 95% CI) 
 
Sex N. 
obs. 
N. 
pos. 
Apparent 
prevalence 
(%) 
True 
prevalence 1 
(%) 
True 
prevalence 2 
(%)* 
Phase 1 
      
RBT Females 1102 19 1.7 (1.1 - 2.7) -0.6 (-1.3 - 0.6) 
 
 
Males 368 2 0.5 (0.1 - 2.1) -2.0 (-2.4 - 0) 
 
iELISA Females 673 22 2.7 (1.7 - 4.0) -0.3 (-1.2 - 0.8) 2.5 (1.6 - 4.0) 
 
Males 223 3 1.2 (0.4 - 3.7) -1.8 (-2.7 - 0.8) 1.0 (0.2 - 3.6) 
Phase 2 
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RBT Females 345 16 4.6 (2.9 - 7.4) 2.9 (0.8 - 6.2) 
 
 
Males 71 1 1.4 (0.2 - 9.3) -0.9 (-2.4 - 8.4) 
 
iELISA Females 345 35 10.1 (7.4 - 
13.8) 
7.7 (4.7 - 11.6) 10.3 (7.4 - 
14.0) 
 
Males 71 0 0 (0 - 4.1) -3.1 (-3.1 - 1.3) -0.2 (-0.2 - 
4.1) 
* Using a 99.8% specificity for true prevalence 2 instead of 97.1% as for true prevalence 
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Stage Two 
Twenty-four cattle herds with either an ELISA or RBT positive sample from stage 1 were 
included in this study. All the animals in the herds (416) were sampled. Of the 416 animals 
sampled 17 (4.1%) were RBT positive and 35/416 (8.4%) were iELISA positive (Table 2). 
RBT and iELISA positive results were found in 13/416 (3.1%) animals. The true 
prevalences for RBT were 2.9% females and -0.9% for males. The true prevalences for 
iELISA were 7.7% for females and -3.1% for males. When a greater specificity of 99.8% 
(true prevalence 2) was used, the iELISA results increased to 10.3% in females and -
0.2% in males (Tables 1). 
 
Six of the 13 animals that were RBT and iELISA positive were younger than two years 
and hence not eligible for the skin test as the serology was more likely to be influenced 
by vaccination (Saegerman et al., 1999). Another animal was not tested for logistical 
reason. This left 6 animals for the ST. A further three animals from stage two herds that 
were RBT positive and iELISA negative (one of these was male) were subjected to the 
ST. The difference in skin thickness varied from 0.42 to 2.5 millimetres three days after 
injection (Table 2). Three animals had differences of more than 1.1 mm (1.78, 1.89 and 
2.5) (Figure 2), which is deemed the cut-off point for positives (Saegerman et al. 1999). 
Two of these three were RBT and iELISA seropositive, the other (1.78mm) was male and 
RBT seropositive only. 
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Table 2. Stage 2 cattle intradermal Brucellin test results with serological results. *Animal 
is the mother of **. Positive results are in bold and italics. 
Herd Sex Age RBT ELISA 
Skin thickness 
change in mm 
1* Female 6 years  POS POS 1.89 
1** Female 4 years POS POS 0.46 
2 Female 4 years POS POS 2.5 
2 Male 3 years  POS NEG 1.78 
2 Female 4 years POS POS 0.94 
3 Female 
5-10 
years POS NEG 0.36 
4 
Female 
5-10 
years POS POS 0.06 
4 Female 8 years POS POS 0.16 
5 Female 
5-10 
years POS NEG 0.42 
 
 
 
Figure 2: Positive skin test of the female in herd 2 with a 2.5 mm increase in skin thickness 
72h after intra-dermal injection of 100 µl of brucellin; (a) front view; (b) profile view 
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In order to assess if the (male) animal that reacted in the ST was sensitised to Brucella 
spp. (wildtype or vaccine type) it was slaughtered and the pre-scapular lymph nodes, 
superficial inguinal lymph nodes, testes and epididymes and spleen were sampled for 
culture to isolate Brucella spp. The culture was found to be negative for Brucella spp. 
 
Goats 
A total of 593 goats from 92 herds were screened. The majority 490 (82.6 %) were female 
of different ages (aged from half a year to twelve years with a median age 3 years). An 
average of 39.5 (12-87) goats were sampled from each diptank of the study area, which 
represented an average of 17% of goat population in each dipping tank. 
 
One in five hundred and ninety-three serum samples was positive for Brucella spp. by 
RBT, giving a prevalence of 0.17%. The seropositive goat was a female of more than 4 
years. The rest of the herd (7 adult goats) were negative by RBT. The positive subject 
serum was iELISA negative. The RBT positive goat and two other herd members, all 
female, were tested with an ST. The average difference between the skin test readings, 
with a 48-hour gap, were 0.9 mm for the RBT positive goat and 0.46 mm and 0.14 for the 
other two goats. These results were deemed negative. As only one animal in herd was 
RBT positive and all herd animals were iELISA negative and the skin test was deemed 
negative the animal the RBT was seen as a false positive for brucellosis infection and the 
animal was not slaughtered for Brucella isolation attempt.  
 
Dogs 
Three hundred fifteen dogs (188 males and 127 females) of different ages (median age 
2 years) were screened. A large majority (99 %) of the sampling was at the dipping tank, 
with a mean of 20 dogs per dipping tank, ranging from 12 to 44 dogs. Although the 
sampling was not completely random dogs have been sampled at every dipping tank, 
except in one (Utha Scheme) where there were no dogs.  
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No dog serum samples were positive by RBT. No iELISA test were done on dogs as there 
were no RBT positive serum samples. 
 
Discussion 
 
This study’s objective was to assess the presence of Brucella spp. in a rural community’s 
livestock that could have come from the neighbouring wild or domestic animals. As 
vaccination of heifers with S19 vaccine between the ages of 4 to 8 month occurs, it is 
challenging to make a serological distinction at low prevalences between true infection 
due to Brucella wildtype infection and vaccine related residual antibodies. 
 
A wild type infection should show 1) an increasing seroprevalence with increasing age, 
2) seropositivity in (non-vaccinated) males, 3) the ability to isolate the organism, 4) 
possible spill-over to other domestic animals and 5) human infections. 
 
If we look at these factors individually: 
1) An increasing seroprevalence with age is seen in unvaccinated buffalo in the Kruger 
National Park nearby (Gorsich et al. 2015; Motsi et al. 2013). Our result of a 
decreasing seroprevalence in female cattle older than 4 years is not supporting a 
wildtype infection (Gomo, de Garine-Wichatitsky, et al. 2012).  
2) If there was wildtype infection male prevalence would be high and similar to the 
female as found in Zimbabwe in unvaccinated males and unvaccinated females 
(Gomo, de Garine-Wichatitsky, et al. 2012). The apparent prevalences in phase 1 are 
lower in males than females (male prevalence less than a third of female for RBT and 
less than half for iELISA), although not statistically significant. However, in phase 2 
the male seroprevalence is very low and the female significantly higher (Fisher exact 
test: p = 0.002), especially with iELISA test. The true prevalence results in males are 
all less than zero, except when the higher iELISA specificity of 99.8% is used giving 
a prevalence of 1 in phase 1. The most likely explanation for the seropositivity in 
males is accidental S19 vaccination or false serological reactions. This highlights the 
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fact that there are residual seropositives in the females, most likely due to vaccination, 
that are not seen in the males.  
3) Neither RBT nor ELISA tests are 100% sensitive or specific and although good, 
screening tests they should not be used alone (Matope et al. 2011). Both tests cross-
react with Yersinia enterocolitica O:9 and other bacteria causing false positive results 
(Godfroid et al. 2002; Kittelberger et al. 1998; Garin-Bastuji et al. 1999). Towards the 
end of the study the confirmatory brucellin skin test, which is seen as more specific 
than the serological test although not as sensitive, was used and only positive in three 
of the nine cattle. The only bull that was RBT and skin test positive had its organs 
negative for culture of Brucella spp. We cannot exclude that this animal could have 
been vaccinated but had cleared the S19 vaccine strain or that these ST positive 
result is a false positive result, the ST not being 100% specific (Saegerman et al 
1999).  
4) The fact that only one goat (0.17%) was RBT positive and then iELISA and ST 
negative points to the likelihood of that RBT result being a false positive result and 
Brucella spp. not being present in this population of goats. These goats are thus likely 
not infected with B. melitensis. In other situations, spill over of B. abortus from cattle 
to goats was detected with a serum agglutination test (Kabagambe et al. 2001; Mellau 
et al. 2009). Dogs usually have close contacts with cattle afterbirths and have been 
seen eating them. Consequently, dogs were expected to act as a spill over species 
for the disease. The fact that they were all RBT seronegative strongly suggests the 
absence of wildtype Brucella spp. in the study area.  
5) An unpublished study that sampled and tested 64 high risk humans (individuals that 
herd and handle livestock and veterinary staff) at 5 of the diptanks in this study found 
that there were no positive reactions with the human BrucellaCapt® agglutination test. 
Although this is a small sample size it is focussed on individuals that would have the 
highest risk to being infected from infected livestock (Hald et al. 2016).  
 
The seroprevalence of brucellosis has recently been estimated in the neighbouring 
Kruger National Park buffalo herds to be from 8.7% to 46.7% (Gorsich et al. 2015). Our 
results indicate the absence of transmission of brucellosis from wildlife to livestock, in 
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spite of frequent fence transgressions by wildlife. The lack of brucellosis, both B. abortus 
and B. melitensis in the cattle, goats and dogs indicates that the control measures in cattle 
(strain 19 vaccination of heifers), movement restrictions for cattle and goats (due to foot 
and mouth disease control measures) and fencing between wildlife and domestic animals 
are adequate to keep brucellosis out of the domestic animal populations in this setting.  
 
Having said the above, there are some limitations to our study. The interpretation of 
serological results is always difficult in the context of vaccination. We did not culture the 
S19 vaccine strain, which would have reinforced our conclusions. Our results strongly 
suggest that there is not a wildtype Brucella infection in livestock that could have 
originated from neighbouring wildlife or domestic animals. In the absence of clinical signs 
suggestive of brucellosis, the low number of seropositive results in cattle with decreasing 
antibodies with age allowed us to conclude that these antibody titres were due to 
vaccination rather than true wildtype infection.  
 
The results of this study allow us to conclude that there is no risk of transmission of 
brucellosis to human beings through contact with livestock and dogs and no foodborne 
risk (mainly through the consumption of raw milk and milk products) in the area at the 
time of the study. 
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CHAPTER 4  
Investigation of brucellosis in humans and human risk factors at a human-wildlife-
livestock interface in Mpumalanga Province, South Africa 
 
Introduction  
 
Brucellosis is the commonest zoonotic disease worldwide with over half a million new 
cases annually (Pappas et al. 2006). Brucellosis is a febrile disease in humans that copies 
many other diseases, both infectious and non-infectious, and although it is rarely fatal it 
is severely debilitating (Franco et al. 2007). Fever is a physiological response to either a 
non-infectious (e.g. vasculitis or cancer) or an infectious cause (e.g. viral, bacterial, fungal 
or parasitic). Studies in sub-Saharan Africa investigating acute febrile illness (AFI) 
patients have found evidence of present or past zoonotic infections (Biggs et al. 2011; 
Prabhu et al. 2011). In a hospital based study in a pastoral community in Kenya 13.7% of 
acute febrile illness patients were found to be serologically positive for brucellosis (Njeru 
et al. 2016).  
 
Humans contract brucellosis from infected animals and animal products. Infected wildlife 
can be a risk to hunters (Pappas 2010) and infected domestic animals to farmers and 
consumers of their animal products (Mcdermott & Arimi 2002). Brucellosis has a higher 
incidence in pastoral production systems (Mcdermott & Arimi 2002) similar to the study 
setting. Brucella spp. have been found in frog species that are common in many parts of 
Africa and are used as human consumption as food or traditional medicine (Mühldorfer 
et al. 2017). Amphibians may play a bigger role in public health than thought (Mühldorfer 
et al. 2017). 
 
Despite the apparent burden of zoonotic disease, human epidemiological surveillance 
(Rodríguez-Prieto et al. 2015) and laboratory capacity remain suboptimal as early 
warning systems for (re)-emerging zoonotic diseases outbreaks or monitoring endemic 
disease. These deficiencies result in a negative feedback loop fostering lack of clinical 
awareness, which causes mis- and under-diagnosis and consequently mismanagement 
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of cases (John et al. 2008). In this light, the early detection of new and emerging human 
pathogens remains problematic (Zumla et al. 2016).  
 
The motivation for this study is that the presence and proportion of brucellosis at this 
livestock-wildlife-human interface in Africa is unknown and therefore detecting if 
brucellosis is present in this community and whether the domestic animals or wildlife 
could be a source of infection is valuable.  
 
The aims of the study were to: 1) detect whether brucellosis is present in humans in the 
area; 2) investigate the proportion of acute febrile illness patients and healthy cattle 
farmers that have evidence of brucellosis; 3) identify risk factors for brucellosis in this 
population and 4) provide input into the current public health surveillance, diagnostic and 
treatment protocols used in this setting.  
 
This study reports laboratory results for an communal rangeland farming community, 
situated in the north-eastern Mpumalanga Province of South Africa, which is in close 
proximity to wildlife. Two groups were evaluated for exposure to brucellosis using a 
combination of immunological and molecular methods.  
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Prevalence of selected zoonotic diseases and risk factors at a human-wildlife-
livestock interface in Mpumalanga Province, South Africa 
 
Abstract 
 
A lack of surveillance and diagnostics for zoonotic diseases in rural human clinics limits 
clinical awareness of these diseases.  We assessed the prevalence of nine zoonotic 
pathogens in a pastoral, low-income, HIV-endemic community bordering wildlife reserves 
in South Africa.  Two groups of participants were included: malaria-negative acute febrile 
illness (AFI) patients, called febrilers, at three clinics (n=74) and secondly farmers, 
herders and veterinary staff found at five government cattle dip-tanks, called dip-tanksters 
(n=64).  Blood samples were tested using one PCR (Bartonella spp.) and eight antibody-
ELISAs, and questionnaires were conducted to assess risk factors.  
 
Seventy-seven percent of febrilers and 98% of dip-tanksters had at least one positive test.  
Bartonella spp. (PCR 9.5%), spotted fever group Rickettsia spp. (IgM 24.1%), Coxiella 
burnetii. (IgM 2.3%) and Leptospira spp. (IgM 6.8%) were present in febrilers and could 
have been the cause of their fever.   Dip-tanksters and febrilers had evidence of past 
infection to Rickettsia spp. (IgG 92.2% and 63.4%, respectively) and C. burnetii (IgG 
60.9% and 37.8%, respectively).  No Brucella infection nor current Bartonella infection 
was found in the dip-tanksters, although they had higher levels of recent exposure to 
Leptospira spp. (IgM 21.9%) compared to the febrilers.  Low levels of West Nile and 
Sindbis, and no Rift Valley fever virus exposure were found in either groups.  The only 
risk factor found to be significant was attending dip-tanks in febrilers for Q fever (p=0.007). 
 
Amoxicillin is the local standard treatment acute febrile illness, but would not be effective 
for Bartonella spp. infections, spotted fever group rickettsiosis, Q fever infections, nor the 
viral infections.  There is a need to revise acute febrile illness treatment algorithms, 
educate medical and veterinary staff about these pathogens, especially spotted fever 
group rickettsiosis and Q fever, support disease surveillance systems and inform the 
population about reducing tick and surface water contact.  
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Introduction  
 
Zoonotic diseases are caused by pathogens naturally transmitted directly or indirectly 
(e.g. by vectors) between animals (usually vertebrates) and humans.  Of all currently 
known human pathogens, 61% are considered to be zoonotic, whilst 73% of all emerging 
and re-emerging infections are also zoonotic (Jones et al. 2008).  An estimated 2.5 billion 
human cases related to zoonotic infections occur globally each year, causing 2.7 million 
deaths (Grace, Mutua, et al. 2012).  Zoonoses are estimated to account for one quarter 
of the disease burden in low-income countries (Grace, Gilbert, et al. 2012).  Poverty raises 
the risk of zoonotic disease in communities living in close contact with their livestock or 
with wildlife (Grace et al. 2017). Although, direct wildlife to human zoonotic transmission 
is rare (Kock 2014). 
 
Studies in sub-Saharan Africa investigating acute febrile illness (AFI) patients have found 
evidence of present or past zoonotic infections (Table I).  In populations with a high 
prevalence of HIV infection, this proportion of zoonotic infections may be even higher due 
to immunosuppression, HIV also increases the clinical severity of many zoonoses and 
results in a more protracted, chronic illness (Froberg et al. 2004; Biggs et al. 2011).   
 
Table I. Selected studies of zoonotic aetiologies of acute febrile illness in sub-Saharan 
Africa.  
Disease Population Result Reference 
Brucellosis Febrile hospital 
patients with a 
history of animal 
contact, north-
eastern Kenya 
(n=1067) 
13.7% qPCR-
positive for Brucella 
abortus, 11% 
ELISA seropositive 
for Brucella spp. 
IgM/IgG 
(Njeru et al. 2016) 
Leptospirosis 9% serologically 
confirmed acute 
(Biggs et al. 2011; 
Prabhu et al. 2011) 
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* Microscopic agglutination test; ** immunofluorescent assay 
Febrile hospital 
inpatients (n=870), 
northern Tanzania 
leptospirosis by 
MAT* (representing 
20 antigen 
serovars) 
Spotted fever group 
rickettsiosis 
8% serologically 
confirmed by  4-
fold increase in IgG 
to Rickettsia conori 
by IFA** 
Q fever 5% serologically 
confirmed acute Q 
fever by  4-fold 
increase in IgG to 
Coxiella burnetii by 
IFA** 
Spotted fever group 
rickettsiosis 
Population based 
infectious disease 
study (n=357) and 
febrile clinic 
patients (n=699), 
western Kenya 
57% had detectable 
IgG against SFG 
antigen and 7% 
were PCR-positive 
(gltA assay) for 
Rickettsia spp. 
(R. felis DNA was 
identified) 
(Maina et al. 2012) 
Bartonellosis Febrile patients, 
Democratic 
Republic of the 
Congo (n=155) 
4.5% serologically 
positive for 
Bartonella 
henselae, B. 
quintana, or B. 
clarridgeiae spp. by 
IFA**. 
(Laudisoit et al. 
2011) 
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A lack of human surveillance for zoonotic diseases (Rodríguez-Prieto et al. 2015) and 
laboratory capacity causes a lack of clinical awareness, leading to under-diagnosis and 
consequently mismanagement of cases (John et al. 2008).  In this light, the early detection 
of new and re-emerging human pathogens is also problematic (Zumla et al. 2016).  Gaps 
in data on the burden of zoonotic infections are especially pressing in the study site, a 
pastoral setting where humans, their domestic animals and wildlife have frequent direct 
and indirect contact.  The zoonoses selected for this study were based on prior 
information concerning infection prevalence and laboratory capacity.  The study aimed to 
document the prevalence of nine zoonoses in this setting; investigate the proportion of 
acute febrile illness patients and high-risk cattle farmers, herders and veterinary staff that 
have evidence of exposure or infection to these zoonoses; and identify risk factors for 
these zoonoses.  Implications for public health surveillance, diagnostic and treatment 
protocols used in this setting are explored.  
 
Materials and methods 
 
Study site 
The study was implemented in three rural government primary health care clinics and five 
government cattle dip-tanks in Bushbuckridge Municipality, Mpumalanga Province, South 
Africa (Figure 1).  The prevalence of HIV infection in the province is 14.5% and the 
municipality is situated in the Ehlanzeni District, where levels of HIV are amongst the 
highest of all districts in the country (between 16% and 22%) (Shisana et al. 2014).  
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Figure 1. Location of the research site, Bushbuckridge Municipality, Mpumalanga 
Province, South Africa.  
 
The study area was in the Mnisi Community Programme area, containing the Hans 
Hoheisen Wildlife Research Station and Hluvukani Animal Clinic, and is a joint initiative 
by the University of Pretoria with the Mpumalanga Veterinary Services and the Mnisi 
Traditional Authority, to promote sustainable livelihoods through research into human and 
animal health, animal production and natural resource utilisation.  Approximately 40,000 
people live in 8,500 households (Statistics South Africa (SSA) 2012), with 72% of all 
households owning at least one species of animal and agro-pastoralist farming being the 
primary subsistence activity (Berrian et al. 2016).  Chickens are owned in 55% of 
households, cattle in 25%, goats in 16%, pigs in 5% and companion animals in 36% 
(Berrian et al. 2016).  The community shares three-quarters of its boundary with wildlife 
reserves.  In the communal area there are hares, small antelope, rodents, small 
carnivores and in the wildlife reserves, all wildlife typical of “big five” reserves in this 
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region.  In these wildlife areas brucellosis has been detected in buffalo, other antelope, 
zebra, lions, hyenas and other animals, including monkeys (De Vos & Van Niekerk 1969; 
Gorsich et al. 2015).  Malaria is endemic in the area, but the average annual incidence of 
the infection has decreased over the past 10 years, due to intensive control activities 
(Maharaj et al. 2013).  The contribution of malaria to the syndrome of AFI has thus 
reduced.  
 
Participant recruitment   
The sample size calculation was done using an infinite population, where 59 samples are 
required to detect a disease with 95% chance when the actual prevalence of the disease 
is 5% (Thrusfield 1995).  In addition, 64 samples give unilateral 95% confidence intervals 
of proportions of 12% maximum, which was deemed sufficient for the study. 
 
The study involved two groups of participants.  The first comprised patients diagnosed 
with AFI at the clinics, hereafter called febrilers.  An AFI case was defined as a patient 
with documented axillary temperature ≥37.5°C, or a history of fever within the previous 
72 hours, whom the clinic staff would routinely test for malaria, in terms of the clinic 
standard operating procedure.  Patients who tested negative for malaria were referred to 
the study nurse to be enrolled in this study.  All patients ≥18 years of age who met this 
case definition were eligible for enrolment from October 2012 to June 2013.  Information 
was captured onto a standard case information form (CIF).  This CIF inquired about a 
variety of symptoms and questions related to risk factors for zoonotic disease, and 
diagnosis, treatment and outcome.  The selected risk factors were a variety of contacts 
(such as handling and consumption) with various domestic animals, presence at dip-tanks 
and tick bites.  Blood samples (one coagulated for serum and one EDTA anticoagulated) 
for laboratory tests were drawn at the time of presentation (acute sample) and the patients 
were asked to return two to three weeks later to provide follow-up convalescent samples.  
A study nurse facilitated enrolment of volunteers at all the clinic sites.   
 
The second group comprised cattle farmers, herders and government veterinary staff 
(animal health technicians and veterinarians), who attended any of five cattle dip-tanks 
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for weekly stock inspections and tick control in the area in one week in June 2013 (Figure 
2).  This group were called dip-tanksters. They were recruited for interviewing and 
provided blood samples as described above for the febrilers, but without follow-up 
samples.  A CIF with the risk factors detailed above was also completed, but excluded 
the clinical symptoms, diagnosis or treatment and outcome information.  All information 
was captured onto a Microsoft Excel database. 
 
 
Figure 2. Sampling of dip-tanksters at a dip-tank. 
 
Laboratory methods 
Laboratory testing for all samples was performed at the National Institute for 
Communicable Diseases.  Tests for a panel of nine known endemic bacterial and viral 
zoonoses in South Africa were used in this study (Table 2).   
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Table 2. Panel of tests performed on blood samples from acute febrile patients and 
healthy subjects.  Sensitivity and specificity are included if available. 
Disease 
agent/s 
Diagnostic 
assay 
Samples 
tested 
Interpretation of 
results 
Reference 
Bartonellosis PCR*: 
Bartonella spp. 
16S/23S reran 
internal 
transcribed 
spacer (ITS) 
region (in-
house) and 
sequencing.  
Acute whole 
blood 
samples from 
all 
participants.  
All positive 
amplicons 
were 
sequenced 
Fragment sizes 
variable depending 
on species 
approximately 640 
– 788 bp for outer 
primers and 481 – 
573 bp for inner 
primers 
(Trataris et 
al. 2012) 
Brucellosis Serology (total 
antibodies): 
Brucellacapt® 
assay (Vircell 
S.L., Spain) 
Acute serum 
samples from 
all participants  
Titres higher than 
1:320 were 
deemed positive 
96% sens. 
& 97.5% 
spec 
(Casao et 
al. 2004) 
Chikungunya, 
Rift Valley 
fever, Sindbis 
fever and 
West Nile 
fever viruses  
HAI:** in-house 
assay  
Serum 
samples from 
all participants 
Titres higher than 
1:20 were deemed 
positive  
(Lennette 
& Schmidt 
1979) 
Chikungunya, 
Rift Valley 
fever, Sindbis 
fever and 
West Nile 
fever viruses  
IgM capture 
ELISA***: in-
house assay  
Serum 
samples that 
tested positive 
per arbovirus 
HAI 
Percentage 
positivity values 
higher than the 
calculated run-
based or 
population based 
cut-off values 
RVF: 
96.5% 
sens. & 
99.4% 
spec. 
(Paweska 
et al. 2005) 
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Leptospirosis IgM ELISA: 
Panbio® 
Leptospira 
(Standard 
Diagnostics 
Inc., Republic of 
Korea). 
Convalescent 
serum 
samples or 
acute 
samples 
where 
convalescent 
samples not 
available 
Index values 
calculated using 
run-based cut-off 
values as per 
manufacturer’s 
recommendations 
90.8% 
sens. & 
55.1% 
spec. 
(Desakorn 
et al. 2012) 
Spotted fever 
group 
Rickettsiae 
spp. 
 
IgG IFA:**** 
Rickettsia 
conorii kits 
(Vircell S.L., 
Spain) 
All AFI 
participants 
and all dip-
tank 
participants 
IgG: titer of 1:40 
deemed positive   
 
 
85% sens. 
& 100% 
spec. 
(Do et al., 
2009) 
IgM IFA: 
Rickettsia 
conorii kits 
(Vircell S.L., 
Spain) 
All AFI 
participants 
IgM: titer of 1:192 
or greater deemed 
positive, or fourfold 
rise in titer  
as per 
manufacturer’s 
recommendations 
94% sens. 
& 95% 
spec. 
(Do et al., 
2009) 
Q fever  
 
IgG ELISA: 
Panbio® 
Coxiella burnetii 
(Q fever) 
(Standard 
Diagnostics 
Inc., Republic of 
Korea) 
Convalescent 
serum 
samples, or 
acute 
samples 
where 
convalescent 
samples not 
available 
Index values 
calculated using 
run-based cut-off 
values as per 
manufacturer’s 
recommendations 
71% sens. 
& 96% 
spec. 
(Field et al. 
2002) 
112 
 
* PCR: polymerase chain reaction; ** HAI: haemagglutination inhibition assay; ***ELISA: enzyme-linked 
immunosorbent assay; ****IFA: indirect immunofluorescence assay  
 
The DNA for the bartonella test was extracted according to Trataris et al. 2012, from 
packed red blood cells (obtained after spinning down EDTA tube) using the UltraClean® 
BloodSpin® DNA Isolation Kit (MoBio Laboratories, Czech Republic).  The tests for 
leptospirosis, Q fever, brucellosis and HAI tests were not done in duplicate.  The 
convalescent samples of the acute febrile illness patients were tested and, if found 
positive, then the corresponding acute samples were tested to detect seroconversion.  
Positive HAI samples were then tested with IgM ELISA. 
 
Statistical analysis 
Data were analysed in multivariable logistic regression models, separately for the clinic 
and dip-tank data.  Test results of each test were used as binary responses variables (in 
different models).  Backward selection of explanatory variables was applied using p = 
0.05 as a cut-off.  The tested explanatory variables were age (continuous), dip-tank 
attendance, eating wild animals, history of tick bites, herding of livestock, slaughtering of 
animals and eating livestock (binary) for both the clinic and dip-tank data.  Confidence 
intervals (CI) of proportions >0 and <1 were calculated using logistic predictors whereas 
the exact method (assuming a binomial distribution) was used for proportions = 0 or 1. 
 
Ethical clearance 
 
IgM ELISA: 
Panbio® 
Coxiella burnetii 
(Q fever) 
(Standard 
Diagnostics 
Inc., Republic of 
Korea) 
Acute serum 
samples if 
convalescent 
sample not 
available or if 
tested positive 
with IgG 
ELISA 
Index values 
calculated using 
run-based cut-off 
values as per 
manufacturer’s 
recommendations 
99% sens. 
& 88% 
spec. 
(Field et al. 
2000)1 
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Ethical approval was obtained from the University of the Witwatersrand Human Ethics 
Committee (certificate number M120667) and signed informed consent obtained from 
study participants.  Further permissions were secured from the Mpumalanga Provincial 
Government for the study to be done at the three clinics.   
 
Results 
 
Participant demographics and symptoms 
In the febrilers, of 119 eligible participants, 74 (62%) were enrolled (45 were excluded as 
they declined consent or the study nurse could not access them).  There were twenty-
three (16/23 were adult) AFI patients malaria test positive during the study period, who 
were not included in the study.  The median age of the 74 febrilers was 34 years 
(interquartile range [IQR] 25-47 years), 46/74 (62%) were females, of which two were 
pregnant.  About half were febrile on examination (38/74, 51%).  The median duration of 
illness was 3 days (IQR 2-7 days).  About 10% (6/74) were referred to hospital, and 62% 
(46/74) received an antibiotic.  A quarter did not return for follow-up blood sampling 
(20/74; 27%). Only 4 febrilers had with no systemic symptoms other than fever, 36/74 
(49%) presented with one other symptom, 20/74 (27%) with two and 4/74 (5%) with three 
other symptoms.  The majority presented with muscle pain (85%), while fewer had 
respiratory symptoms (14%).  A total of 64 dip-tanksters were recruited, of whom, 46 
(72%) were male and a median 55 years old (IQR 42-68 years).  The median duration of 
dip-tank attendance was 15 years (IQR 6-30 years).   
 
Clinical and laboratory findings 
In summary, 77% (57/74) of febrilers tested positive for at least one of the zoonotic 
pathogens included in the panel (Table 3).  The most prevalent past infection was the 
spotted fever group (SFG) (Rickettsia spp.), with 63.4% (45/71, 95% CI 51.6-73.7%) 
testing positive for anti-Rickettsia IgG, while anti-Rickettsia IgM was positive in 24.5% 
(13/53, 95% CI 14.8-37.8%) of febrilers, indicating a more recent or current infection.  Of 
the 13 anti-Rickettsia IgM positive patients, twelve were anti-Rickettsia IgG positive.  
Antibodies (IgG) to Coxiella burnetii, the causative agent of Q fever, were detected in 
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38.3% (28/73, 95% CI 28.0-49.9%) of patients.  Other bacterial pathogens included 
bartonellosis with 9.5% PCR-positive (7/74, 95% CI 4.6-18.5%), that were identified as 
Bartonella vinsonii subspecies berkoffii (n=1) (which has a dog reservoir), B. henselae 
(n=2) (domestic cat reservoir), B. quintana (n=1) (human reservoir (Zeaiter et al. 2002)), 
B. thailandensis (n=1) (rodent reservoir (Saisongkorh et al. 2009)) and two Bartonella 
positives are unnamed, but rodent borne.  Leptospirosis with 6.8% (5/74, 95% CI 2.8-
15.2%) group-specific IgM antibodies and brucellosis with 1.4% (1/74, 95% CI 0.2-9.0%) 
group-specific total antibodies were also found.  West Nile and Sindbis fever antibodies 
were detected in 4.1% (3/73, 95% CI 1.2-12.0%) and 1.4% (1/73, 95% CI 0.2-9.1%) of 
febrilers respectively.  No chikungunya or Rift Valley fever (RVF) antibodies were found.   
 
In the dip-tanksters, the proportion with anti-Rickettsia IgG antibodies was also high at 
92.2 % (59/64, 95% CI 82.6-96.7%), and 60.9% (39/64, 95% CI 48.6-72.1%) had anti-
Coxiella IgG antibodies.  No evidence for exposure to Brucella spp. was detected, but 
21.9% (14/64, 95% CI 13.4-33.6%) tested positive for Leptospira IgM antibodies.  For 
viral aetiologies, 3.1% (2/64, 95% CI 0.8-11.7%) of dip-tanksters tested positive for West 
Nile virus IgM, 4.7% (3/64, 95% CI 1.5-13.6%) for chikungunya and 3.1% (2/64, 95% CI 
0.8-11.7%) for Sindbis virus antibodies.  No RVF antibodies were detected.   
 
Table 3. Results of laboratory tests for selected zoonotic pathogens in AFI and diptank 
participants with 95% confidence interval  
 
Febrilers Dip-tanksters 
 
Positive Sample 
size 
% positive 
(95% CI) 
Positive Sample 
size 
% positive 
(95% CI) 
SFG IgG 45 71 63.4 (51.6-
73.7) 
59 64 92.2 (82.6-
96.7) 
SFG IgM* 13 53 24.5 (14.8-
37.8) 
-  - - 
Q fever IgG 28 73 38.3 (28.0-
49.9) 
39 64 60.9 (48.6-
72.1) 
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Q fever IgM** 1 43 2.3 (0.3-
14.8) 
0 39 0 (0-7.4) 
Bartonella spp. 
PCR 
7 74 9.5 (4.6-
18.5) 
0 64 0 (0-4.6) 
Leptospira IgM 5 74 6.8 (2.8-
15.2) 
14 64 21.9 (13.4-
33.6) 
Brucella Ig 1 74 1.4 (0.2-9.0) 0 64 0 (0-4.6) 
Chikungunya Ig 0 73 0 (0-4.0) 3 64 4.7 (1.5-13.6) 
West Nile virus Ig 3 73 4.1 (1.3-
12.0) 
2 64 3.1 (0.8-11.7) 
Sindbis Ig 1 73 1.4 (0.2-9.1) 2 64 3.1 (0.8-11.7) 
Rift Valley fever Ig 0 73 0 (0-4.0) 0 64 0 (0-4.6) 
*SFG rickettsiosis IgM (recent) done on the 45 AFI participants who were positive on 
SFG rickettsiosis IgG (past) and 19 IgG negative and one IgG untested participants, 
**IgM for Q fever done on acute specimens for which there was no convalescent 
specimen and in participants that were positive for IgG. 
 
The AFI participant arbovirus HAI positive samples were retested with IgM ELISA and 
had the following results: the three WNV positive samples had two negative results and 
one untested and the Sindbis positive was also IgM positive. Amongst dip-tank 
participants: for chikungunya one of the three HAI-positive samples was also IgM positive, 
one was negative and the last untested; both WNV HAI-positive samples were IgM 
negative, and both Sindbis HAI-positive samples were also IgM positive.  
 
The only risk factor that was statistically significantly associated with a disease was 
attending dip-tanks in febrilers for Q fever IgG (p=0.007).  Thirteen of the 74 (18%) 
febrilers were found to have previously attended dip-tanks and of those tested 77% 
(10/13) were IgG positive compared to 31% (19/62).  None of the risk factors for the dip-
tanksters were associated with the test results.  
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Article discussion 
 
Our study looked at both acutely febrile participants in clinics and cattle dip-tank 
participants at high risk for zoonoses.  Undifferentiated acute febrile illness is among the 
most common presenting signs in patients seeking medical care in Africa (Perkins et al. 
1997; Crump et al. 2003; Van Hemelrijck et al. 2009).   Despite this, the syndrome is 
frequently misdiagnosed, and the aetiologies still poorly understood.  Febrile illness is 
often misclassified as malaria, especially in adults living in areas with low to moderate 
malaria transmission (Reyburn 2004; Chandler et al. 2008; Nankabirwa et al. 2009).  
Misdiagnosis leads to delays in appropriate treatment and higher case-fatality rates 
(Chandler et al. 2008).  
 
This study showed that 77% of febrilers and 98% of dip-tanksters had at least one positive 
test.  Bartonellosis (PCR 9.5%), spotted fever (IgM 24.1%), and less likely, leptospirosis 
(IgM 6.8%) and Q fever (IgM 2.3%) could have been the cause of the acute febrile illness 
in the febrilers, as IgM and PCR suggest recent or current infection.  This is a valuable 
finding, relevant to the management of clinic patients, as amoxicillin is the standard 
treatment for patients with AFI, but it would not be effective for these diseases.  Therefore, 
the AFI treatment algorithms in this and similar settings need to be reconsidered and 
health staff educated on these infections. 
 
The febrilers also showed a high past exposure (IgG) to SFG Rickettsia spp. (63.4%) and 
Q fever (37.8%), not previously described in this population.  The high proportion of 
exposure to Rickettsia spp. is understandable, given that 70% of tick pools and 100% of 
flea pools taken from dogs in the area were positive for Rickettsia spp. (Kolo et al. 2016).  
Over 70% (50/71) of febrilers had either an SFG Rickettsia spp. or Q fever positive result, 
while 95% of dip-tanksters had either an SFG Rickettsia spp. or Q fever positive result.  
We expect veterinary staff or livestock herders and farmers presenting at the dip-tanks 
with their livestock to be at a higher risk for zoonotic diseases (especially for those 
diseases transmitted by vectors/reservoirs and associated with livestock) in this 
population.  However, the only diseases where dip-tanksters had a confidence interval 
117 
 
higher than febrilers was spotted fever (IgG).  There are differences between proportions 
of participants positive in the febrilers and dip-tanksters but this is not strongly statistically 
supported in this study.   
 
Dip-tanksters are on average 21 years older than febrilers and therefore have had more 
time for exposure to pathogens.  Although, the number of zoonotic illnesses per individual 
was not correlated with years of dip-tank attendance in the dip-tank group, contact with 
cattle dip-tanks was positively associated with Q fever exposure in AFI patients.  The 
higher proportion of spotted fever IgG in dip-tank participants could be from cattle owners 
having higher levels of exposure to ticks, related to their dogs and other domestic animals 
that they will interact with daily.  There was little evidence of other risk factors contributing 
to positive serology.  The lack of positive associations may be due to a relatively small 
sample size and test-positives. Also, the environment is homogenous such that even if 
people say they do not own or work with animals, some contact is inevitable, due to the 
free-ranging nature of the animals and their close proximity to humans; for example, 
almost a fifth of the febrilers had some contact with the dip-tanks.   
 
The higher bartonellosis test-positive proportion in febrilers could be as the test was 
detecting organisms and not antibodies, which would be more closely associated with 
patients presenting with fever than compared to dip-tanksters.  Bartonella infection rate 
in other studies was also found to be high in HIV-infected individuals (Frean et al. 2002; 
Trataris et al. 2012), and although our participants were not tested for HIV, HIV 
prevalence may have been higher in the febrilers that had an average age of 34 years 
compared to the dip-tankster with an average age of 55 years, which correlates with the 
provincial age and HIV prevalence demographics (Shisana et al. 2014).  The Bartonella 
species found in the febrilers were associated with humans (n=1) and domestic dogs and 
cats (n=3) and rodents (n=2).  Bartonella infections have been found to be common in 
cats (23.5%) and dogs (9%) in a southern African study (Trataris et al. 2012), and in fleas 
(36.3%) elsewhere in Africa (Leulmi et al. 2014). 
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A review of leptospirosis in sub-Saharan Africa, noted very few human studies, with most 
data being from animals studies (De Vries et al. 2014).  In our study evidence of 
leptospirosis was higher in the dip-tanksters, although with confidence intervals 
overlapping, which again makes sense given that transmission to humans is from the 
urine of infected animals, commonly rodents, pigs and other domestic animals.  Cattle in 
a neighbouring province had a leptospirosis prevalence of almost 20% (Hesterberg et al. 
2009) and a South African study found leptospirosis in 4.7% (25/530) of dogs tested 
(Roach et al. 2010).  What is more difficult to understand is the dip-tanksters having a 
threefold higher IgM (which should indicate current or recent infection), than AFI patients.  
The dip-tank participants may be more consistently exposed to Leptospira spp., but not 
present with fever at the clinic.  The Leptospira ELISA IgM is known to have a low 
specificity (55%) and diagnostic accuracy, which may influence the reliability of the results 
(Desakorn et al. 2012).  
  
The brucellosis results are reflective of what has been found in domestic animals in the 
area.  Although brucellosis is present in the region (Hesterberg et al. 2008), unpublished 
studies suggest that there is no brucellosis in the cattle, goats and dogs in the study area 
(Dr G Simpson, Pers. comm.,15th June 2017).  This indicates that the control mechanisms 
of heifer vaccination and movement control may be keeping the disease at bay, even 
though there are high seroprevalences in buffalo (8.7-47.6%) across the neighbouring 
reserve fences (Gorsich et al. 2015). 
 
The febrilers had 5.5% (4/73) showing at least one positive arbovirus positive result 
compared to the dip-tanksters with 10.9% (7/64).  Little is known about the epidemiology 
of chikungunya virus in the region, although baboons (Papio ursinus) were previously 
found to be the primary vertebrate reservoir (Mcintosh et al. 1977).  The vectors are tree 
canopy-associated Aedes fucifer-taylori group, which are less likely to be found in a peri-
domestic situation, and which rarely feed on humans.  The dip-tank participants may be 
more at risk as they take their cattle and goats into the surrounding bushveld for grazing.  
The presence of West Nile and Sindbis virus infections, although at low levels, is of 
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interest as patients are not routinely tested for these diseases.  There are also veterinary 
implications associated with their presence.  
 
Vectors can move pathogens between wildlife and domestic animals species (Bengis et 
al. 2004).  This phenomenon is of growing concern with the expanding human 
populations, habitat destruction, intensification of wildlife and potentially greater contact 
between humans and wildlife (Bengis et al. 2004).  The diseases investigated in this study 
can be transmitted to humans through vectors, food, contact or contamination of the 
environment, which has implications for vector, hygiene and environmental control.  
Malaria control in the area, for example, has had a negative impact on some mosquito 
populations, which may affect other mosquito-transmitted diseases.  Further vector 
control, disease control in animals, as well as food and other hygiene improvements, 
would be beneficial in decreasing the burden of these diseases.  There is also a need to 
educate the population about reducing tick and surface water contact. 
 
A limitation of our study was that sample sizes were small.  There was only one nurse 
covering three clinics for AFI patients, which made it difficult to access all the eligible 
patients.  The dip-tank participants were opportunistically selected in a non-random 
manner.  This could influence the extrapolation of the results to all the dip-tank attendees.  
 
Article conclusions 
 
Bartonella spp., Rickettsia spp., Coxiella burnetii and Leptospira spp. are present and 
could be undetected causes of fever and illness in a community bordering wildlife 
reserves in the north-east of South Africa.  Some acute febrile illness patients (9.5%) were 
infected with Bartonella spp. associated with human, rodent and domestic dog and cat 
reservoirs.  A high proportion of cattle dip-tank attendees and acute febrile illness patients 
had evidence of past infection or background exposure to Rickettsia spp. and Coxiella 
burnetii, which is of relevance to public and veterinary health.  Current acute febrile illness 
treatment algorithms at the clinics prescribe amoxicillin, which would not be effective for 
these diseases.  The low proportion of brucellosis and viral infections is encouraging, but 
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should continue to be monitored.  The vector control strategies for livestock and public 
health should take into account ticks and fleas as they transmit Bartonella spp. and 
Rickettsia spp.  Animal husbandry should be adapted to include means of infection 
prevention, such as disinfection, after contact with animal excretions to decrease Q fever, 
leptospirosis and potentially brucellosis.  This is an opportunity for public and animal 
health organisations to discuss control programs to tackle common afflictions.  Wider 
zoonotic surveillance should be continued, and veterinary and public health services 
should be aware of these diseases, their diagnoses and treatments, and educate their 
patients and owners in prevention methods and care seeking.   
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Discussion 
 
Brucellosis is a cause of acute febrile illness. The results provide valuable insights on the 
presence of brucellosis in this area. Our study looked at evidence of brucellosis in both 
acutely ill (AFI) participants in clinics and healthy (diptank) participants at high risk for 
zoonoses. The brucellosis results indicate that the disease is absent or rare in the area. 
The fact that there are no positive results in the high-risk group indicate that the domestic 
animals in the area are not transmitting brucellosis to humans. The blood of the positive 
result in the clinic patient was haemolysed, which could have influenced the result or they 
could have contracted the disease outside of the study area in a neighbouring infected 
area. These results are reflective of what has been found in domestic animals in this area. 
Although, brucellosis is present in the region (Hesterberg et al. 2008), unpublished 
studies indicate there is no brucellosis in the cattle, goats and dogs in the study area (Dr 
G Simpson, Pers. comm.,15th June 2017). This indicates that the control mechanisms of 
heifer vaccination, movement control of cloven hoofed animals due to foot and mouth 
disease restrictions and fencing between wildlife and domestic animals may be keeping 
brucellosis at bay even though there are high seroprevalences in buffalo (8.7-47.6%) 
across the neighbouring reserve fences (Gorsich et al. 2015) and in domestic animals in 
other areas. 
 
There was no statistical significant differences between proportions of participants 
positive in the AFI and high-risk healthy group (diptank participants). There was no 
evidence of any risk factors contributing to positive serology. The lack of positive 
associations between risk factors and disease may be due to the fact that the sample 
sizes and test-positive numbers are small and the environment is ubiquitous, such that 
even if people say they do not own or have contact with animals and their parasites, some 
contact is inevitable, due to the free-ranging nature of the animals and their close 
proximity to humans. Thirteen of the 74 (18%) of the clinic participants also had some 
contact with the diptanks.  
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A limitation of our study is that sample sizes were small. There was only one nurse 
covering three clinics for AFI patients, which made it difficult to access all the eligible 
patients, hence the high non-enrolment rate of 38%.  
 
Conclusions 
 
Our conclusion is that brucellosis is not being transmitted from the local domestic animals 
to humans. One acute febrile illness patient could have had a false positive or got the 
disease from surrounding areas with infected animals and wildlife. The current control 
strategies for brucellosis should be maintained and wider zoonotic surveillance should be 
continued to get a bigger epidemiological picture and veterinary and public health 
services should be aware of brucellosis diagnoses and treatments, and educate their 
patients and owners in prevention methods and care seeking.  
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CHAPTER 5 
Immunological response to Brucella abortus strain 19 vaccination of cattle in a 
communal area in South Africa  
 
Abstract 
 
Brucellosis is of worldwide economic and public health importance. Heifer vaccination 
with live attenuated Brucella abortus strain 19 (S19) is the cornerstone of control in low 
and middle income countries. Antibody persistence induced by S19 is directly correlated 
with the number of Colony Forming Units (CFU) per dose. There are two vaccination 
methods: a “high” dose (5-8 × 1010 CFU) subcutaneously injected or one or two “low” 
doses (5 × 109 CFU) by the conjunctival route. Previous research in cattle at the study 
site found a low sero-prevalence of brucellosis and this study is to understand the 
influence of “high” dose vaccination on serological testing and therefore the possible 
implications on disease control.  
 
This study included 58 female cases, vaccinated at Day 0, and 29 male controls. Sera 
was drawn repeatedly and tested for Brucella antibodies using the Rose Bengal Test 
(RBT) and an indirect Enzyme-Linked Immunosorbent Assay (iELISA).  
 
The cases showed a rapid antibody response with a peak RBT positivity (98%) at two 
weeks and iELISA (95%) at eight weeks, then decreased in an inverse sigmoid curve to 
14% RBT and 32 % iELISA positive at 59 weeks and at four and a half years 57% (4/7 
cases) demonstrated a persistent immune response (RBT, iELISA or brucellin skin test) 
to Brucella spp.  
 
Our study is the first of its kind documenting persistence of antibodies in an African 
communal farming setting for over a year to years after vaccination of a “high” dose S19, 
which can be difficult to differentiate from a wildtype Brucella abortus infection response 
using serology alone. A recommendation could be use a “low” dose or different route for 
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vaccination that produces a shorter period of antibody response with equivalent 
protection. 
 
Introduction 
 
Brucellosis caused by Brucella abortus, a gram-negative coccobacilli bacteria is a widely-
distributed zoonosis of importance to public health (Corbel 2006). Animal brucellosis 
affects mammals including livestock and wildlife and commonly causes abortion in 
females and orchitis in males (Chaparro et al. 1990; Elaine M S Dorneles et al. 2015). In 
humans, symptoms include fever, malaise, orchitis and a variety of nonspecific symptoms 
(Doganay & Aygen 2003). The Kwazulu-Natal province in South Africa, with a setting 
similar to the study site, had an estimated prevalence of 0-1.5% (Hesterberg et al. 2008, 
p.15). In southern Africa, studies in pastoral production systems have shown the 
prevalence of brucellosis to be higher with larger herds, extensive movement of animals 
and co-mingling of herds at common grazing sites (Mcdermott & Arimi 2002). 
 
In South Africa, where heifer vaccination is mandatory, cattle are seen to be the greatest 
source of outbreaks (Hesterberg et al. 2008). Detection of disease is done using the Rose 
Bengal test (RBT) as the serological screening test and the complement fixation test 
(CFT) as the confirmatory test. Both tests can give false positive reactions due to strain 
19 (S19) vaccination (World Organisation for Animal Health 2009). Testing is voluntary, 
except for dairy cattle, where it is compulsory. The government has a voluntary Bovine 
Brucellosis Scheme to encourage animal owners to participate in eradicating brucellosis 
through testing and slaughtering of infected animals (South African Government Gazette 
1988). Testing frequency is influenced by veterinary services resources and animal 
owners’ motivation. Infected herds are quarantined, infected animals removed and the 
herd only deemed brucellosis-free after two negative tests at least three months apart 
(South African Government Gazette 1988). Although, in resource limited settings 
slaughter of positives is often not possible due to financial limitations (Moriyón et al. 2004).  
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Vaccination of heifers along with brucellosis testing and slaughter of positive animals is 
the foundation for control of brucellosis in cattle in endemic areas (Nicoletti 2010). Males 
are not vaccinated because of the potential complication of orchitis (Olsen & Palmer 
2014) and the limited role they play in transmission (Olsen & Tatum 2010). Humans who 
work with these animals or consume their milk and meat are indirectly protected through 
the vaccination of cattle (Corbel 2006; Godfroid et al. 2011). Several strains are used for 
vaccination, where the disease endemic, as in many low to middle income countries 
(LMICs), S19 is preferred to RB51 (Moriyón et al. 2004). 
 
The World Organisation for Animal Health (OIE) advises vaccinating 5-8 x 1010 organisms 
(“high” dose) of S19 to heifers between 3 and 8 months of age (World Organisation for 
Animal Health 2016). S19 is effective at inducing an immunological response but, unlike 
RB51, this response interferes with the serological screening of natural infections 
(Schuurman 1983). S19 has a O-chain lipopolysaccharide, unlike RB51, that results in 
antibody persistence (Schurig et al. 2002). Little is known about the duration of the 
antibody response to S19 using the government recommended dose of 5 x 1010 
organisms between 4 and 8 months in heifers and its interference in serological 
diagnostics in the longer term in the study site.  
 
A reduced dose of 3 x108 to 5 x 109 organisms (“low” dose) can be given by subcutaneous 
or conjunctival route to decrease the antibody response (World Organisation for Animal 
Health 2016; Nicoletti 1984). The downside is that this route is harder to administer, 
especially in a setting without practical and safe animal handling facilities to protect the 
animal and vaccinator from injury or self-vaccination. The only similar study in an African 
setting used a reduced dose of 3 x 109 organisms and found that in 92 adult communal 
cattle the RBT positive results decreased from 48% at one month post vaccination to 2.2 
% at 9 months and disappeared within one year (Schuurman 1983). In Brazil, the same 
dose was given to adult animals and by 9 months the RBT positives dropped to 0% from 
100% at 1 month and indirect enzyme-linked immunosorbent assay (iELISA) to 4% from 
100% at 1 month (Poester et al. 2000). In Argentina, a greater but still reduced vaccination 
dose of 3 x 1010 organisms in dairy heifers resulted in 100% buffered plate agglutination 
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test (BPA) positive and 95% iELISA positive at 3 weeks, but 10% BPA positive and 0% 
iELISA positive at 50 weeks (Aguirre et al. 2002). Other studies have documented 
antibody and cell-mediated responses to vaccination (Elaine M.S. Dorneles et al. 2015; 
Nielsen & Duncan 1988; Saegerman et al. 1999; Stevens, Olsen & Cheville 1995), but it 
is difficult to use these studies to make inferences about using serological tests for 
disease control post vaccination in a communal farming setting as they looked at different 
indicators of the immune response. These studies also used different colonies forming 
units (CFU) vaccination dosages, ages of animals, breeds and settings. 
 
The objective of this study was to follow the serological response to the Brucella abortus 
S19 vaccine (“high” dose) in cattle in a rural community bordered by wildlife protected 
areas using the current government vaccination protocol. We describe the proportion of 
cattle that seroconverted and the persistence of antibodies in the blood. These results will 
provide valuable information for understanding brucellosis screening in this study site and 
similar settings in Africa where “high” dose S19 vaccine is used.  
 
Research methods and design 
 
Setting 
The Mnisi community consists of 30 000 hectares of savannah biome on the western 
border of the Kruger National Park in South Africa and is in the Greater Limpopo 
Transfrontier Conservation Area (Figure 1). The Hluvukani animal clinic, in the middle of 
the community was used as the base for the study. A quarter of households in the 
community, of around 40.000 people, possess cattle (Berrian et al. 2016). As there is a 
close contact between the cattle, their products, and their handlers, this community is at 
risk of contracting brucellosis if the disease was endemic in their livestock. The area is 
surrounded on three sides by private and public nature reserves containing elephant, 
rhino, buffalo, lion, leopard and associated wildlife, which is seen as a potential source of 
brucellosis (Muma et al. 2006). This study adds to previous research in the area that 
explored the brucellosis epidemiology in humans, cattle, goats and dogs and suggested 
that brucellosis was absent in these species at this site (Simpson et al. 2017). This 
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epidemiological situation allowed us to follow the serological responses induced by the 
S19 vaccination over time in the absence of a B. abortus wildtype infection, while in a 
rural communal livestock farming community bordering the Kruger National Park, South 
Africa. 
 
 
Figure 1. Map of the Mnisi research site. The sampling was done at the two research dip 
tanks indicated by black dots (see legend). 
 
The Mnisi community has an estimated 16 000 cattle in the proximity of 19 dip tanks. Dip 
tanks were initially constructed to control tick-borne diseases and are used as 
administrative centres for livestock health surveillance. The study was discussed with the 
dip tank committees and six owners volunteered to have their herds enrolled in the study 
at the Athol and Utha Scheme diptanks. The cattle enrolled per owner varied from 2 to 35 
according to their herd size.  
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Study design 
This was a longitudinal cohort study following the routine government control programme. 
Heifers (n=58) with estimated age range between 3 and 12 months (median was 5 
months) were vaccinated subcutaneously with 5 millilitres of Onderstepoort Biological 
Products (OBP), Pretoria, South Africa, Brucella abortus S19 vaccine. The OBP S19 
vaccine has approximately 5 x 1010 organisms per dose of 5 ml (R. Macdonald, OBP, 
personal communication, September 3rd 2014). Twenty-nine unvaccinated males of 3 to 
12 months (median was 6 months) in the same herds as the females served as controls. 
Eight percent of cases were estimated to be younger than 4 months and 8% were 
estimated to be older than 4 months.  
 
The immunological response to vaccination was measured by two serological tests: RBT 
and iELISA. Blood was tested on the day of vaccination (Day 0) and subsequently on 2, 
4, 10, 14, 19, 24, 32, 43, 51 and 59 weeks post vaccination. All animals had to be RBT 
negative at beginning to be included in the study. Four and half years later, the 
immunological response was again measured with the aid of these two serological tests 
and an intradermal brucellin skin test (ST) in as many cases that could be traced. 
 
Sampling 
Each animal was individually identified by ear tag and photograph. At sampling, 10 ml of 
blood was collected from the jugular or tail veins. The sera were separated by centrifuging 
at 1200 g for 10 min, within 24 hours after blood collection and 1.4 ml of each serum was 
stored in cryvials at -20°C.  
 
Serological testing 
The RBT was performed as described (Alton et al. 1988) and any visible agglutination 
deemed the test as positive. The sera taken on weeks 2, 4, 10, 14, 43, 51, 59 post 
vaccination were also tested with iELISA. The samples taken at 4.5 years post 
vaccination were tested with both RBT and iELISA. The iELISA used was the IDEXX 
Brucellosis antibody test kit (IDEXX, Montpellier, France).  
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Brucellin skin test (ST) 
Four and a half years after their vaccination with the S19 vaccine, traced cases had a ST 
performed. The ST was performed as described (Saegerman et al. 1999, p.214) using 
standardized antigen, prepared from B. melitensis B115 rough strain 
(BRUCELLERGENE OCB®, Synbiotics Europe, France). The Brucellin was injected on 
day 0 and skin thickness measured on days 0 and 3.  
 
Statistical analysis 
RBT data were analysed in a mixed logistic regression using time and time2 as continuous 
explanatory variables (StatCorp 2009). Individual animals were taken as random effects 
to account for repeated samplings of the same animals. iELISA data were analysed in a 
similar model, except for the explanatory variable. Here, a categorical variable was used: 
2 months after vaccination (1-3 months) and 1 year after vaccination (10-14 months). The 
agreement between RBT and iELISA was evaluated using Cohen’s kappa test. 
 
In preliminary models, the effect of age at vaccination (continuous explanatory variable) 
and that of missing values (multiple imputation) on the serological responses were 
evaluated and found insignificant. Therefore, they were ignored in the statistical analyses 
presented in this article. 
 
Results 
 
A total of 691 samples were collected from the 58 cases and 29 controls. Sampling 
success at each sampling date differed through the study and went as low as 53% for 
cases and 52% for controls at week 22 (Figure 2).  
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Figure 2. Proportion of animals sampled over time. 
Key: Black diamond: are female/case proportion; white circle: male/control proportion; 
black circle: female and male proportion sampled are the same (51 weeks). 
 
All cases and controls were RBT negative at the beginning of the study on the day of 
vaccination. One sample of a control animal was RBT positive during the study, but 
iELISA negative. There were no other control RBT or iELISA positive samples. All the 
control animal study results when corrected for sensitivity and specificity were found to 
be 0% (95% confidence interval (CI): 0.0- 10.4) (Thrusfield 1995). 
  
At the second sampling, at two weeks, all except one of the 49 cases that turned were 
sampled were positive with RBT. All the 58 cases tested positive at least once with the 
RBT within 12 weeks. For three cases, it took 8 weeks to get the first post-vaccination 
positive result. The percentage RBT and iELISA positive decreased from their peak after 
two and eight weeks post vaccination respectively, but there were still positive animals, 
14% for RBT and 32 % for iELISA, 59 weeks after vaccination (Figures 3 and 4).  
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Figure 3. Observed proportion and prediction of RBT positive case results over time using 
quadratic logistic regression and with 95% confidence intervals. 
 
 
Figure 4. Observed proportion and prediction of iELISA positive case results over time 
using categorical logistic regression and with 95% confidence intervals. 
 
Four and a half years after vaccination blood samples were taken from all cases that 
could be traced, which was only 7 (12%). Out of seven cases tested with RBT, ELISA, 
and Brucellin ST, one was positive with RBT and iELISA and three other cows were 
positive on ST only (Table 1).  
0
0,25
0,5
0,75
1
0 10 20 30 40 50 60
P
ro
p
o
rt
io
n
 o
f 
R
B
T 
p
o
si
ti
ve
 h
ei
fe
rs
Weeks post vaccination
0
0,25
0,5
0,75
1
0 10 20 30 40 50 60
P
ro
p
o
rt
io
n
 o
f 
EL
IS
A
 p
o
si
ti
ve
 h
ei
fe
rs
Weeks post vaccination
132 
 
 
Table 1. Table of serological and ST results of 7 cases four and a half years after 
vaccination. 
ANIMAL RBT iELISA ST 
1 N N N 
2 N N P 
3 N N N 
4 N N P 
5 N N N 
6 P P N 
7 N N P 
 
N = negative and P = positive. 
 
Discussion 
 
The RBT is seen as the best screening test for brucellosis in this context (Godfroid et al. 
2010) and iELISA is seen as a confirmatory test as it is more specific than the RBT (Corbel 
2006), both of which are recommended by the OIE. The ST is an assessment of the cell-
mediated immunity as opposed to the humoral immunity assessed by the serological tests 
and is seen as more specific but less sensitive that the RBT and iELISA and more suitable 
to low prevalence settings (Godfroid et al. 2002; MacDiarmid & Hellstrom 1987; 
Saegerman et al. 1999). 
 
The expected seroconversion of cases was 100% (Lord et al. 1998). A sample size of 58 
cases that all seroconvert is required to obtain 95% as a lower limit of the 95% confidence 
interval (Thrusfield 1995). The results demonstrated a robust and rapid serological 
response to vaccination in 100% of animals. Ninety eight % (48/49) of cases 
seroconverted with RBT by week 2, which is reported in other publications (Stevens, 
Olsen & Pugh 1995), and all cases seroconverted using iELISA by 12 weeks. Cases took 
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longer to seroconvert to iELISA, but all seroconverted at least once to the iELISA within 
12 weeks. 
 
The proportion of RBT positive results decreased rapidly after 8 weeks. This decrease 
changed after 14 weeks to create an inverse sigmoid curve that plateaued after 43 weeks 
(Figure 3). This trend is linked to the significant quadratic term of time (time2). According 
to the model, the median seroconversion sample date from RBT positive to negative 
(proportion of heifers that had turned negative) was 24 weeks post vaccination, whereas 
5% of the heifers remained RBT seropositive a year after vaccination. The proportion of 
iELISA positive cases dropped from 99% (95% CI: 95 – 99.8%) 4 to 14 weeks post 
immunisation to 17% (95% CI: 7 – 39%) 43 to 59 weeks after vaccination (Figure 4). The 
decline in antibodies over time follows a sigmoidal curve. The response declines more 
sharply with RBT compared to iELISA (5% RBT positive and 17% iELISA positive cases 
between 10 and 14 months). The RBT is known to mainly detect immunoglobulins M (IgM) 
and immunoglobulins G (IgG) whereas the iELISA detects solely IgG (Nielsen et al. 2005). 
Hence, earlier RBT positivity and decline are expected since the IgM response to 
vaccination is quicker than the IgG response and does not last as long as the IgG 
(Godfroid et al. 2010). The apparent discrepancy between observed and fitted data in 
figure 4 and, to some extent, figure 3 is due to the random effect (animal) included in the 
mixed model. There is a substantial agreement between the RBT and iELISA results as 
shown with a kappa coefficient of 0.63, which indicates that the tests follow a similar 
pattern over time. The increase in positives from 51 to 59 weeks is due to cases that were 
not tested in week 51 and were tested in week 59 and found to be positive (1 RBT positive 
and 4 iELISA positive).  
 
Four and a half years after vaccination out of seven cases, the rest were lost to follow-up 
due to slaughter, death from disease or movement, one animal (14%) was positive with 
RBT and iELISA and three other cows were positive (43%) with the ST only. The fact that 
one animal was positive on both serological tests and not on the ST and three were only 
ST positive reflects the different immunological responses detected by the different tests. 
The four positive animals at four and a half years were vaccinated at 3 (RBT and iELISA 
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positive), 4 (iELISA and skin test positive), 5 (skin test positive), and 8 (skin test positive) 
months. Therefore, their positivity was probably not due to being vaccinated after eight 
months of age, which has been suggested to be one of the main cause of persistence of 
an antibody response, although the age estimation is subjective.  
 
This comprehensive response to the vaccine demonstrates the ability of the vaccine to 
induce a robust immunological response in an African savannah rangeland farming 
setting, which can be used to assess vaccine coverage assuming an absence of wild type 
infection. A concern during the study was that the animals would be subjected to wildtype 
infection. Vaccinated heifers that are infected by wildtype B. abortus will show a classical 
“boost effect”, which is the hallmark of a secondary immune response (Fensterbank & 
Plommet 1979). This was not seen in our study. As there was only one RBT positive 
sample in the controls and no iELISA positive controls over the 59 weeks follow-up, a wild 
type infection is unlikely to have interfered with the antibody responses in the cases. The 
fact that non-vaccinated bulls remained negative also strongly suggests that there was 
no circulation of wildtype B. abortus in this setting throughout the duration of the study. A 
companion study at the same time by the authors documents that there was indeed no 
wildtype infection (manuscript submitted for publication). A “boost effect” seen during 
disease surveillance, should always be thoroughly investigated by veterinary service.  
 
Limitations of the study 
 
The study had gaps in the sampling and testing of the animals as it was not always 
possible to sample an animal and due to financial constraints not all samples had an 
iELISA test. This gives an incomplete picture of the iELISA results curve. The study was 
undertaken by the primary authors and was as they experienced it. The RBT is subjective 
and therefore results could have bias. 
 
Ageing of the animals may have been inaccurate because only visual indicators, such as 
size, condition, teeth present and questioning the owner were used. Combined with this 
inaccurate aging is the variation of genetics, feeding and husbandry between the herds 
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in the communal farming setting resulting in animals growing at different rates. These 
variations may result in heifers’ age being underestimated and being vaccinated outside 
of the four to the eight-month window, which in turn may be responsible for a prolonging 
of the serological and allergenic positive responses as the older an animal is at 
vaccination the longer is the persistence of the ST reaction (Saegerman et al. 1999).  
 
Recommendations 
 
In South Africa where brucellosis is endemic, vaccination is compulsory but testing is not 
compulsory, it is important for owners and veterinary officials to know the status of 
animals. The fact that 17% of the cases had an iELISA positive response and 5% have 
RBT positive response around a year after vaccination and that four and a half years after 
vaccination there are still serological and allergenic test positives, shows that there can 
be immunological persistence to the vaccination for many years, which has been 
previously documented in dairy and beef cattle in Belgium (Saegerman et al. 1999). This 
is relevant for disease control as these positives may be seen and incorrectly interpreted 
as wild type infections and not vaccine responses as they are so many years post 
vaccination. If there is confusion over whether animals are reacting from vaccination or 
wildtype infection the infection history of herd, area, and animals brought into the herd is 
of importance. This antibody persistence after vaccination could also cause false positive 
reactions with the confirmatory CFT (World Organisation for Animal Health 2009) that is 
used in South Africa. 
 
This necessitates a careful interpretation of serological results or the use of multiple tests 
(Abernethy et al. 2012), such as use of a competitive ELISA (cELISA), which gives less 
false positives from vaccination (Gall & Nielsen 2004), and ideally culturing of B. abortus, 
seen as the gold standard (World Organisation for Animal Health 2009) in order to confirm 
the presence of wildtype infection and not the vaccine type. The iELISA uses smooth 
lipopolysaccharides or O-polysaccharides as antigens, which is also sensitive for the 
antibodies produces by S19 vaccination, while the cELISA adds a monoclonal antibody 
that is specific for Brucella spp. O-polysaccharides that decreases false positives from 
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vaccination (World Organisation for Animal Health 2009). While disease status of 
individuals are being determined, it would be wise to identify and separate the animals 
that appear to be infected until their status can be assured or they are slaughtered.  
 
This study used a high vaccine dose of 5 x 1010 organisms that is in line with the 
recommendations of the OIE (5-8 x 1010 organisms) (World Organisation for Animal 
Health 2016). It revealed a longer and more comprehensive antibody response than a 
similar study in Zambia that used a reduced dose of S19 (3 x 109 Brucella bacteria) and 
had no young animals (8-18 months at vaccination) RBT positive by 6 months 
(Schuurman 1983). This reduced dose will result in less interference with diagnostics, and 
has been shown to induce the same level of protection than high doses both 
experimentally (Fensterbank & Plommet 1979; Plommet et al. 1976) and in field work 
(Nicoletti et al. 1978).  
 
Another option is to administer a reduced dose (5 x 109 organisms) via the conjunctival 
route that yields a lower serological response compared to subcutaneous injection 
(Nicoletti 1984; Plommet et al. 1976; World Organisation for Animal Health 2016). This 
will result in less interference with disease control by serological means, but is much more 
difficult and time consuming to administer in these settings and requires the animal to be 
well restrained to avoid unnecessary trauma to the animal or self-injection.  
 
Conclusions 
 
This study revealed a comprehensive and rapid antibody response in heifers vaccinated 
with S19 vaccine in this communal farming setting. Ninety-eight percent of animals 
seroconverted to the RBT by week 2 and all cases seroconverted to RBT and iELISA by 
12 weeks. The antibody presence decreased in an inverse sigmoid fashion to half of the 
animals being RBT positive at 6 months and around 5% of animals RBT positive and 17% 
iELISA positive one year after vaccination. The serological effects of vaccination therefore 
can persist for more than a year and possibly several years as seen in one animal when 
tested four and a half years after vaccination. This can confuse evaluation of the disease 
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status of a herd by serological testing when there has been a history of vaccination with 
S19. This must be taken into consideration in making herd disease control 
recommendations after serological testing for brucellosis in this setting.  
 
The constant decrease in serological titres in vaccinated heifers over time combined with 
the absence of seroconversion in non-vaccinated bulls and with the absence of clinical 
signs suggestive of brucellosis (i.e., high rate of abortion), allow us to suggest the 
absence of brucellosis in the presence of positive serological reactions induced 
exclusively by S19 vaccination (“high” dose). It may be advised to use a “low dose” 
vaccination that could result in less antibody persistence.  
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GENERAL CONCLUSIONS AND PERSPECTIVES  
 
Brucellosis is believed to be a neglected zoonosis that infects domestic animals and 
wildlife as well as humans causing significant health and economic impacts. The overall 
goal of this body of research is to better understand the epidemiology of brucellosis in the 
Mnisi community, which is an African example of an “One Health” setting, where domestic 
animals, humans and wildlife live in close proximity and come into indirect and direct 
contact. To correctly understand the epidemiology at this site we explored the published 
literature on brucellosis in wildlife in Africa and then the evidence of brucellosis in buffalo, 
humans, goats, dogs, cattle and buffalo at the study site. 
 
The systematic review of literature found that brucellosis had been serologically 
documented in sixty-one wildlife species and identified nine times in six species of wildlife 
and rodents in Africa. The identification of Brucella species was first made in the 1960’s 
in Africa and has been made infrequently since. The identification of Brucella spp. in 
Egypt, Kenya, Tanzania, Zimbabwe and South Africa, indicates that brucellosis is spread 
widely across the continent and most likely is underdiagnosed and more ubiquitous than 
previously thought. Nine identification studies in over fifty years for the whole continent 
highlights the need to conduct more identification of Brucella species infecting populations 
so that we can better understand the epidemiological picture in Africa. There is also a gap 
in literature on B. suis infection in wild and domestic suids in Africa. It has been identified 
in cattle in Zimbabwe (Ledwaba et al. 2014), which indicates that there must be a source 
in another species, possibly wildlife, as cattle are spill over hosts (Fretin et al. 2013). 
 
Wildlife is thought to have become infected from domestic animals and then certain 
wildlife species could have become a reservoir for infection. The Kafue lechwe in Zambia, 
for instance, were most likely infected from cattle that moved into their area in the 1970’s 
and have remained infected either due to continued spill over from domestic animals or 
other species or have become a reservoir (Muma et al. 2011). Interestingly in Zimbabwe, 
in the Greater Limpopo Transfrontier Conservation Area, research found a positive sero-
prevalence of 9.9% in cattle (n=1158) and giraffe (n=1) and yet, no sero-prevalence in 
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buffalos (n=47), impala (n=33) and kudu (n=16) (Gomo, Musari, et al. 2012). Even though 
the domestic animals and wildlife in this study are in close contact the disease had not 
yet spread to all susceptible species.  
 
The majority of wildlife studies identified in the systematic review were opportunistic 
studies and the accuracy of using these results as a sero-prevalence is questionable as 
the population sizes would not have been know and true random sampling would not 
have been conducted. Yet, the studies do give us an indication of the epidemiology of the 
disease and evidence of its presence or not.  
 
Bearing the above in mind, our meta-analysis found a positive association with livestock 
contact with antelope and carnivore species and not with buffalo. The independence of 
prevalence in buffalo from livestock contact indicates that buffalo maybe able to sustain 
Brucella infection independent of influx of bacteria from other host species and is thus a 
reservoir of B. abortus for other wildlife species and may also spill back to cattle. The 
meta-analysis also indicated that buffalo populations more likely to be infected, had a 
higher seroprevalence than other species.  
 
Gregarious wildlife species such as buffalos, eland, impala and wildebeest are reported 
to have a higher seroprevalence than solitary animals such as rhinoceros (Ducrotoy et al. 
2017). Although, that cannot be the only factor affecting seroprevalence. A driver for 
tuberculosis spread between buffalo is thought to be their social nature and large herd 
sizes, an average of 250 per herd in the Kruger National Park (Michel et al. 2006). The 
higher within herd infection rate and higher prevalence of brucellosis in buffalo 
populations could also be due to their social nature and large herd sizes. 
 
Our meta-analysis of the results from the systematic review revealed an association with 
higher rainfall and more herds infected and infected populations showed a higher 
seroprevalence. This could be due to higher rainfall areas may having a higher density of 
animals and larger herds due to better grazing, which may result in higher transmission 
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rates and a higher likelihood of a herd being infected. The bacteria also survives for longer 
in wetter environments which may give more time for transmission to susceptible animals.  
 
Our meta-analysis also found studies published after the year 2000 had higher sero-
prevalences than studies published before 1980. This may be due to bias in that there 
are more studies recently focusing on populations that are more likely to be infected, but 
it could also be due to the disease becoming more established in populations. The rising 
seroprevalences in the study settings will mean a greater risk to public and veterinary 
health that will need reliable control and prevention methods. It is harder to control a 
disease and rarely justified to do so in free ranging wildlife in comparison to domestic 
animals, but there are economical and effective control methods for domestic animals, 
such as vaccination, that can be used to induce immunity to infection from wildlife to 
domestic animals.  
 
It is worth bearing in mind that serological tests for brucellosis in wildlife species are not 
validated so results must be interpreted with caution (International Office of Epizootics. 
Biological Standards Commission. 2012). This is certainly more relevant when comparing 
the same test used in different species as opposed to within one species. Although, it is 
also relevant when comparing different tests. Our meta-analysis of prevalence studies 
did not find convincingly significant difference between the agglutination and ELISA tests. 
There are methods to improve test reliability, for example RBT testing of wildlife sera has 
been found to have a better coherence with iELISA after a chloroform/centrifugation 
cleaning (Godfroid et al. 2016). 
 
To understand our local situation better we sampled, tested and identified brucellosis in 
African buffalo in the study site in the Kruger National Park alongside the community we 
studied. Besides B. abortus infection, we identified B. melitensis infection in buffalo. This 
is an unexpected and worrisome information as B. melitensis has not been identified in 
African buffalo and not found in any animal in the Kruger National Park. B. melitensis has 
only been identified previously in impala antelope (Aepyceros melampus) (Schiemann & 
Staak 1971) in Tanzania and Nile catfish (Clarias gariepinus) in Egypt (El-Tras et al. 2010) 
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in published research. It has been identified in sable antelope (Hippotragus niger) in 
South Africa in 2007, 2015 and 2016 (National Department of Agriculture n.d.) outside of 
the KNP. These results suggest that B. melitensis has spilled over from a small stock 
population neighbouring the park. However, we cannot exclude or another wildlife species 
in the KNP that has been infected from the small stock. It is very unlikely that B. melitensis 
has become established in the buffalo populations and had not been detected until now. 
Control of the disease in wildlife in the park is currently not a possibility. But preventing 
the infection from going out of the park to uninfected domestic animals (spill back) is of 
importance. The results also have a public health implication as there is human 
consumption of wildlife from the park. This must be taken into consideration during 
processing of slaughtered wildlife to protect abattoir workers and wildlife products must 
be treated accordingly to prevent transmission to humans. It is also worth bearing in mind 
that although transmission from wildlife to humans has been documented as being rare 
there are borders in the Greater Limpopo Transfrontier Park where people go inside the 
park to hunt for “bushmeat”. In sub-Saharan Africa, no proof of direct transmission of 
Brucella spp. form wildlife to humans has been reported in the international scientific 
literature, although transmission from preparing and consuming buffalo bushmeat has 
been suggested in Botswana (Alexander et al. 2012). Nevertheless, education in these 
communities of the brucellosis risks from hunting wildlife may be of public health benefit. 
 
In most settings in Africa, where there are domestic animals and wildlife in close proximity 
there are no or compromised fences and controlling brucellosis by testing with slaughter 
of livestock is not economically feasible. In these settings, there will most likely be more 
contact between domestic animals and wildlife than in our study site, which means the 
risk of inter-species transmission will be greater than in our study site. This will place more 
emphasis on the success of vaccination to protect domestic animals and then humans. 
Wider and continuous vaccination of livestock could be considered in these settings.  
 
The isolation of B. melitensis in buffalo for the first time in Africa indicates the buffalo has 
become a spillover host. Goats were thought to be the reservoir of B. melitensis, but it 
has since been found in sable antelope (Hippotragus niger) in South Africa and now 
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buffalo, which indicates that the dynamics of Brucella infection at the wildlife/livestock 
interface is changing. We only tested buffalo so we cannot exclude the presence of 
undetected B. melitensis in other wildlife species. Unpublished research in the Limpopo 
National Park (LNP), Mozambique, where there were 25 000 people living in the park 
found that over 80% of households had goats and over 40% saw domestic animals and 
wildlife mixing (G. Simpson 2007). In this setting the only fencing between wildlife and 
domestic animals is when the livestock are brought home for the night. It is possible the 
buffalo were infected from these livestock and the disease moved through the park. A 
study of buffalo and cattle in the LNP found both infected with RBT and ELISA, but 
unfortunately not identification of species was made (Tanner et al. 2015). 
 
Further molecular epidemiological studies (MLVA) should be done to establish the source 
of the bacteria to establish its transmission and assess which are reservoir species 
(vectors) and which are only spillover species (victims). This will have an impact on 
disease control and is of relevance in transfrontier conservation areas where wildlife can 
move across country boundaries and spread unnoticed with possible severe public health 
consequences if not controlled.   
 
Research conducted at the study site found nearly three quarters of the households 
owning at least one animal, one quarter had cattle and 61% of respondents believed 
diseases of animals could be transmitted to humans, although brucellosis was not 
mentioned (Berrian et al. 2016). In order to fully understand the epidemiological situation 
in the study site we looked for evidence of infection in the domestic animals and humans. 
Sampling of dogs was included to the cattle and goats as the dogs ingest abortion 
materials in the field and carcasses of dead animals thereby potentially being exposed to 
brucellosis. Goats have been found to be infected with B. melitensis in South Africa 
(Ribeiro et al. 1990) and spillover of B. abortus from cattle to goats was detected with a 
serum agglutination test in a similar setting in Uganda (Kabagambe et al. 2001; Mellau et 
al. 2009). In our study site the lack of evidence of infection in goats and dogs strongly 
suggest that B. melitensis and B. abortus infections are absent in the animal reservoir in 
this community.  
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The cattle showed a low sero-prevalence of 1.4%. It is not straight forward making a 
serological distinction between true infection due to Brucella wild type infection and 
vaccine related residual antibodies at low sero-prevalences. Neither RBT nor ELISA tests 
are 100% sensitive or specific and although good screening tests they should not be used 
alone (Matope et al. 2011). Both tests cross-react with Yersinia enterocolitica O:9 and 
other bacteria causing false positive results (Godfroid et al. 2002; Kittelberger et al. 1998; 
Garin-Bastuji et al. 1999).  
 
A wild type infection should show 1) an increasing seroprevalence with increasing age, 
2) seropositivity in (non-vaccinated) males, 3) the ability to isolate the organism, 4) 
possible spill-over to other domestic animals and 5) human infections. We found the 
opposite with seroprevalence decreasing with age, the male true seroprevalence is zero 
and we were unable to isolate the organism indicating the absence of the disease in cattle.  
 
To understand if the sero-prevalance pattern found was due to vaccination we conducted 
a longitudinal cohort study of vaccinated heifers and compared them to unvaccinated 
male calves. We found a comprehensive and rapid antibody response to RBT and iELISA 
by 12 weeks. The antibody presence decreased in an inverse sigmoid fashion to half of 
the animals being RBT positive at 6 months and around 5% of animals RBT positive and 
17% iELISA positive one year after vaccination. The serological effects of vaccination 
therefore can persist for more than a year and possibly several years as seen in one 
animal when tested four and a half years after vaccination. This can explain the antibody 
picture found in the serological testing of the cattle.  
 
The healthy immunological response to a high vaccine dose of 5 x 1010 organisms, that 
is in line with the recommendations of the OIE (5-8 x 1010 organisms) (World Organisation 
for Animal Health 2016), in the heifers in the field is both encouraging and confusing from 
a disease control perspective. The vaccine induce immunological response will lead to 
false positive tests results in disease control. Thus careful interpretation of serological 
results or the use of multiple tests (Abernethy et al. 2012), such as use of a competitive 
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ELISA (cELISA), which gives less false positives from vaccination (Gall & Nielsen 2004), 
and ideally culturing of B. abortus, seen as the gold standard (World Organisation for 
Animal Health 2009) is needed in order to confirm the presence of wildtype infection and 
not the vaccine type. The iELISA uses smooth lipopolysaccharides or O-polysaccharides 
as antigens, which is also sensitive for the antibodies produces by S19 vaccination, while 
the cELISA adds a monoclonal antibody that is specific for Brucella spp. O-
polysaccharides that decreases false positives from vaccination (World Organisation for 
Animal Health 2009). 
 
Another option would be to consider using a lower dose of vaccine or a different method 
of inoculation. In Zambia a lower dose (3 x 109 Brucella bacteria) was used in older 
animals (8-18 months at vaccination) and the serological results did not last longer than 
6 months (Schuurman 1983). The reduced dose has shown the same level of protection 
as high doses both experimentally (Fensterbank & Plommet 1979; Plommet et al. 1976) 
and in the field (Nicoletti et al. 1978).  
 
A reduced dose (5 x 109 organisms) could also be administered by a conjunctival route 
that will result in a lower serological response compared to subcutaneous injection 
(Nicoletti 1984; Plommet et al. 1976; World Organisation for Animal Health 2016). This 
will be more beneficial from a disease control perspective, but the conjunctival route is 
harder to administer, and more time consuming in these settings and requires the animal 
to be well restrained to avoid unnecessary trauma to the animal or self-injection, which 
could have a serious consequence. If there is a suitable head clamp or holding facilities 
it may be possible to use this route, but this is unlikely in this setting.  
 
Brucellosis is an old and persistent disease that has adapted to infect a wide variety of 
species. Although, it causes significant morbidity and mortality the disease is not 
controlled in many “One Health” settings, especially if there are infected wild species. Our 
testing of high risk humans that were herding cattle through the cattle diptank showed no 
sero-positive individuals. This correlates to what we found in the cattle and other domestic 
animals. As the cattle showed a low to negative true seroprevalence and absence of 
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isolation, the goats, dogs and humans free of brucellosis, we deemed the domestic 
animals and community free of infection with B. abortus and B. melitensis. Brucellosis 
has also not been introduced from infected domestic animals from out of the area. This 
means that, currently, there is no risk of transmission of brucellosis to humans through 
contact with livestock and dogs and no foodborne risk (mainly through raw milk or milk 
products). It is encouraging to know that in a setting where there is infected wildlife the 
domestic animals and humans can be free from disease. Transmission depends on a 
viable source of sufficient bacteria coming in contact with susceptible animals. It would 
be valuable to know the reasons for the absence of infection in the community. If the 
wildlife is infected and the domestic animals and humans are free of disease, this 
suggests that well maintained fences play a major role in avoiding contact between 
infected wildlife and non-infected livestock and thus avoiding that Brucella infection is 
transmitted across the fence from the wildlife.  
 
There has been decades of similar stocking densities of domestic animals alongside 
these wildlife reserves. The lack of transmission across the fence could be due to the 
control methods of fencing between wildlife and domestic animals, vaccination and 
movement restrictions of cloven hoofed animals due to foot and mouth disease control 
measures, but it is not possible to make that deduction from the research. There are fence 
transgressions by wildlife from the park to the communal areas and vice-versa, although 
in buffalo the fence transgressions are more likely to be made by young males than 
aborting females. The environmental conditions of this setting may also not be conducive 
to transmission. Abortions in buffalo, if they follow a similar pattern to cattle, should occur 
at the end of the dry season and beginning of wet season. There is plenty of sunshine 
and although there may be rain the day time temperatures will be over thirty degrees, 
which is not conducive to bacterial survival. Transmission from wildlife to domestic 
animals may also be harder than we think and there may be a greater risk of brucellosis 
being brought into the area from infected domestic animals than from wildlife. The lack of 
brucellosis in domestic animals and humans could be also due to the other control method 
of vaccination in heifers that avoids having a susceptible population in the cattle. As the 
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domestic animals are free of the disease livestock should be tested for brucellosis before 
being imported into the area.  
 
Our studies found that brucellosis was present in the wildlife but not in the domestic 
animals and people of the study site. The setting has a fence between wildlife and 
domestic animals, control through vaccination and movement restriction of cloven hoofed 
animals due to foot and mouth restrictions. These factors have played an important role 
in preventing the disease being transmitted into the community and should be maintained 
to avoid any introduction of Brucella spp. in the future. 
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Abstract 
We used a community engagement approach to develop a One Health profile of an agro-
pastoralist population at the interface of wildlife areas in eastern South Africa. 
Representatives from 262 randomly-selected households participated in an in-person, 
cross-sectional survey. Questions were designed to ascertain the participants’ 
knowledge, attitudes, and practices with regard to human health, domestic animal health, 
and natural resources including wildlife and water. Surveys were conducted within four 
selected villages by a team of trained surveyors and translators over four weeks in July-
August 2013. Questions were a combination of multiple choice (single answer), multiple 
selection, open-ended, and Likert scale. 
The study found that nearly three-quarters of all households surveyed reported owning 
at least one animal (55% owned chickens, 31% dogs, 25% cattle, 16% goats, 9% cats, 
and 5% pigs). Among the animal-owning respondents, health concerns identified included 
dissatisfaction with government-run cattle dip facilities (97%) and frequent morbidity and 
mortality of chickens that had clinical signs consistent with Newcastle disease (49%). 
Sixty-one percent of participants believed that diseases of animals could be transmitted 
to humans. Ninety-six percent of respondents desired greater knowledge about animal 
diseases. With regard to human health issues, the primary barrier to health care access 
was related to transportation to/from the community health clinics. Environmental health 
issues revealed by the survey included disparities by village in drinking water reliability 
and frequent domiciliary rodent sightings positively associated with increased household 
size and chicken ownership. Attitudes towards conservation were generally favorable; 
however, the community demonstrated a strong preference for a dichotomous approach 
to wildlife management, one that separated wildlife from humans. 
Due to the location of the community, which neighbors the Great Limpopo 
Transfrontier Conservation Area, and the livestock-dependent lifestyle of the resource-
poor inhabitants, a One Health approach that takes into consideration the 
interconnectedness of human, animal, and environmental health is necessary. The 
community profile described in this study provides a foundation for health research and 
planning initiatives that are driven by community engagement and consider the multitude 
of factors affecting health at the human-domestic animal-wildlife interface. Furthermore, 
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it allows for the determination and quantification of the linkages between human, animal, 
and environmental health.  
 
Introduction  
Africa has experienced dramatic shifts in human and animal population dynamics over 
the last century. Armed conflict, changes in land use, and a rapid rise in the human 
population have forced the movement of people and the re-establishment of communities 
in previously uninhabited areas (Kock et al., 2002). In southern Africa, another such 
change in land use was the development of transfrontier conservation areas (TFCAs) in 
the early 2000s. There are currently 13 TFCAs under active development in Southern 
Africa. TFCAs have been promoted as a way to reconcile conservation and development 
objectives through increased cross-border collaboration and ecotourism (de Garine-
Wichatitsky et al., 2013). TFCAs seek to limit barriers between countries, thus allowing 
wildlife to roam more freely and promoting regional peace, cooperation, and socio-
economic development (Department of Environmental Affairs, 2015). However, the 
increased movement of animals across the boundaries of these re-connected 
conservation areas presents new challenges for animal health and, in turn, adjacent 
human communities (Bengis, 2005). With the growing recognition of the interconnectivity 
of the health of all species with that of their environment, mitigation of disease 
transmission at the human-wildlife-livestock interface has become a major development 
and conservation objective (de Garine-Wichatitsky et al., 2013). 
The land of the Mnisi Traditional Authority (MTA) within the Bushbuckridge Local 
Municipality, Mpumalanga, South Africa exemplifies this interface. The Municipality 
contains over 500,000 people, and its entire eastern boundary borders the Great Limpopo 
TFCA. The Great Limpopo TFCA is one of the largest TFCAs in Southern Africa with a 
land area of nearly 100,000 km2. It spans three countries (South Africa, Zimbabwe, and 
Mozambique) and contains five national parks. The people who reside in the 
Bushbuckridge Local Municipality on the periphery of the Great Limpopo TFCA are 
characterized by a high degree of poverty and many rely on land-based activities such as 
agriculture and natural resource use for their livelihoods (Andersson et al., 2013). In this 
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area, the co-existence of humans, domestic animals, and wildlife is required and critical 
to the sustainability of the parks and success of wildlife conservation efforts.  
Within the MTA, livestock dependence, coupled with proximity to wildlife areas, makes 
health promotion and poverty alleviation a more complex problem. A One Health (OH) 
approach that recognizes the interconnectedness of human, animal, and ecosystem 
health and encourages collaboration between diverse disciplines is ideally suited to 
address these types of problems (Mazet et al., 2009; Conrad et al., 2013; Grace, 2014). 
Integrated animal-human health surveillance using simultaneous data collection is a 
method by which to better understand these complex relationships (Thumbi et al., 2015). 
The goal of our study was to establish a baseline profile of a selected area within the 
MTA in order to plan follow-up research and activities that use a community-engaged, 
OH approach for the purposes of informing disease prevention and mitigation efforts in 
both human and animal populations. A community-engaged approach seeks participation 
from inhabitants and draws on the capacities and resources of those people, rather than 
a top-down approach. Community engagement is a core element of any research effort 
involving communities and may enhance a community’s ability to identify and address its 
own health needs, disparities, and goals. In addition, results of community-engaged 
research are used to guide the development of interventions, education, or policies 
(Ahmed et al., 2010).  
This study seeks to describe human and animal demography within the study area 
and the perspectives of the people in terms of how they view their health; whether they 
acknowledge a connection between their health, the health of their animals, and 
environmental factors; what they consider to be priority concerns for their community; how 
they perceive wildlife and conservation; their self-reported health history; and their 
satisfaction with health services. Triangulating knowledge, attitudes, and practices with 
self-reported health and disease history is an important step in community health 
research and planning that requires a community-engaged approach. Furthermore, 
quantifying linkages between livestock and human health remains a priority for developing 
sustainable poverty relief and public health interventions for livestock-dependent 
communities (Thumbi et al., 2015). The result of this study will be a comprehensive OH 
profile of the study area. This profile can be used for subsequent health planning and 
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research aimed at improving health and livelihoods of community members and mitigating 
disease risks.  
 
Materials and methods  
Study area 
The study was carried out in a selected area within the MTA, hereafter referred to as 
the “Mnisi study area,” located in the Mpumalanga Province in the Republic of South 
Africa. The Mnisi study area is situated in the northeastern corner of the Bushbuckridge 
Local Municipality and is the core research and engagement area of the Mnisi Community 
Programme, Faculty of Veterinary Science, University of Pretoria (UP). The study area 
contains approximately 29,500ha of communal land, of which more than 75% borders 
private and provincial conservation areas (Figure 1). The study area includes the adjacent 
Andover and Manyeleti provincial game reserves, of which Manyeleti has open access to 
the Kruger National Park and is thus part of the Great Limpopo TFCA.  
 
Population and sample size 
The total population in the Mnisi study area is estimated at 40,000-50,000 individuals 
in approximately 8,500 households (Statistics South Africa, 2012). This study involved a 
stratified random sample of households within four purposively-selected villages: Athol, 
Gottenburg, Thlavekisa, and Utha (Figure 1). These villages were selected based on their 
close proximity to private and provincial game reserves as well as the presence or 
absence of a community health clinic (two with and two without). Within each village, each 
household was numbered using Google Earth™ images (Google Inc., Mountain View, 
CA, USA) and randomly selected using a random number generator (Microsoft Excel, 
Redmond, WA, USA). Sample size was determined by the following parameters for a 
population survey with random sampling: 2,300 total estimated households within the four 
selected villages (unit of analysis), an expected difference between villages of 15%, 95% 
confidence level, and 90% power. As a result, a total of 256 surveys were determined to 
provide sufficient statistical power (WinEpi, 2010).  
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Figure 1. Map of the Mnisi study area (outlined in light green), Mpumalanga Province, 
Republic of South Africa, highlighting the location of the four selected villages (circles). 
Image courtesy of Mnisi Community Programme, University of Pretoria 
 
Data collection method 
A cross-sectional, in-person survey using a structured questionnaire administered in 
the participants’ household was used to obtain information from selected individuals. 
Responses were collected on personal digital assistants (PDAs) using SurveyToGo 
mobile survey software (Dooblo Ltd., Kfar Sava, Israel), which was previously deployed 
in the study area with success (Madder et al., 2012). The questionnaire underwent 
content validation by subject matter experts and community representatives to ensure 
appropriateness, relevancy, and cultural sensitivity of questions. A pilot questionnaire was 
trialed in a region not included in the final study site and adapted to maximize participant 
comprehension. All questionnaires were completed over four weeks between July and 
August 2013 by surveyors accompanied by a trained Shangaan-English translator 
employed by the Mnisi Community Programme. Potential participants were provided with 
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an oral description of the study goals, the voluntary and confidential nature of their 
participation, and a time estimate for their involvement. Only those participants aged 18 
years or older from whom consent was obtained were surveyed. This study was reviewed 
by the University of California, Davis Institutional Review Board and determined to be 
exempt from human subjects regulations. Ethics approval was also obtained through the 
University of Pretoria Research Ethics Committee, Faculty Humanities and permissions 
were granted by the Mnisi Traditional Council as well as village leaders. The information 
obtained from the questionnaires was recorded by the investigators in such a manner that 
subjects could not be personally identified, either directly or through identifiers linked to 
the subjects. 
 
Survey design 
The survey was designed to collect data on human and domestic animal population 
demographics, animal health and services, human health and services, wildlife, and 
environmental health (Figure 2). The survey employed a structured questionnaire, which 
included a combination of multiple choice (single answer), multiple selection, open-ended, 
and Likert scale questions. The first section, which focused on participant demographics, 
was designed to determine study eligibility and preferred language as well as to classify 
participants by education level, status within the household, occupation, and household 
size.  
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Figure 2. Schematic representation of the One Health framework used to design the 
topics to be included in the Mnisi study area questionnaire  
 
The second section aimed at describing the domestic animal composition of the 
household, the health priorities and history of those animals as described by the 
participant, the participant’s perception of veterinary services in the community, and 
his/her knowledge of animal diseases and transmission. Participants were also asked 
about their consumption of animal products and the preparation of those products. 
The third section of the questionnaire focused on human health factors, including 
nutrition, access to and satisfaction with available health care, and priority health 
concerns in adults and children as described by the participant. Participants were also 
asked about their household’s health history, specifically the occurrence of diseases 
linked to animals, sanitation, and water. 
The final section of the questionnaire focused on natural resources and environmental 
health, and included topics such as waste disposal, interactions with wildlife including 
rodents, source of and satisfaction with water, and participants’ perceptions of 
conservation efforts in and around their community. 
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Data analysis 
Descriptive statistics were used to summarize the main features of the data collected. 
Summary statistics including mean, median, standard deviation (SD), range, and 
maximum values for continuous variables and frequency and proportions for categorical 
variables were calculated. The chi-square test for homogeneity was used to test for 
village-level differences. Exploratory results suggested the importance of rodent sightings 
around the home. For that reason, and because rodent-borne zoonoses have been 
identified to be prevalent and a major concern in the community (Quan et al., 2014), we 
were particularly interested in identifying factors contributing to rodent presence at the 
household level. For this purpose, we used a multilevel logistic regression model with 
village as a random effect to identify factors contributing to observation or not of rodents 
at the household level (coded as 1/0, respectively). Rodent observation was considered 
as an ordinal variable with three response categories (daily, less than daily, never), but 
we found this categorization did not result in an improved model. The model is expressed 
as follows: 
yij~Bernoulli (πij); logit (πij) = β0 + β1X1ij + β2X2ij + … + βkXkij + uj 
where yij is the binary dependent variable—observation of rodents yes/no—for household 
i in village j; πij is the expected probability of rodent observation within the household; β0 
is the intercept; β1ij, β2ij,…, βkij are the slopes; and uj is the random effect, which accounts 
for clustering of households within villages. Model construction was initiated with a 
univariate analysis of hypothesized risk factors using a liberal p-value < 0.2. Then a 
multilevel model was evaluated using forward selection. Quantitative variables were 
tested as predictors in their quantitative and binomial form, after being transformed using 
the median as the cut-off point. The best fitting multivariable model was assumed to be 
the one with the lower Akaike information criterion (AIC) and containing statistically 
significant predictors (p-value < 0.05). We also evaluated the effect of livestock ownership 
on the frequency of consumption of animal products by using a simple linear regression 
model. Statistical analyses were performed in SAS version 9.3 (SAS Institute, Cary, NC). 
 
Results  
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Demographic characteristics of participants 
A total of 262 surveys were completed, representing an approximately equal 
proportion of respondents from each of the four selected villages (n ~ 65 per village). The 
participation rate exceeded 99%. Participant characteristics by village are summarized in 
Table 1. The majority (78%) of the respondents were female. The mean (± SD) household 
size among all participants was 6.1 ± 3.2; the mean number of children per household 
was 2.5 ± 1.8, and the mean number of adults was 3.6 ± 2.3. All participants spoke 
Shangaan, followed by English (23%) and Sotho (15%). The highest education level 
completed was Grade 12 (matriculation) for 82 respondents (31%); the next highest 
proportion of respondents (27%) reported completing no education (n = 70). Only seven 
respondents (3%), three of whom were female, reported receiving training beyond 
secondary school, including tertiary education or a certificate program. Of those 
respondents who had completed Grade 12 (n = 89), 79% were female and the mean age 
was 30 ± 7.7. Seventy-nine percent of respondents reported receiving government 
assistance in the form of social grants (pension, child care, or disability).  
 
Table 1. Demographic characteristics of survey participants (n = 262) in 4 villages in the 
Mnisi study area, Mpumalanga Province, Republic of South Africa 
 Athol Gottenburg Thlavekisa Utha Total 
Sex 
Male, n (%)          
Female, n (%) 
 
17 (24)       55 
(76) 
 
12 (20)       49 
(80) 
 
16 (25)       48 
(75) 
 
12 (18)               
53 (82) 
 
57 (22) 
205 
(78) 
Age, mean (range), 
in years 
40.6 (19 – 
83) 
42.4 (18 – 
100) 
42.2 (18 – 
82) 
40.5 (19 – 
83) 
41.4 
Household size†, 
mean (SD) 
6.5 (3.7) 6 (2.9) 6.2 (3.3) 5.7 (2.9) 6.1 
(3.2) 
Head of 
household‡, n (%) 
51 (71) 43 (79) 44 (69) 41 (63) 179 
(68) 
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Unemployed, n (%) 58 (81) 40 (66) 45 (70) 47 (72) 190 
(73) 
Total surveyed, n 
(%) 
72 (27) 61 (23) 64 (24) 65 (25) 262 
†Total number of people living in the same dwelling space for at least 3 months and 
providing jointly for purposes of food 
‡Self-identification as the head of the household 
SD = standard deviation 
 
Domestic animal demography and health 
Domestic animal ownership statistics are described in Table 2. Seventy-two percent 
of all households surveyed reported owning at least one animal (n = 189). Sixty-eight 
percent of all households owned livestock species, including cattle, goats, pigs, or 
chickens; and 36% of all households included a dog or cat. Among the animal-owning 
households, the most frequently owned animals were chickens (76%), followed by dogs 
(42%), cattle (35%), goats (22%), cats (12%), pigs (7%), ducks (<1%), and pigeons 
(<1%). Respondents with no formal education were more likely to own animals (one-sided 
chi-square test, p = 0.0285). 
Livestock-owning participants were asked to identify the major health problems in their 
animals. Forty-nine percent described a condition in chickens characterized by swollen 
eyes, diarrhea, and sudden death. These clinical signs, used along with the Shangaan 
term “mzungu,” was consistent with Newcastle disease, a viral infection of domestic 
poultry caused by avian paramyxovirus type 1 that is endemic to parts of Africa (Ashraf 
et al., 2014). Other major health problems identified in livestock included ticks and tick-
borne diseases (11%), foot and mouth disease (FMD) (5%), rabies (1%), and lumpy skin 
disease (1%). With regard to preventive health, 42% of participants from livestock-owning 
households reported not administering or receiving vaccinations for their animals in the 
past 12 months. Cattle-owning participants (n = 66) were asked about health practices 
specific to cattle including the dipping or topical application of acaricides. With the 
exception of one individual, all participants reported that they dip their cattle for ticks. 
However, when asked how many times in the last month their cattle were dipped for ticks, 
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23 (35%) reported no dipping. Forty-three cattle-owning households (65%) reported that 
they use their own dip supplies. Using a five-point Likert scale, animal-owning participants 
(n = 189) were asked about their satisfaction with veterinary services in their communities; 
results are shown in Figure 3.  
 
Table 2. Frequency and proportion of households surveyed in the Mnisi study area, 
Mpumalanga Province, Republic of South Africa (n = 262) reporting domestic animal 
ownership, by species, and the summary statistics for number of animals per household  
Domestic animal 
ownership 
Frequency (%) Mean Median Maximum 
Own at least one species 189 (72)    
Livestock 177 (68)    
Chickens 144 (55) 13.4 12 40 
Cattle 66 (25) 12.4 7 78 
Goats 42 (16) 6.9 6 17 
Pigs 14 (5) 3.1 2.5 8 
Ducks† 1 (0.4) n/a n/a n/a 
Pigeons† 1 (0.4) n/a n/a n/a 
Companion 95 (36)    
Dogs 80 (31) 2 1.5 6 
Cats 23 (9) 2.3 2 5 
†Number of animals was not collected for households owning ducks and pigeons 
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Figure 3. Stacked chart illustrating the perceptions of veterinary services among animal-
owning survey participants in the Mnisi study area, Mpumalanga Province, Republic of 
South Africa (n = 189). †Pertains only to cattle-owning participants (n = 66) 
 
Satisfaction with human health services 
Participants were asked whether they or a member of their household had utilized a 
community health clinic in the past 12 months. For those who did access a clinic (n = 210, 
80%), individuals were asked whether they were satisfied with the quality of care they or 
the member of their household received. Ninety-four percent responded favorably. In 
addition, 85% of participants responded that they were satisfied with the accessibility of 
the clinic. The proportion of respondents who were satisfied with health clinic accessibility 
did vary by village (two-sided chi-square test, p = 0.0002). Those respondents who 
resided in villages without a community health clinic were more likely to be dissatisfied 
with clinic accessibility than respondents from villages with a clinic (24% vs. 6%). The 
primary barriers to health clinic access identified by respondents included cost of 
transportation to the clinic followed by being too ill/debilitated to travel. 
 
Human health and nutrition 
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Priority health problems for both adults and children, as perceived by the surveyed 
participants, are summarized in Table 3. “Flu” was the most commonly reported health 
problem for both children and adults; symptoms described included coughing, sneezing, 
runny nose, fever, and/or chills.  
Only 3% of participants (n = 9) reported a history of an illness linked to animals in 
either themselves or a household member. When asked to describe the illness, surveyed 
individuals reported internal parasites, tuberculosis, rabies, malaria, and pruritus/skin 
lesions. Participants were not asked to differentiate between Mycobacterium tuberculosis 
and Mycobacterium bovis. Eight percent (n = 22) reported a history of an illness linked to 
poor water quality; symptoms included diarrhea, vomiting, headaches, and swollen hands 
and feet.  
 
Table 3. Priority health problems in children and adults in the Mnisi study area, 
Mpumalanga Province, Republic of South Africa as identified by survey participants (n = 
262)  
Children (n) Adults (n) 
Flu† (215) Flu (93) 
Diarrhea (82) Hypertension (69) 
Chickenpox (35) Back/joint pain (68) 
Itchy scalp (19) HIV (62) 
Vomiting (11) Headaches (51) 
Fever (11) Diabetes (49) 
Wounds (9) Tuberculosis (43) 
Respiratory (coughing, asthma) 
(8) 
Diarrhea (17) 
Headaches (7) Cancer (13) 
†Participants used “flu” to describe an illness with coughing, sneezing, runny nose, fever, 
and/or chills. Etiology was not confirmed. 
 
All surveyed individuals were asked about their diets and frequency of consumption 
of selected food items. The most frequently consumed food item was pap, a traditional 
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ground maize porridge, eaten on average 13.3 ± 4.4 times per week. Bread was 
consumed 5.9 ± 2.9 times per week, followed by poultry at 4.1 ± 2.8 times per week, and 
eggs and fruit both consumed 3.1 ± 2.7 times per week. Less common sources of protein 
included fish, beef, goat, and wild animals (predominantly impala, duikers, and scrub 
hares). A small, yet statistically significant relationship existed between poultry and red 
meat (beef, goat, pork) consumption and the total number of chickens and cattle owned, 
respectively. Household poultry consumption increased 0.04 times per week for every 
increase by one in the number of chickens owned (p = 0.0244); more frequent red meat 
consumption in a household, defined as more than monthly, increased by 4% for every 
increase by one in the number of cattle owned (p = 0.037). A statistically significant 
relationship between consumption of eggs and milk did not exist between poultry and 
cattle ownership, respectively. 
 
Zoonotic disease knowledge and practices  
All participants were asked about their perception of disease transfer from animals to 
humans. Sixty-one percent of those surveyed thought that some diseases of animals 
could be passed to humans. For these participants, open responses regarding what 
diseases could be passed from animals to humans included: rabies, food-borne diseases, 
foot and mouth disease, Newcastle disease, skin conditions consisting of pruritus and 
alopecia, tuberculosis, influenza, chickenpox, and joint problems from a new “fast-
growing breed” of chickens; the most common response was “I don’t know.” The animal 
species of most concern with regard to disease transmission to humans was dogs (n = 
125), followed by cattle (n = 25), and cats (n = 11).  
Forty-eight percent of respondents thought that how you handle or prepare food 
products from animals could determine whether you got sick. Among those participants 
who reported owning milking animals, such as cattle or goats (n = 92), 36% drank the 
milk from their animals. Of those individuals, 24% preferred to drink their milk fresh (not 
boiled). For those participants who reported boiling their milk, their reasons for boiling 
included to “kill germs” and to “get rid of the smell.”  
Eighty-five percent (n = 224) of those surveyed believed that shared water sources 
among people, livestock, and wild animals could be a health risk. However, 118 (45%) of 
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individuals reported that they collect water for their household from places where animals 
are known to use the water. A similar proportion reported washing clothes where animals 
(domestic or wildlife) drink the water. There was not a statistically significant relationship 
between knowledge of potential health risks of shared water and water collection 
behaviors (two-sided chi-square test, p = 0.877). 
 
Environmental health  
Individuals were asked about their perception of drinking water reliability and safety 
using a five-point Likert scale. The percentage of respondents who perceived water 
reliability favorably differed by village (two-sided chi-square test, p = 0.0033). Utha 
community members perceived water reliability least favorably; Gottenburg residents 
perceived water reliability most favorably. Water safety was generally recognized as 
favorable across all villages with 117 (45%) responding “strongly agree” and 131 (50%) 
responding “agree.” 
All participants were asked about their utilization of disposable diapers. For those that 
had a young child in the household, 80% reported that they used disposable diapers. 
Among those individuals, the disposal methods included: burning (44%), throwing in pit 
toilet (22%), burying (21%), throwing in the bush (10%), and throwing in/around the river 
(6%). 
Firewood was used for cooking energy in 94% of households. The primary source of 
firewood was self-collection from the bush (96%). Forty percent (n = 106) of households 
reported using cattle manure for either fire or fertilizer. 
 
Wildlife (including rodents) and conservation 
Seventy-six percent (n = 198) of those surveyed reported seeing rodents in and 
around their home; of those, 62% reported daily observations, 27% reported observations 
1-6 times per week, and 9% reported monthly observations. Control techniques included 
rodenticides, glue traps, cats, beating with sticks, and chasing away. Significant risk 
factors for rodent sightings included high household size (defined as ≥ 6 persons per 
household) (OR = 2.742, 95% CI = 1.473 – 5.104, p = 0.0016) and chicken ownership 
(OR = 2.059, 95% CI = 1.113 – 3.811, p = 0.0217). Cat ownership was associated with a 
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decreased risk of rodent observations in and around the home (OR = 0.287, 95% CI = 
0.107 – 0.767, p = 0.0131) (Table 4). No interaction terms were found to be significant. 
Participants were asked about wildlife interactions with household members, domestic 
animals, and crops. Human-wildlife interactions were predominantly associated with 
hunting or with trapping/killing rodents. Livestock-wildlife interactions included shared or 
neighboring grazing areas with antelope species, buffalo, and wildebeest; predation of 
smaller livestock such as goats and calves by cheetah, hyenas, and lions; and snake 
bites on chickens. Companion animal-wildlife interactions included predation on rodents 
by cats and dogs used for hunting small mammals such as scrub hares and duikers. 
Thirty-eight percent (n = 99) of those surveyed reported wildlife contact with crops, 
predominantly by elephants (n = 24), rodents and hares (n = 21), baboons (n = 16), and 
birds (n = 13). 
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Table 4. Independent predictors, beta coefficients, odds ratios (OR) and 95% confidence intervals (CI) obtained for 
univariable and multivariable multilevel logistic regression model (with village as random effect) of domiciliary rodent 
observation (yes/no) in households within the Mnisi study area, Mpumalanga Province, Republic of South Africa 
Predictors (n)* β Univariable 
OR 
95% CI p-
value 
β Multivariable 
OR† 
95% CI p-
value 
X1‡. Household dwellers 
coded as 1 - ≥ 6 
(median) (136), 0 - < 6 
(126) 
0.9520 2.591 1.567 – 
5.031 
0.0015 1.0056 2.734 1.461 – 
5.114 
0.0018 
X6. Chicken ownership 
coded as 1 – yes (144), 
0 – no (118) 
0.6828 1.979 1.118 – 
3.505 
0.0191 0.7213 2.057 1.108 – 
3.818 
0.0224 
X8. Cat ownership   
coded as 1- yes (23), 0 
– no (239) 
-
0.7658 
0.465 0.191 – 
1.132 
0.0917 -
1.2427 
0.289 0.107 – 
0.777 
0.0141 
Fit statistics for 
multivariable model 
        
σj2 (SE)      0.1264 (0.1596)   
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AUC (ROC)      0.71   
*Number of observations in each class of the predictor variable 
†Final multivariable model included only those variables that were significant (p<0.2) in the univariable model and significant 
(p<0.05) in the multivariable model 
‡Variable X1 was tested both as continuous and binomial (0 = value < median; 1 = value ≥ median) variables to determine 
the best model fit 
Model fit statistics: σj2 = variance of the random effect; SE = standard error; AUC = area under curve; ROC = receiver 
operating characteristics 
 Seventy-four percent of participants agreed that diseases affecting wild animals 
could be transmitted to domestic animals; of the remaining, an equal proportion 
disagreed and responded, “I don’t know.” Participants’ perceptions of wildlife and 
neighboring conservation areas are shown in Figure 4. When asked about advantages 
of adjacent conservation areas, the primary responses included employment 
opportunities, recreation, wildlife conservation, protection from wildlife, educational 
opportunities, and donations. Disadvantages included wildlife damage to crops and 
predation of livestock, safety risks to community members, unfair employment 
practices, wildlife poaching/crime, and restricted access to natural resources such as 
grazing land and firewood. 
 
 
Figure 4. Stacked chart illustrating the perceptions of wildlife and conservation among 
survey participants in the Mnisi study area, Mpumalanga Province, Republic of South 
Africa (n = 262) 
 
Discussion 
This study describes a method by which to initiate integrated health research and 
planning at the community level that combines community engagement and the OH 
approach. The result is a comprehensive profile of animal and human demographics 
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and health priorities and a description of environmental practices including waste 
disposal, water collection as well as wildlife-domestic animal-human interactions. With 
regard to animal demography, 72% of all surveyed households reported owning at 
least one animal and 68% reported owning livestock. This proportion of livestock 
ownership is consistent with similar rural, resource-poor communities (Livestock in 
Development, 1999; Pica-Ciamarra et al., 2011). The majority of animal-owning 
respondents were satisfied with the availability and affordability of veterinary services 
within the community. In the Mnisi study area, there is no privatized animal health 
care. Veterinary care is made available through the state veterinary service and the 
UP-run Hluvukani Animal Health Clinic which provides clinical services at a subsidized 
rate as part of student training. Cattle-owning participants across all villages, however, 
revealed a distinct need for a better-functioning cattle plunge dip for the administration 
of acaricides to prevent the transmission of tick-borne diseases and injury produced 
by tick bites. In this region, tick-borne diseases of cattle, including babesiosis, 
anaplasmosis, and heartwater, are prevalent (Masika et al., 1997; Rikhotso et al., 
2005). The economic impact of ticks and tick-borne diseases is great and can be 
expressed in terms of mortality, production loss, cost of control, and, in some cases, 
movement restrictions of animals (Mbati et al., 2002). In addition, specific cattle ticks 
(Amblyomma hebraeum) can carry African tick bite fever, the most prevalent rickettsial 
disease in South Africa among humans (Frean et al., 2008). The Mnisi study area is 
in a FMD protection zone with vaccination, and the South African government 
(Mpumalanga Veterinary Services) mandates weekly inspection of cattle at registered 
facilities. At this inspection, cattle are typically exposed to an acaricide by plunge 
dipping, but sometimes pour-on treatment is used in the absence of a dip tank at the 
inspection point. Frequent dipping was introduced to prevent cattle losses from the 
buffalo-borne corridor disease (Theileria parva) which is transmitted mainly by the 
brown ear tick (Rhipicephalus appendiculatus), as well as to serve as an incentive for 
farmers to participate in the weekly inspections related to FMD control policy. 
However, due to government budget restraints affecting water supply infrastructure to 
plunge dip tanks and even villages in especially the dry season, weekly dipping 
frequency is sometimes interrupted. The survey revealed that one-third of cattle 
owners had not dipped their cattle for ticks in the past month. While the survey was 
conducted in the winter months when ticks are less prevalent, the dissatisfaction with 
cattle dip facilities is likely due, in part, to this lack of consistency in dipping frequency. 
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Prior studies in the area have shown that intensive acaricide application may be 
unnecessary and that a strategic regimen, one that considers relative tick abundance, 
may be effective in producing endemic stability of tick-borne diseases in communally-
grazed cattle (Rikhotso et al., 2005). If well-communicated, a strategic tick control 
regimen could be favored among farmers in the Mnisi study area due to some of the 
documented disadvantages of intensive cattle dipping, including physical injuries, 
stress, and labor costs (Rikhotso et al., 2005). 
Among the livestock-owning respondents, a disease of poultry consistent with 
Newcastle disease was the most prevalent health concern of food-producing animals 
described. Chickens are a valuable protein source for resource-poor South Africans 
as they are inexpensive to keep. However, given the free-range nature of chickens in 
this region, the risk of infectious disease outbreaks among poultry is high and difficult 
to control without proper interventions (Thekisoe et al., 2004). Newcastle disease is a 
viral disease, and although it is endemic to South Africa, poultry losses are largely 
preventable with proper vaccination (Thekisoe et al., 2004). Preventive health 
measures such as vaccination and segregation of sick animals could be effective tools 
in these communities. Improved poultry health could have significant implications for 
public health and nutrition given the reliance on eggs and poultry for protein in the 
Mnisi study area. 
This study identified a linkage between human nutrition and animal ownership. 
Households owning larger flocks of chickens and herds of cattle reported an increased 
consumption of poultry and red meat, respectively. The association between animal 
ownership and likelihood of consuming animal source foods has been previously 
demonstrated by Thumbi et al. (2015), albeit with egg and milk consumption. Our study 
did not show a statistically significant relationship between livestock ownership and 
egg or milk consumption. This finding may suggest a difference in dietary preferences 
or that these animal products are used in an alternative way, such as an income 
source. Although we identified an association between human nutrition and animal 
ownership, it is important to consider the possible confounding effect of household 
socioeconomic status, including non-livestock income sources, which we did not 
measure in our study and which may be positively associated with both animal 
ownership and household consumption of animal products (Thumbi et al., 2015). 
Future surveys in the study area should consider including household income as it is 
a possible explanatory or confounding variable. 
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This survey highlighted many opportunities to improve animal health education in 
this community, not only pertaining to animal diseases for the sake of improving 
production and perhaps livelihoods, but also for improving public health. Zoonotic 
diseases such as rabies, tuberculosis, and brucellosis continue to pose a threat to 
public health in many parts of South Africa, including the Mnisi study area (Marcotty 
et al., 2009; Conan et al., 2015). Few households reported a history of an illness that 
could be linked to animals; however, zoonoses are likely underdiagnosed and 
misinterpreted in this community (Quan et al., 2014). The perception by the survey 
respondents of malaria as a human disease linked to animals may indicate a 
misunderstanding of the zoonotic potential of malarial parasites and, thus, an 
opportunity for health education in this community. Additionally, in this study, one-
quarter of those who drank the milk from their own animals preferred to drink the milk 
fresh as opposed to boiling first. The handling and consumption of fresh milk can be a 
source of zoonotic tuberculosis and brucellosis (Marcotty et al., 2009). This health risk 
is preventable with proper education. Increased education about animal diseases was 
desired by 96% of animal-owning survey respondents. In this study, animal-owning 
individuals were more likely to have no formal education; thus, health education 
targeted towards animal-owning community members may be a sound approach to 
addressing critical infectious disease control points within the Mnisi study area.  
With some public health risks, such as the collection and household utilization of 
water from sources shared by domestic animals and wildlife, it was evident that 
knowledge of health risks was not sufficient to alter behavior. Therefore, it is likely that, 
with regard to this particular public health issue, there are other factors to consider, 
including availability of water by established taps or proximity to such taps. Participants 
from Gottenburg revealed the highest satisfaction with water reliability, therefore 
follow-up studies could evaluate location-specific factors affecting water supply. 
Prior to this survey, there was no knowledge on the frequency of utilization of 
disposable diapers or disposal practices. This study revealed that the majority of 
households with young children utilized disposable diapers and that nearly half of 
these households opted for burning the waste; however, throwing the waste in the 
bush or near the river was also described. Not only is the degradation process for 
disposable diapers slow, the contamination of waterways by human feces is a public 
health concern. As the frequency of these practices is likely to increase, future 
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research that focuses on evaluating water quality in relation to waste disposal may 
become a priority.  
With regard to satisfaction with available public health services, overall the 
respondents were very satisfied with the community health clinics; however, the 
survey revealed a statistically significant difference between those respondents 
residing in villages with a community health clinic versus those without a clinic. Those 
individuals from villages without a clinic who cannot afford transport or who are too ill 
to travel may not be able to access care. Despite the health services being provided 
by the government at no cost, if an individual cannot access the clinic, they are not 
able to benefit from the services. The survey revealed a need for enhanced 
transportation options or mobile health service delivery to improve access to 
disadvantaged members of the community. 
Due to the random selection of surveyed households and the high participation 
rate, results of this study are likely highly generalizable to other households within the 
four villages. However, it is probable to assume that our survey demographics likely 
over-represented unemployed, less educated household members. The survey 
included a skewed distribution of respondents by sex, education, and employment 
status. Surveys were conducted during the working hours of 8 a.m. – 5 p.m. on 
weekdays when most employed household members would not be available for 
questioning. In addition, it is likely that these individuals would be less aware of 
household practices pertaining to livestock care which are typically performed by 
males. Also, as this study relies on self-reported disease and health data, responses 
were subject to recall bias. Correlating these data with human and animal medical 
records would be one method by which to validate participant responses. Although the 
objective of the current study was largely descriptive of a single defined population, a 
lack of a comparison group may be considered a limitation. Follow-up studies should 
consider evaluating significant associations in additional communities. 
In this study, “flu” was described as a priority health problem in both children and 
adults. It is important to acknowledge that responses may have been influenced by 
the seasonality of data collection as all surveys were conducted during the winter 
months. Future studies could evaluate the effect of temporality on human and animal 
health priorities. Further, participants described flu symptoms and not necessarily a 
diagnosis of influenza. Participants used “flu” to describe illness with coughing, 
sneezing, runny nose, fever, and/or chills. Etiology was not confirmed. 
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Diagnostic capability at community clinics is limited, therefore, a targeted effort 
should be made to determine the etiology of observed human and animal illnesses 
and the concurrent collection of economic, social, and biological determinants of 
health that have proven to be significant in this study. Zoonoses are likely 
underdiagnosed, therefore, additional studies focused on quantifying the burden of 
zoonotic diseases in this population are warranted. 
Wildlife are an important potential reservoir for zoonoses, particularly peri-domestic 
wildlife such as rodents which were observed in three-quarters of all surveyed 
households. The observation of rodents around the home has been shown to be an 
independent risk factor for zoonotic diseases such as leptospirosis, regardless of 
direct contact (Sarkar et al., 2002). In the current study, household rodent sightings 
were frequent across all villages and significantly associated with increased household 
size and chicken ownership, presumably due to increased food availability and/or 
more suitable rodent habitat (i.e., poor external hygiene). Bonner et al. (2007) 
demonstrated that poor external hygiene may act as a risk factor for domiciliary rodent 
infestation and the transmission of rodent-borne zoonoses. Another possible 
explanation for the observed association between household size and rodent sightings 
is the increased likelihood of witnessing and reporting of rodent observations by 
household occupants to the adult survey respondent. The presence of a cat in the 
household significantly reduced the risk of household rodent sightings in our study. 
Endemic zoonoses such as leptospirosis can present with non-specific symptoms, 
thus posing a challenge to human and veterinary clinicians in resource-poor areas 
(Halliday et al., 2015). Thus, regionally-specific risk factors such as these may be very 
helpful in refining diagnostic and treatment algorithms, leading to improved disease 
management. 
Over 90% of study participants were in favor of the regulation of access to natural 
resources, including rangeland, wildlife, firewood, and water, indicating a strong sense 
of environmentally sustainable practices. In addition, the majority of participants 
believed the conservation areas played an important role in their community. 
Advantages of the adjacent conservation areas included economic (e.g., employment 
opportunities, donations) and non-economic (e.g., recreation, education, wildlife 
protection) factors. Prior studies involving communities adjacent to parks indicate that 
perceptions of biodiversity conservation are strongly related to locally-perceived 
benefits (Anthony, 2007; Vodouhê et al., 2010). Thus, an environmentally aware, 
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conservation-conscious community is more likely to arise from one that benefits from 
the activities directly. Despite this appreciation for wildlife conservation, most survey 
participants indicated a dislike for wildlife around their community and a perceived 
threat by wildlife to personal safety. Together, these results suggest a preference by 
the community for a dichotomous approach to wildlife management, one that 
separates wildlife from humans, as opposed to one that is more integrative. This 
paradox has been previously described in communities adjacent to Kruger National 
Park (Anthony, 2007). It must be added that perceptions regarding models for the 
potential integration of, for instance, livestock and wildlife, in parts of the landscape 
where it might be feasible, were not explicitly tested. These findings, however, 
demonstrate the complexity of the landscape and the need for a broad, social-
ecological approach to health.  
 
Conclusion 
In low-income countries, the linkages between livestock keeping and human health 
are complex and include both positive (e.g., animal source food availability) and 
negative (e.g., zoonotic and food-borne diseases) effects (Nicholson et al., 2003; 
Randolph et al., 2007). To improve health at the community level, the goal must be to 
maximize the positive linkages while minimizing the negative effects of the human-
animal connections. Future steps should include the identification of priority diseases 
in humans and domestic animals, the quantification of the burden of these diseases, 
and the identification of their risk factors. This type of detailed data which summarizes 
agricultural practices, food consumption and water-use habits, illness in animals and 
people, and access to health care can be used to tailor education efforts for priority 
diseases and pandemic prevention (Mazet et al., 2009). A healthier Mnisi community, 
part of a region delicately balancing on the fringe of the Great Limpopo TFCA of 
eastern South Africa, would provide benefits not only within the boundaries of the 
community but beyond the fences, potentially impacting health and conservation 
efforts in the regional network of protected areas.  
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